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5Executive Summary
For a long time, human odors and vapors have been known for their diagnostic power.
Therefore, the analysis of the metabolic composition of human breath and odors creates
the opportunity for a non-invasive tool for clinical diagnostics. Innovative analytical tech-
nologies to capture the metabolic profile of a patient’s breath are available, such as, for
instance, the ion mobility spectrometry coupled to a multicapilary collumn. However, we
are lacking automated systems to process, analyse and evaluate large clinical studies of
the human exhaled air. To fill this gap, a number of computational challenges need to be
addressed. For instance, breath studies generate large amounts of heterogeneous data that
requires automated preprocessing, peak-detection and identification as a basis for a so-
phisticated follow up analysis. In addition, generalizable statistical evaluation frameworks
for the detection of breath biomarker profiles that are robust enough to be employed in
routine clinical practice are necessary. In particular since breath metabolomics is suscep-
tible to specific confounding factors and background noise, similar to other clinical diag-
nostics technologies. Moreover, spesific manifestations of disease stages and progression,
may largely influence the breathomics profiles. To this end, this thesis will address these
challenges to move towards more automatization and generalization in clinical breath
research. In particular I present methods to support the search for biomarker profiles
that enable a non-invasive detection of diseases, treatment optimization and prognosis to
provide a new powerful tool for precision medicine.
Kurzzusammenfassung
Seit jeher ist bekannt, dass Ko¨rpergeruch und der Atem Hinweise zu deren Gesundheit-
szustand liefern ko¨nnen. Eine Analyse der Atemluft auf molekularer Ebene verspricht da-
her neue Ansa¨tze zur Diagnose spezifischer Krankheiten. Inovative Technologien wie die
Ionen Mobilitaets Spectrometrie in Kombination mit einer Multikapilarsa¨ule, erlauben
erstmals hochauflo¨sende metabolische Profile der Atemluft innerhalb ku¨rzester Zeit zu
erzeugen. Zur Zeit fehlen jedoch die notwendigen computergestu¨tzten Applikationen zur
automatischen Organisation und Auswertung der generierten Daten. Eine besondere Her-
rausforderung stellen dabei die großen Mengen heterogenener klinischer und analytischer
Daten und deren Verarbeitung. A¨hnlich wie andere Hochdurchsatzverfahren unterliegt
die Atemluft dem Einfluss von Hintergrundsignalen wie der Umgebungsluft oder Anderen
die Ergebnisse verzerrenden Faktoren, wie zum Beispiel Erna¨hrung, Lebensgewohnheiten
oder Medikation. Dies erfordert den Einsatz von modernen Methoden der Statistik und
des maschinellen Lernens, um robuste und generalisierbare Krankheitsmarker zu identi-
fizieren. Ein besonderer Augenmerk gilt hierbei auch Krankheiten deren metabolischer
Fingerabdruck sich im Krankheitsverlauf drastisch vera¨ndern ko¨nnen. Das Ziel meiner Ar-
beit ist es Lo¨sungen fuer die beschriebenen Probleme zu finden und damit die Suche nach
praxistauglichen Krankheitsmarkern mit bioinformatischen Methoden zu unterstu¨tzen.
Im Rahmen mehrerer Studien und Softwareprojekten wurden grundlegende Methodiken
vorgestellt, evaluiert und etabliert, insbesondere im Hinblick auf die Entwicklung comput-
ergestu¨tzter Systeme zur automatischen Analyse von Atemluftdaten. Die vorgestellten
Verfahren legen den Grundstein fu¨r die nicht invasive Detektion von Krankheiten, Opti-
mierung und Prognose von Behandlungen und daru¨ber hinnaus fu¨r ein weiteres Werkzeug
der personalisierten Medizin.
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Odors and vapors of the body and breath have been known for their diagnostic power
for millennia. More recent history confirmed this knowledge within clinical studies by
successfully training dogs and mice to detect diseases, by sniffing specific volatile organic
profiles. Like a vertebrate nose, there exist analytical technologies capable of capturing
such metabolites. The science of analyzing the aggregation of all metabolites within the
breath of an organism is called breathomics. The crucial task is to identify discriminating
patterns that are predictive for certain diseases. Additionally, like other diagnostic tech-
nologies, breath is influenced by various sources of systematic or random noise. The field
needs to move from separability to predictability by evolving from pilot studies to large
scale screening studies. Therefore, there is a necessity for further standardization and
automatization in managing, analyzing and evaluating this novel type of metabolomics
data. In order to achieve this, several challenges remain to be addressed: data accumu-
lation and heterogeneity; manual peak finding; unknown metabolites; robust statistics
and biomarkers; background noise and confounding factors; heterogeneous diseases and
disease stages; usability, maintainability, and re-usability.
In this thesis I will describe six projects that propose possible solutions to these challenges.
(1) The IMSDB is the first functional and flexible comprehensive breatomics database. It
provides flexible yet quick storage of heterogeneous clinical and large amounts of metabolic
breath data. (2) A pilot study lays the foundations for a more robust and adequate pre-
diction, evaluation and feature selection of breathomics data, by introducing established
machine learning techniques to the field of breath analysis. (3) Further, the thesis presents
the first qualitative analysis of the performance of automated peak detection methods and
thereby proves their ability to compete with the manual gold standard. (4) The MIMA
software tool enables the automated identification of the captured organic components
by mapping different analytical technologies. (5) The Carotta software system provides
a user friendly unsupervised learning platform, that enables easy discovery of hidden
structures in metabolomic breath data such as disease subtypes or confounding factors.
(6) Finally, I will introduce the first longitudinal modeling of breath metabolite behavior
during the course of an evolving disease.
In conclusion, the aggregation of these projects builds the foundation for a more robust
and standardized analysis schema, leading to more comparability and generalization of
future breathomics studies. Moreover, it sets the basis for automated frameworks in-
tegrating the described tools and approaches into steps of a continuous breath analysis
pipeline.
7
8
Acknowledgements
First, I would like to express my gratitude to my supervisors Prof. Jan Baumbach and
Prof. Volkhard Helms for their persistent support and guidance through out my thesis.
I dedicate special thanks to Prof. Jan Baumbach and Prof. Jo¨rg Ingo Baumbach for
giving me the possibility to work on such and interesting and motivating topic and for
involving me in many exiting projects. Further I want to thank them for their priceless
scientific guidance and inspiring discussions in the fields of breath analysis and computa-
tional biology. To Prof. Jan Baumbach I am deeply grateful for the constant motivation
and scientific advices and inspirations but also for creating such a fruitful research envi-
ronment allowing me to cultivate and follow my own ideas.
My gratitude and deep appreciation to all my collaboration partners, namely Prof. Sandy
P. Eckel at the Division of Biostatistics, University of Southern California (USC), Los An-
geles, United States, Prof. Sasha Kreuer, Tobias Fink and Felix Maurer at the Depart-
ment of Anesthesiology, Intensive Care, and Pain Therapy, Saarland University Medical
Center, Homburg (Saar), Germany, and Prof. Sven Rahmann, Marianna D’Addario and
Dr. Dominik Kopczynski at the Bioinformatics group at the technical university of Dort-
mund. Further I am very thankful for the fruitful collaborations with my Master and
Bachelor students Till Schneider, Tobias Frisch and Rune Sostack Clausen.
I would like to thank all of my colleagues in Germany and Denmark for all the discussions
and interesting conversations and for creating such a inspiring work environment. Thanks
to all the former colleagues at the Korean Institute of Science and Technology Kathrin
Eisinger, Sasidhar Maddula and Felix Maurer for the interesting discussions about breath
analysis and technologies behind it. Moreover, thanks to all the members of the Baum-
bach groups, in Saarbru¨cken, Josh, Peng, Rachid, and Richard as well as in Odense,
Anders, Christian, Diogo, Eudes, Lucas, Markus, Nicolas, Paolo, Richa, Richard, for all
the exiting discussions about computational and statistical challenges we were facing.
There are countless friends that supported me during the course of my career in Ger-
many and many that I made during my time in Denmark and I would like to name a
few, Juliane, Daniel and Charlotte, Peter, Thomas, Alejandro, Markus, Fabian, Verena,
Matthias, David and Elena, Marie-Pier, Manuela and Andre, Linda, Susanna, Sophia and
Pancho, Liza and Eliot. You made the time of my PhD a lovely and enjoyable experience
in my life even in stressful times.
9
10
A special thanks to all of you that motivated and supported me during the difficult time
of Thesis writing.
I would also like to thank my dear ex-husband Markus, your encouragement and constant
motivation that helped me through countless stressful moments throughout my PhD. I
am happy to call you my friend.
Most importantly, I would like to thank my parents, Johann and Anette who have self-
lessly supported me throughout my entire life. for their financial and invaluable moral
support. They gave me encouragement throughout my education even though they did
not not always agree with my decisions.
Contents
Executive Summary 5
Kurzzusammenfassung 5
Summary 7
Acknowledgements 9
Content 11
1 Introduction 15
1.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
1.2 Computational Challenges in Breathomics . . . . . . . . . . . . . . . . . . 17
1.3 Key Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
1.4 First Author Publications . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
1.5 Other Publications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
1.6 Overview and Structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2 Background and Related Work 27
2.1 Analytical Technologies . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.1.1 Ion Mobility Spectrometry . . . . . . . . . . . . . . . . . . . . . . 27
2.1.2 Gas Chromatography / Mass Spectrometry . . . . . . . . . . . . . 30
2.2 Preprocessing of Breath Data . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.2.1 RIP-detailing and Baseline Correction . . . . . . . . . . . . . . . . 32
2.2.2 Denoising and Smoothing . . . . . . . . . . . . . . . . . . . . . . . 32
2.2.3 Peak Detection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.2.4 Data Integration . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2.3 Data Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.4 Hypothesis Testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.5 Multivariate Machine Learning . . . . . . . . . . . . . . . . . . . . . . . . 39
2.5.1 Exploratory Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.5.2 Unsupervised Statistical Learning . . . . . . . . . . . . . . . . . . 41
2.5.3 Supervised Learning . . . . . . . . . . . . . . . . . . . . . . . . . . 45
2.6 Longitudinal Analysis and Mixture Models . . . . . . . . . . . . . . . . . 51
2.7 Validation and Permutation . . . . . . . . . . . . . . . . . . . . . . . . . . 52
11
12 CONTENTS
2.7.1 Traditional Conservative Validation . . . . . . . . . . . . . . . . . 53
2.7.2 Cross Validation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
2.7.3 Randomization and Permutation Tests . . . . . . . . . . . . . . . . 54
2.8 Overview of Related Work in Breathomics . . . . . . . . . . . . . . . . . . 54
2.8.1 Previous Breathomics Studies . . . . . . . . . . . . . . . . . . . . . 55
2.8.2 State of the Art Software Packages . . . . . . . . . . . . . . . . . . 56
3 Data Sets 59
3.1 COPD and Lung Cancer Data . . . . . . . . . . . . . . . . . . . . . . . . 59
3.2 GC/MS - MCC/IMS Comparison Data . . . . . . . . . . . . . . . . . . . 60
3.3 Anonymous Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
3.4 Artificial Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
3.5 Longitudinal Rat Breath Data . . . . . . . . . . . . . . . . . . . . . . . . 62
3.6 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
4 Clinical Breath Data Management 65
4.1 Requirements and State of the Art . . . . . . . . . . . . . . . . . . . . . . 66
4.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
4.2.1 Structure of MCC/IMS Data . . . . . . . . . . . . . . . . . . . . . 68
4.2.2 Structured Data Model . . . . . . . . . . . . . . . . . . . . . . . . 69
4.3 Implementation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
4.3.1 Validation and Integration . . . . . . . . . . . . . . . . . . . . . . . 72
4.3.2 Data Retrieval and Reorganization into data sets . . . . . . . . . . 72
4.4 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
4.4.1 Database Upload . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
4.4.2 Decision Tree Classification and Performance Evaluation . . . . . . 74
4.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
5 Towards Robust Machine Learning in Breathomics 77
5.1 Requirements and State of the Art . . . . . . . . . . . . . . . . . . . . . . 78
5.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
5.2.1 Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
5.2.2 Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
5.2.3 Preprocessing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
5.2.4 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
5.2.5 Statistical Analysis and Validation . . . . . . . . . . . . . . . . . . 81
5.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
5.4 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
6 Evaluating Automated Peak Detection 89
6.1 Requirements and State of the Art . . . . . . . . . . . . . . . . . . . . . . 90
6.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
6.2.1 Preprocessing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
6.2.2 Peak Detection and Postprocessing . . . . . . . . . . . . . . . . . . 92
6.2.3 Evaluation Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 93
6.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
CONTENTS 13
6.3.1 Peak Position Comparison . . . . . . . . . . . . . . . . . . . . . . . 95
6.3.2 Evaluation via Statistical Learning . . . . . . . . . . . . . . . . . . 96
6.4 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
7 Metabolite Identification with MIMA 101
7.1 Requirements and State of the Art . . . . . . . . . . . . . . . . . . . . . . 102
7.2 Implementation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
7.2.1 MCC/IMS - MCC/IMS Mapping . . . . . . . . . . . . . . . . . . . 103
7.2.2 MCC/IMS - GC/MS Mapping . . . . . . . . . . . . . . . . . . . . 103
7.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
7.4 Discussion and Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
8 Uncovering Hidden Structures with CAROTTA 109
8.1 Requirements and State of the Art . . . . . . . . . . . . . . . . . . . . . . 110
8.2 Structure and Implementation . . . . . . . . . . . . . . . . . . . . . . . . . 111
8.2.1 Visualization of Data and Results . . . . . . . . . . . . . . . . . . 113
8.2.2 Modularity and Extendibility . . . . . . . . . . . . . . . . . . . . . 115
8.2.3 Import and Export . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
8.2.4 Language and Packages . . . . . . . . . . . . . . . . . . . . . . . . 116
8.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
8.3.1 Results for Artificial Data Analysis . . . . . . . . . . . . . . . . . . 116
8.3.2 Results for COPD Data Analysis . . . . . . . . . . . . . . . . . . . 117
8.3.3 Comparison to Existing Software . . . . . . . . . . . . . . . . . . . 120
8.4 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
9 Longitudinal Breath Analysis 123
9.1 Requirements and State of the Art . . . . . . . . . . . . . . . . . . . . . . 124
9.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
9.2.1 Preprocessing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
9.2.2 Background Screening . . . . . . . . . . . . . . . . . . . . . . . . . 126
9.2.3 Model Selection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
9.2.4 Evaluation and Identification . . . . . . . . . . . . . . . . . . . . . 130
9.2.5 Implementation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
9.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
9.3.1 Peak Screening . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
9.3.2 Model Selection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
9.3.3 Model Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
9.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
9.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
10 Discussion and Conclusion 137
10.1 Data Accumulation and Heterogeneity . . . . . . . . . . . . . . . . . . . . 137
10.2 Robust and Generalizable Statistical Analysis and Evaluation . . . . . . . 138
10.3 Peak Detection Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
10.4 Unknown Metabolites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
10.5 Background Noise and Confounding Factors . . . . . . . . . . . . . . . . . 141
14 CONTENTS
10.6 Heterogeneous Diseases and Disease Stages . . . . . . . . . . . . . . . . . 142
10.7 Usability, Maintainability and Re-Usability . . . . . . . . . . . . . . . . . 142
11 Conclusion 145
12 Outlook 147
Bibliography 149
Acronyms 170
List of Figures 173
List of Tables 180
Appendices 183
A IMSDB 185
Chapter 1
1
1
1
1
0
0
0
0
0
1
1
1
1
0
0
0
0
1
1
1
0
0
1
Introduction
1.1 Motivation
Every organism emits a complex array of volatile and nonvolatile compounds which
are defined by an individuals genetics, lifestyle and health (233). The sum of volatile
organic compounds that are emitted by all living cells and tissues is called the vola-
tolom (105; 199). Already the Greek and Chinese medicine used human odors and vapors
for diagnostic purposes, for instance for diagnosing infectious diseases. In more recent
history, odors have been used for recognizing gas gangrene on the battlefield and diabetic
ketoacidosis in the emergency rooms (32).
However, over the last century, odors and vapors only played a minor role in clinical di-
agnostics. Contrarily, newly developed high throughput methods for Omics (Proteomics,
Metabolomics, Transcriptomics, Genomics) allow analyzing human blood, urine, other
body fluids or tissue samples and represent nowadays one of the most prominent ap-
proaches to detect diseases (27; 28). These innovations developed quickly and led to
comprehensive analyses of diseases not only on the cellular but even molecular level.
Nevertheless, many obstacles remain. Most of these techniques are either invasive and
therefore inconvenient for the patients, or show low sensitivity or specificity. In addition,
they are often expensive, difficult to interpret, or simply too time consuming for certain
fast progressing diseases, such as sepsis (84).
Over the last decade the evaluation of odors and vapors in human breath has regained
more and more attention, particularly in the diagnostics of pulmonary diseases. Its po-
tential has been validated in various studies, as analyzing the performance of canines or
rodents to scent lung or prostate cancer (74; 59). This indicates the existence of informa-
15
16 CHAPTER 1. INTRODUCTION
tive volatile excretions recognizable by these animals, implying that they are in principal
detectable by modern analytical techniques. Observations like these, initiated the novel
field of breathomics, defined as the metabolomics study of human exhaled air, which grows
tremendously. One of the major goals in the field is the development of technologies to
non-invasively “sniff biomarker molecules that are predictive for the biomedical fate of
individual patients. The integration of breathomics approaches into the so-called person-
alized or precision medicine offer great hope to extend the therapeutic windows to earlier
stages of disease progression and hopefully improve chances of survival and recovery.
Various analytical high-throughput and high-resolution technologies are now available,
that are capable of overcoming some of the obstacles occurring in the analysis of exhaled
air, as humidity or the variability of molecule density and composition. These advances
of modern analytical techniques, especially in chromatography and spectrometry, now
facilitates the replacement of human and animal senses with refined chemical measure-
ments (75). Currently, the major spectrometric techniques employed in breathomics
are gas chromatography/mass spectrometry (GC/MS) (141; 117; 158), sensor technol-
ogy, such as the electronic nose (55; 68), proton transfer reaction mass spectrometry
(PTR/MS) (25; 109) and multi capillary column coupled with an ion mobility spectrom-
eter (231; 103; 24; 230; 216). In principal, all these approaches allow for many possible
applications, especially in medicine (187; 20; 83) and biomedicine (147). They have been
shown to identify medically relevant patterns in the spectrum of exhaled substances as-
sociated with certain diseases or disease progression stages. Consequently, they have the
potential to enable early and fast diagnosis as well as therapy optimization.
MCC/IMS and GC/MS are two of the most widely used technologies for breathomics.
Currently, GC/MS is the most popular analytical technique in breathomics, mainly owed
to the availability of exhaustive mass profile databases that can be used for identification
of the detected compounds. Due to its novelty, comparable databases for MCC/IMS are
still in their infancies. However, there are a number of disadvantages of GC/MS in com-
parison to MCC/IMS, such as longer sample processing times (1–3 hours), equipment is
more expensive, and requires expert knowledge to operate. In contrast to this, the MC-
C/IMS has many advantages, such as the short sampling time (about 10 s) and sample
processing (about 5–10 min), as well as a robust and easy handling in every day practice.
These characteristics make it well suited for large-scale screening studies and disease or
drug monitoring (20; 83). Therefore, the majority of this work focuses on developing
bioinformatics methods for the MCC/IMS technology.
While the analytical issues in breathomics are mostly solved, one faces the traditional
biomarker research barrier: A lack of robustness and automatization in the sub-sequent
computational analysis hinders the translation to the world outside of scientific labora-
tories. The field is lacking the computational infrastructure and customized systems for
breath analysis. The required components comprise automated software for storage and
processing, as well as the establishment of state of the art statistical analysis and evalu-
ation for breathomics. The aim of this thesis is to develop bioinformatics methods and
tools for computational breath analysis, with the goal of moving from biomarker discovery
to validation, from separability to predictability, and from manual to automated analy-
sis. This combination of analytical technologies and computational approaches has the
potential to strongly contribute to the development of non-invasive biomedical decision
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making.
The long term vision is to pave the way for novel, breathomics based diagnostic tools to
complement the set of techniques for medical decision making which could revolutionize
every days’ clinical diagnostic procedures.
1.2 Computational Challenges in Breathomics
In order to achieve the transition from pilot studies to screening studies and, subsequently,
clinical practice, a number of challenges have to be addressed.
1. Data Accumulation and Heterogeneity
Similarly to other omics technologies like genomics and transcriptomics, data quan-
tity and complexity increases tremendously as experimentalists move from small
pilot studies to large clinical trials (170). Additionally, data management systems
need to adjust for the development of novel analytical instruments with increased
quality and/or resolution, furthering the data growth even more. For instance, the
change from PTR/MS to proton transfer reaction time of flight mass spectrometry
(PTR/TOF/MS) led to a 10-fold increase in the number of detected compounds
(ca. 200 to 2000) (144). This issue arises in particular in breath analysis applying
MCC/IMS, which is fast and easy to use in clinical practice, leading to a rapid
accumulation of huge amounts of data. Additionally, the data needs permanent
storage for future reanalysis with improved statistical methods. Therefore, the au-
tomatization of storage and analysis is a key challenge in the field.
In addition, the accumulated clinical data is becoming increasingly complex and
heterogeneous. Especially, the investigations of numerous diseases lead to a diverse
set of clinical parameters. Furthermore, we need to deal with an increased number
of studies dealing with time series data, and with the integration of various ana-
lytical techniques, such as GC/MS or PTR/MS. This fusion of information from
different sources further increases complexity of the data. Therefore, an efficient,
flexible, and robust data management system is needed as a basis to address the
described challenge.
2. Robust and Generalizable Statistics and Biomarkers
One of the major goals in breathomics is to identify the smallest subset of exhaled
compounds that can serve as potential biomarkers. Moreover, there is a necessity
for statistical methodologies to model breath data in order to find these biomarkers
and predict clinical outcomes, in diagnostics, and for the management of disease
and drug response. These computational models need to provide high quality (e.g.
high sensitivity as well as specificity), robustness against noise, and generalizability
from the training set to novel samples. The field of supervised learning offers a
variety of methods that serve this purpose. Previous studies focused on exploratory
data analysis approaches, such as hypothesis tests, principal component analysis or
linear or one dimensional relations evaluation to the clinical outcome.
These relatively simple inference statistics can distinguish between two groups with
respect to a present data set in many cases. However, without proper evaluation,
this does not allow for conclusions about the predictive power of a statistical model,
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and therefore the predictability of clinical outcomes and diagnosis in real applica-
tion might still be low. This holds true especially in pilot studies, when the number
of study participants (N) is small (e.g., N < 50 as in (31)) and the number of
compounds (p) is much larger than N (N << p as in (221; 85; 231; 103)). This
constellation leads to immense problems of robustness and generalizability due to
overfitting of the model, often referred to as the ”curse of dimensionality”. This can
result in both, an overestimation of the prediction performance and false positives
among the informative features, sometimes called ”Voodoo Biomarkers” (156). Es-
pecially, in circumstances where prediction models are trained and tested on the
same data set, the overfitted prediction models are not generalizable to the tar-
get population. Comparative investigations showed, that the combination of small
sample sizes and a lack of reliability in evaluation can lead to a lack of concordance
between studies, especially in terms of robust biomarker selection(173; 156).
A large body of bioinformatics and machine learning approaches solving the de-
scribed problems exists, but have not been adapted for breathomics data. There-
fore, more sophisticated and nonlinear statistical learning methods combined with
advanced evaluation techniques need to be adapted accordingly. The main objec-
tive here is a more robust estimation of the accuracy as well as a robust feature set
selection.
3. Manual Peak Finding
An important step in automatic high-throughput multi capillary column coupled
with an ion mobility spectrometer (MCC/IMS) data analysis is the preprocessing
and in particular the peak finding. Each so-called peak represents a specific molecule
in the sampled air (see Background Section 2.2.3). Such an automatic peak detec-
tion method should be at least as accurate as a human annotation, but fast enough
to cope with thousands of measurements. Several peak detection algorithms for MC-
C/IMS data have been proposed and described in the literature (180; 37; 49; 128).
However, they were generally evaluated using intrinsic quality measures, i.e. crite-
ria that can be derived from the data, such as goodness of fit, but have not been
evaluated quantitatively nor qualitatively in large scale in a real world breathomics
setting.This lack of qualitative and quantitative analysis prohibited a broad appli-
cation of those methods in the practice of clinical pilot studies. Consequently, a
proper evaluation of the existing peak detection algorithms is required in order to
identify the most effective approach and generally establish more confidence in this
automated methodology.
4. Unknown Metabolites
Although the MCC/IMS technology overcomes many practical problems in nowa-
days chase for biomedical markers, a remaining problem is to identify the molecular
compounds detected by the device. Knowing the identity allows for further research
of the metabolic pathways of the disease and further ensures the direct relation of
marker and disease. This can rule out false positive features that correspond to
confounding factors and increases the likelihood for an approval as clinical rele-
vant indicator. Other more established analytical technologies, such as GC are
combined with a mass spectrometer. This technology has been used for decades
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and therefore provides specific fragment profiles enabling the identification of com-
pounds using various commercial databases. The largest and most widely used
is the NIST/EPA/NIH mass spectral library, which was developed by the NIST
(NIST-library) containing several hundred thousand entries. In the past, most IMS
research was funded by the military and focused on detection of drugs and explo-
sives, and thus the actual component coordinates were therefore hardly published.
Furthermore, the resolution of single IMS often does not allow for the separation
of complex samples, such as human exhaled air (21). In contrast, the MCC/IMS
technology has been developed more recently and allows for a better separation
of the components. Thus, the MCC/IMS - molecule database consists of only a
few hundred entries so far and is therefore unable to identify a large portion of
compounds. Proper solutions to cope with this obstacle have to be found.
5. Background Noise and Confounding Factors
Even more than for other human excretions used for biomarker discovery the meta-
bolic patterns of the human exhaled air are influenced by various sources of dis-
turbance originating from genetics, environment, nutrition or variation of the back-
ground (36). Especially, environmental influences like toothpaste (185; 186), med-
ication (129) or disease variations (127), might give rise to hidden structures in
the data, unrelated to the question under consideration and heavily conceal the
important information. Furthermore, the previously described lack of reliable sta-
tistical evaluation of the data might lead to false positive biomarker candidates.
Therefore, guidelines for thorough study design, a detailed documentation and an
diligent processing and identification of confounders related metabolites is needed.
6. Heterogeneous Diseases and Disease Stages
The focus of current breathomics research relies solely on snapshots of certain dis-
eases. However, most diseases consist of various subtypes, depend on environmen-
tal influences or strongly evolve during their stages of development, e.g. cancer
subtypes (231), subtypes of pulmonary diseases (88), sepsis (176) or lateral sclero-
sis (239). This may lead to largely neglecting potential biomarkers whose relative
change over time is much more informative than a single observation. For instance,
a very recent study of Langley et al. suggests that this might be the case for sepsis
in primates (135). Additionally, in many circumstances, the metabolic background
of diseases is unknown and hidden sub classes largely influence the susceptibility to
medication. For this reason, advanced approaches uncovering so far unknown sub-
structures in the data are crucial and methods accounting and adapting to present
sub classes and evolving diseases are required.
7. Usability, Maintainability, and Re-usability
Besides functionality, three of the main requirements for breathomics software tools
especially for those developed for non-computer science experts, are usability, main-
tainability and re-usability. One of the main reasons for the tentative usage of
modern bioinformatics methods in breathomics is the fact that most of the various
software packages for more advanced analysis require expert knowledge in the area
of statistics and often even expertise in programming. Popular examples are graphi-
cal tools, like Weka (99) and RapidMiner (157), or statistical learning environments,
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like R (115). An application has a high usability if it meets the requirements of
providing an intuitive and easy to access graphical user interface for target users
and leads to a good overall user experience. Therefore, an adequate graphical in-
terface should provide intuitive menus and wizards, views and perspectives for data
visualization and an informative tutorial (204; 228). A system is maintainable, if
changes and extensions are integrated relatively easily. Another main factor is the
re-usability of software packages and the availability as open source software for
future projects and groups, as well as the ability to reuse previous studies, analysis
approaches, settings and results (144; 76).
In the following section, I will discuss the objectives and requirements to overcome the
previously described challenges.
1.3 Key Objectives
The previous section highlighted different challenges in computational analyses in breath-
omics: (1) the fast data accumulation and heterogeneous clinical data, (2) the lack of a
appropriate evaluation of peak detection algorithms, (3) the identification of unknown
metabolites, (4) robust statistics and reliable biomarkers, (5) the consideration of back-
ground perturbations and confounding factors, (6) the heterogeneity of diseases and (7)
the necessity of user-friendly software packages. In this section I will summarize the six
key objectives addressed in this thesis to overcome the described challenges and necessary
to support more automatization in MCC/IMS data assessment. Figure 1.1 depicts these
requirements in a mind map.
Clinical IMS Database To address the problem of fast growing amounts of increas-
ingly complex data in clinical studies, there is a necessity for a flexible and com-
prehensive centralized data repository, which is capable of gathering all kinds of re-
lated information. Additionally it requires an intuitive user interface that provides
easy and quick access to the platforms’ functionality: automated data integration
and integrity validation, versioning and roll-back strategies, data retrieval as well
as semi-automatic data mining and machine learning capabilities. Chapter 4 will
present the IMSDB a database for clinical IMS data aiming at this challenge.
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Summary:
Challenge Huge amounts of breathomics data and het-
erogeneous clinical factors.
Solution
Build a flexible and intuitive database man-
agement system, providing fast and easy ac-
cess to the data.
Supervised Learning To demonstrate the benefits of the application of sophisticated
statistical learning methods in breathomics a pilot study applying these techniques
to a breath data set is required as a proof of concept. Moreover, a robust and gener-
alizable model evaluation utilizing cross-validation ensures reliable performance and
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Figure 1.1: Key objectives of this thesis: (1) Clinical IMS Database; (2) Peak Detec-
tion Evaluation; (3) Metabolite Identification; (4) Supervised Learning; (5) Unsupervised
Learning; (6) Longitudinal Analysis.
feature importance estimations. The study presented in Chapter 5 will show a thor-
ough analysis of different linear and non-linear learning approaches on MCC/IMS
breath data.
Summary:
Challenge Missing reliable statistical analysis and mod-
eling.
Solution
Application of sophisticated statistical learn-
ing methods and robust and generalizable
evaluation.
Peak Detection Evaluation In order to overcome the common doubts in the quality
and reliability of automated peak detection, we require a thorough evaluation of the
peak detection methods. Chapter 6 describes a qualitative and quantitative analysis
of show the power and accuracy of those methods and compare it to a manually
generated gold standard.
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Summary:
Challenge Lack of trust in automated peak detection
methods.
Solution Reliable evaluation and comparison to a
manually curated data sets.
Metabolite Identification A simple solution to speeding up the time consuming metabo-
lite identification is the automated mapping of the results of parallel GC/MS and
MCC/IMS measurements. The MIMA software tool depicted in Chapter 7 solves
this issue.
MIMA
Summary:
Challenge Tedious and time consuming manual peak
identification.
Solution Automated mapping of GC/MS and MC-
C/IMS metabolite lists via MIMA.
Uncovering Hidden Structures The goal is to develop a user-friendly software tool-
box supporting unsupervised learning methods specifically designed to identify hid-
den subgroups and characterize human breath profiles. It requires a modular struc-
ture to enable extendability on the one hand and nested analysis on the other hand.
Particular emphasis lies on the visualization and export. The Carotta tool box is
presented in Chapter 8. It addresses the problem of hidden substructures as disease
subtypes and confounding metabolite clusters.
Summary:
Challenge Unknown confounding factors and hidden
structures.
Solution
Utilization of widespread unsupervised
learning methods on MCC/IMS data and
development of a user-friendly software
package.
Longitudinal Analysis The rapid analysis utilizing MCC/IMS technology nowadays
enables online monitoring (129). Therefore, future MCC/IMS studies require ma-
ture methods for longitudinal analysis. To establish such a sophisticated pipeline
is the major requirement of the final study in this thesis. Chapter 9 aims at the
challenge of proper modeling of the metabolite changes as well as identifying those
showing the most divergent intensity course between certain groups.
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Summary:
Challenge Focus on single time point assessment even
in longitudinal data sets.
Solution Establish advanced pipeline for longitudinal
breath analysis.
1.4 First Author Publications
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1.6 Overview and Structure
Chapter 1 In this Chapter, the motivation for this thesis is presented and the various
challenges are pointed out. It further gives a detailed description of the different
objectives and requirements of this project.
Chapter 2 This Chapter provides the reader with all basic definitions of the state of the
art methodology used in different steps of breathomics as well as more sophisticated
methods applied and adapted in this thesis. In the remainder, we describe data
managements systems, preprocessing, peak detection as well as statistical analysis
methods of the past and the future with respect to the usage in the breathomics
community. Large sections of this Chapter are inspired by two review papers I
contributed, Hauschild et al. 2012 and Smolinska et al. 2014 as well as other
methodological papers (106; 72; 195; 103; 107; 108).
Chapter 3 In this Chapter, the different data sets utilized in this thesis are intro-
duced (106; 152; 195; 107; 103).
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Chapter 4 The IMSDB is described in this Chapter. It is a newly developed database
for metabolomics data based on the MCC/IMS technology combined with sample
related data, for instance clinical anamnesis data or other treatment details in an-
imal experiments. This Chapter is written on the basis of the paper Schneider &
Hauschild et al. in 2013 (195).
Chapter 5 This Chapter presents a pilot study on robust machine learning techniques
used to discriminate patients suffering pulmonary diseases, namely chronical ob-
structive pulmonary disease, and bronchial carcinoma, from healthy volunteers. We
highlight the importance of the robust and generalizable evaluation of the perfor-
mance as well as the feature selection. The content of this Chapter originates from
the paper Hauschild et al. 2012 (103).
Chapter 6 A sophisticated evaluation of the previously developed peak detection ap-
proaches is presented. It shows how modern machine learning techniques and robust
performance assessment elucidate the strengths and weaknesses in comparison to
the common manual peak finding. The Chapter summarizes the study of Hauschild
et al. 2013 (107).
Chapter 7 The MIMA software toolkit is introduced in this Chapter. At first, it de-
scribes the manual standard procedure, of MCC/IMS peak picking and mapping
to GC/MS measurements. Secondly, the functionality and benefits of applying the
MIMA software will be shown with the aid of an example data set. The MIMA
paper has been published in 2014 (152) and is the basis of this Chapter.
Chapter 8 This Chapter presents the CAROTTA software for unsupervised learning
in breathomics data, published by Hauschild and Frisch et al. in 2015 (106). After
describing the particular challenges of confounding factors in breath data, the con-
cept of using unsupervised methods to tackle these issues and on a real world data
set is given.
Chapter 9 In this Chapter, the analysis of a longitudinal rat sepsis data utilizing linear
mixed effect models is described. At first a mature screening of the non-relevant
volatile metabolites is shown, followed by a description of the model selection and
the final model evaluation. The manuscript of this study is in preparation.
Chapter 10 Discussion and conclusion elaborates the powers and limitations of the
presented projects and studies. In comparison to the previous Chapters which
also contain a small discussion and conclusion, this Chapter focuses on the overall
context of the entire thesis and the challenges described previously.
Chapter 12 In the last Chapter, I will give an outlook on possible future developments
and suggest follow-up studies to overcome some of the limitations outlined in the
discussion Chapter.
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Chapter 2
Background and Related Work
2.1 Analytical Technologies
Likewise the field of breathomics, analytical technologies for adequate analysis of ex-
haled air are rapidly evolving. The most widely applied spectrometric methods are gas
chromatography/mass spectrometry (141; 117; 158), solid phase micro extraction/gas
chromatography coupled with mass spectrometry (SPME-GC/MS) (141; 140; 50), elec-
tronic noses (55; 68; 69), proton transfer reaction mass spectrometry (25; 109) and multi
capillary column coupled with an ion mobility spectrometer (171; 24; 19; 230; 216; 14).
Real time analysis systems like PTR-MS and MCC/IMS provide the huge advantage
making the pre-concentration step unnecessary (125). All of these technologies are non-
invasive and can for instance provide early and fast diagnosis or therapy monitoring and
can be used for the identification of disease-specific biomarkers (108). Due to the advan-
tages described previously, this work will focus on the analysis of GC/MS and MCC/IMS
technologies. They will be introduced in more detail in the following.
2.1.1 Ion Mobility Spectrometry
The ion mobility spectrometer (IMS) technology was developed in the early 1970s and
originally used for military applications (22; 110) and the detection of drugs or explosives,
e.g., at airports. In combination with a multi capillary column (MCC) it is a well-known
technology for detecting volatile organic compound (VOC) in air. The main analytical
advantages of the MCC/IMS technique are the ability to handle the moisture in exhaled
air and the high sensitivity (detection limit at nanograms to picograms per liter) compared
to other spectrometric techniques (e.g., GC/MS). The carrier gas guides the analytes into
a MCC, where the pre-separation takes place (20). After passing the column containing
approximately 1000 parallel capillaries with an inner diameter of 40 µm, they reach the
ionization chamber. Here, the analytes become chemically ionized by collisions with
the reactant ions, which are carrier gas molecules previously ionized by a radioactive
ionization source (usually 63Ni). An ion shutter opens cyclically, and the resulting ions
enter the drift region. Similarly, to an TOF -MS, described later, the ions gain energy
from an external electric field and are guided towards a Faraday-plate. Meanwhile the
27
28 CHAPTER 2. BACKGROUND AND RELATED WORK
time / s
vo
lu
m
e 
/
 L
fl
ow
 /
 m
L/
s
-20 -10 0
-2
00
0
-2
00
0
0
10
00
20
00
R
et
en
tio
n 
Ti
m
e 
(s
)
Inverse Ion Mobility (Vs/cm2)
Figure 2.1: Sample and data flow: BioScout device; corresponding CO2 profile; resulting
MCC/IMS chromatogram. The CO2 profile allows for precise analysis of air originating
from certain parts of the respiratory system. For instance, solely end tidal air. Pictures of
the BioScout device taken from the B&S Analytik website, http://www.bs-analytik.
de/.
so-called drift gas will flow in the opposite direction and prevent neutral molecules from
entering the drift region. During their flight, the ionized molecules collide with the neutral
drift gas molecules and are thereby separated by mass, shape and polarity. The signal
recorded by the Faraday plate is called ion mobility spectrum. The MCC/IMS technique
has a number of advantages in performance, costs and applicability compared to the
GC/MS. It has a low detection limit, measurements are inexpensive (<5 EUR) and fast
(<5 min), and it can handle the moisture that comes with exhaled air, which makes
it suitable for many medical (20; 187) and biomedical (147) applications as well as for
process analysis (19). The MCC/IMS BioScout device (188; 21) built by B&S Analytik
(Dortmund, Germany)1 is a commercialized version of the technology and particularly
designed for medical applications, see Figure 2.1.
An example of a MCC/IMS chromatogram recorded by the BioScout device is shown in
Figure 2.2. The Y axis corresponds to the retention time of the MCC and the X axis to the
reduced inverse ion mobility 1/K0. To describe the drift time independently of technical
properties like drift tube length, drift gas flow or electric field strength, a normalized unit,
called inverse reduced mobility (Vs/cm2), proportional to the drift time is used(209). The
signal height corresponds to the signal strength detected by the Faraday plate in the IMS
device (199).
Data Format The raw file yields 12, 500 data points per single IMS spectrum at high-
est resolution, which equals to a sample rate of 250 kHz. Let T be the set of possible
x-axis values (inverse reduced mobility or “drift times”) and R be the set of possible
y-axis values (“retention times”).
Omitting meta-information, e.g. device adjustment parameters, we obtain an |R| × |T |
matrix S = (S(r, t))r∈R,t∈T , which can be visualized as a heat map (Figure 2.2). A single
IMS spectrum corresponds to a row of the matrix, while a column of the matrix is called
contour line. The entire matrix is called IMS chromatogram (107).
A broader area of application led to new requirements in terms of tracking experimental
conditions which may influence not only the measurement itself, but also its interpreta-
1http://www.bs-analytik.de/
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Figure 2.2: An example of MCC/IMS chromatogram. The X-axis corresponds to the
reduced inverse ion mobility 1/K0 (Vs/cm
2) and it is proportional to the drift time (IMS),
while the Y-axis corresponds to the retention time r (MCC) which is proportional to the
substance’s affinity for the stationary phase. The colors reflect the signal height: the
yellow color for the highest signal and the white color the lowest [white < blue < purple
< red < yellow].
tion and give vital information for further data processing, such as the combined analysis
of data from different studies. Thus, a sophisticated uniform data format required the
storage of not only the data itself but also experimental and technical conditions. The
corresponding standard file format consists of a header and the data matrix. The header
comprises all sampling conditions such as general information, sample information, IMS
(device) information, external sampling control, and statistics. They also provide stan-
dard nomenclature rules and an extension that is dedicated to sensor-controlled sampling.
For details, please refer to supplementary material of Vautz et al. (214). An further ex-
tension of this file format allows cross-linking MCC/IMS data to GC/MS data suggested
by Maddula et al. (149).
Applications in Breath Analysis For decades, the application of ion mobility spec-
trometry was primarily focused on explosive and drug detection for the military and safety
industry (75; 11). However, recent developments enable an expansion to other fields,
such as forensics (119), food technology (120; 213; 217) and medicine (97; 172; 216; 230).
The previously mentioned combination to chromatographic technologies for preseparation
further increased in specificity of the device (214; 36; 20). Thereby, the MCC/IMS has
developed into an interesting non-invasive device for breath analysis in clinical diagnostic
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since it is portable, sensitive, fast and inexpensive (117; 171; 16). See Section 2.8 for a
comprehensive list of studies.
2.1.2 Gas Chromatography / Mass Spectrometry
The gas chromatography / mass spectrometry is one of the long-established analyical
technologies in metabolomics, and besides MCC/IMS most commonly applied to measure
volatile organic compounds in complex mixtures such as exhaled air (225; 158; 77). The
system is comprised of two components to first separate and subsequently identify the
different compounds in the sample, respectively. At first, the gas chromatographic column
separates the composition of molecules based on interactions with the mobile phase and
the stationary phase defined by the coating of the capillary column. These two phases
define the nature of the separation, for instance most commonly by molecular mass and
polarity of the compounds. Adjacently, the molecules enter the second component that
consists of an ionization source and a mass spectrometer (MS). Various methods are
available to ionize the molecules, such as electron ionization (EI) or chemical ionization
(CI) (64). During the most widely applied EI, the molecules are bombarded with free
electrons, causing a characteristic fragmentation pattern. Finally, the molecules enter the
so called time-of-flight (ToF)-MS which measures the time necessary to travel through
the electric field from the ionization source to a detector plate. The electric field transfers
the same kinetic energy (E = 12mv
2) to all ions. Based on their velocity which is related
to their mass, the ions with different mass-to-charge ratio (m/z values) are separated into
groups or packets (199). According to several studies, the GC-ToF-MS is sensitive, robust
and highly accurate method to analyze exhaled air samples (50; 77). It produces a specific
mass fingerprint for each ionized compound leading to a high level of reproducibility (50;
225). These can be matched to spectral libraries of manufacturer-supplied software or
huge libraries like the NIST-library2 containing more than 200,000 compounds. This
leads to a robust identification of compounds. Nevertheless, in contrast to the MCC/IMS
the analysis is time consuming and online measurements are unfeasible, which in certain
clinical application is mandatory.
2.2 Preprocessing of Breath Data
Both analytical techniques described before produce specific types of raw data. A proper
preprocessing of this data is crucial to obtain a reliable data matrix in order apply the
actual statistical analysis. Unreliable data will jeopardize the robustness and trustwor-
thiness of the results of the multivariate analysis (garbage in >> garbage out). Currently
many commercial and free tools and methods exist for preprocessing of MCC/IMS (35;
12; 49; 219; 128; 152) as well as GC/MS data (174; 143; 112; 111; ChromaTOF). Data
preprocessing includes on various sub-steps, such as denoising (smoothing), baseline cor-
rection, alignment across all samples, peak picking and combining of the peaks originating
from the same compound occurring in multiple samples. Finally, the peak areas matching
different compounds are collected and converted into a data matrix for statistical analysis.
In the following I will focus on preprocessing of MCC/IMS data.
2see http://webbook.nist.gov/chemistry/
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Figure 2.3: Example of a processing strategy of MCC/IMS data involving RIP-detailing
(Step 1) and denoising and baseline correction (Step 2), peak picking (Step 3).
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2.2.1 RIP-detailing and Baseline Correction
Every MCC/IMS chromatogram contains a characteristic structure named the RIP (199).
This structure can be considered as a source of disturbance in a measurement, and it ap-
pears in the shape of a broad vertical line in each chromatogram at an inverse mobility
of 1/K0=0.46 Vs/cm
2. The decreasing signal on the right side of the RIP is called RIP
tailing. To remove the influence of this disturbance, RIP-detailing or RIP compensation
approaches are applied as the first step of MCC/IMS data preprocessing (see Figure 2.2,
Step 1). Several methods have been proposed for this purpose. For instance, fitting a
log-normal function to the mean of all spectra and subtracted this function from each
spectrum in the chromatogram (12). Another approaches achieved RIP de-tailing by
subtracting the 25% quantile or 50% quantile (median) intensity determined for each
1/K0 value from each IMS spectrum in the data matrix (37; 49). The consecutive step
aims to improve the comparability of IMS chromatograms by correcting baseline. This
is done by subtracting the mean intensity of pure noise region from all measured spec-
tra (12). The noise region is chosen to be in the right or left upper corner of an MCC/IMS
chromatogram.
2.2.2 Denoising and Smoothing
Besides RIP-detailing and baseline correction, the improve of the signal to noise ratio
is a very important step of preprocessing. This is done by denoising and smoothing
(Step 2 in Figure 2.2). One of the first approaches performed a multi-resolution analysis,
which includes discrete wavelet transformations on different levels of resolution for both
denoising and smoothing (12). Subsequently, the original chromatogram is reconstructed
using the corresponding wavelet coefficients, which can be altered using hard and soft
thresholding. To smooth the data, the coefficients corresponding to the high frequency
regions are eliminated independently of the coefficient amplitude. Removing the low
amplitude coefficients regardless of frequency, results in denoising. The resulting IMS-
chromatogram is reduced by at least 75% of the original data with negligible loss of
information. A more recent approach proposed a pipeline of filters: At first, the median
filter is applied for denoising, followed by a Savitzky-Golay filter (49). The Savitzky-Golay
filter smooths the spectrum by computing a weighted average across a defined window of
data points (192). The final step smooths the data by using a two-dimensional Gaussian
blur (163).
2.2.3 Peak Detection
The peak detection is the last and third step of data pre-processing procedure. Several
automated strategies are available such as merged peak cluster localization (MPCL) (13),
growing interval merging (GIM) (12), and wavelet-based multiscale peak detection (WBMPD) (12),
water shed transformation (WST) (49) and peak model estimation (PME) (128). After
introducing the a general definition of a MCC/IMS peak, the most widely used approaches
for MCC/IMS peak detection and their key ideas are depicted.
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MCC/IMS Peak Definition
In each measurement, several regions with high signal values stand out; these regions
called peaks are defined by the position and the intensity of the local maxima in this
region. These parameters give information about a particular VOC and its concentration.
In the literature we may find several mathematical formalizations of what a peak is, e.g.,
a parametric model describing the shape with statistical functions (220; 128). In this
paper, we simply define a peak within one MCC/IMS measurement with three parameters:
retention time r, inverse reduced mobility t and signal intensity s. In other words, a peak
P is a triple P = (r, t, s).
Manual Peak Detection in VisualNow
The easiest and most intuitive way of peak detection is manual evaluation of a visual-
ization of the measurement. The human eye and visual cortex is optimized for pattern
recognition in 3D. Therefore one can immediately spot most of the peaks in the measure-
ment (see Figure 2.2 Step 3). The VisualNow software allows to visualize the measurement
and to pick regions that define a compound. While analyzing a whole set of measure-
ments, this procedure has to be done for each of them. There are several drawbacks of
this procedure. On the one hand it is time consuming and therefore inappropriate in a
high-throughput context, on the other hand the results depend on a subjective assess-
ment, and are therefore hardly reproducible. Nevertheless, it is still the state of the art
for the evaluation of smaller MCC/IMS data sets. Thus, the manual created peak lists
still remains the “gold standard” and is used in the majority of MCC/IMS studies.
Automated Local Maxima Search
This approach identifies local maxima, which is the simplest computer-aided way to iden-
tify peaks. Most of the more complex methods, such as the below described, use this as
initial procedure to find “seeds” for their algorithms. A point (r, t) is a local maximum
if all 8 neighbors in the matrix have a lower intensity than the intensity at (r, t). In
addition, we call the neighborhood of a point (r, t) “significant” if its own intensity, that
of its 8 neighbors, and that of A additional adjacent points, lie above a given threshold I.
Here, we use intensity threshold I = 10 and A = 2 additional points. The local maxima
search (LMS) reports all such local maxima that satisfy the “significant” neighborhood
condition for these values.
Merged Peak Cluster Localization
The merged peak cluster localization algorithm for MCC/IMS was first introduced by
Bader et al. (13). The MPCL consists of two phases: (1) clustering and (2) merging.
In the first phase, each data point in the chromatogram is assigned to one of the two
classes, either peak or non-peak. A clustering method similar to the traditional k-means
is used, based on the Euclidean distance metric of the intensity values. In the second
phase, neighboring data points that belong to the peak-label and therefore the same peak
are merged together. The simplicity of the method causes a few limitations such as the
distinction of two neighboring peaks, where the signal intensity of the overlap is above the
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peak-to-noise-threshold. Finally, each peak of the analyzed measurement is characterized
by the centroid point, i.e. that data point, which has the smallest mean distance to all
other points in the peak region (35). This approach is implemented in the commercial
software package VisualNow (B&S Analytik, Dortmund, Germany), for instance.
Water Shed Transformation
The WST approach for MCC/IMS peak detection mainly builds on the watershed al-
gorithm (219). The IMS chromatogram is treated like a landscape including hills and
valleys. The algorithm starts with a water level above the highest intensity followed by a
continuous lowering of the level while uncovering more and more of the local maxima. In
each step, the new uncovered data points are annotated by the label of adjacent labeled
neighbors. Those data points that remain unlabeled are identified as a new peak and
receive a new label. The highest data point among a set of new labeled positions defines
the peak coordinate. Finally, the algorithm stops if all data points are labeled or the level
drops below a defined threshold. An implementation of the of the WST for MCC/IMS
datais provided by the IPHEx tool, see Section 2.8.2.
Peak Model Estimation
At first, the PME method was designed to describe peaks with statistical mixture models
of parametric distributions. Later it proved to be a new opportunity for high quality peak
detection. The expectation maximization (EM) algorithm is the core of the algorithm and
is used to optimize the parameters of a mixture model from a given set of starting values.
The algorithm requires a given set of “seed” coordinates for each peak to be modeled.
In general, any of the previously described peak detection methods is suitable to provide
these initial ” seeds”. However, this implies that the quality of the results strongly depend
on the chosen seed-finding approach.
Utilizing the EM algorithm, each peak is described by a model function consisting of two
shifted inverse Gaussian distribution and an additional peak volume parameter. Finally,
the set of model functions plus a noise component describe the whole MCC/IMS measure-
ment. According to the authors, this approach uses continuous functions providing real
valued peak positions, which are more precise than the discrete results of the previous
methods, but also introduces an additional level of variance and noise.
The PeaX software published by Kopczinski et al. provides the only implementation of
this approach so far (128). It includes a seed-finding method described by Fong et al. (86),
which is based on finding roots in the first derivatives of both spectra and chromatograms.
For more details on PeaX tool, see Section 2.8.2.
2.2.4 Data Integration
Each peak detector produces a list of peaks for each measurement. However, the aim
is to create a matrix of peaks and measurements that provides the intensity of the cor-
responding peak which can than be interpreted as a list of feature vectors utilized for
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subsequent statistical analysis (following Sections). Therefore, two circumstances need to
be corrected for:
1. False separate peaks in a single measurement that are too close to each other to be
two different peaks in reality and should be merged to a single one instead;
2. A set of peaks that occur in different measurements at “slightly” different positions,
which we will refer to as “peak clusters” in the remainder of this paper.
The peak merging method described by Boedecker et al. (37) can be utilized to resolved
those issues. Initially, all peaks are sorted by descending intensity. Potential peaks P and
Q with s(P ) > s(Q) are merged (i.e. labelled P ) if the following conditions are satisfied:
|t(P )− t(Q)| < 0.003 and |r(P )− r(Q)| < 3.0 + r(P ) · 0.1. Note that this procedure only
needs to be applied to the automated peak detection results. The VisualNow software
package automatically applies the described algorithm directly on the resulting peak lists
of a set of measurements.
Similarly to GC-MS, the final product is a data matrix containing observations in rows.
The values in columns correspond to the relative amount of VOCs, i.e. their intensities.
The label of each column (i.e. VOC1, VOC2 etc.) represents a specific MCC/IMS coor-
dinate corresponding to a previously described peak cluster. Such general representation
of the data allows one to apply various machine learning techniques.
2.3 Data Management
In 2007, Lesniak developed the first schema to organize IMS data and a database pro-
totype (138). It categorizes the information into the following three different groups,
“Patient”, “Biological Elements” and “Measurement” that are converted to an Oracle
database schema. However, this preliminary study can only serve as a proof of concept,
since it solely provided a manual insertion of data via the Oracle database interface.
Moreover, the schema is fairly inflexible and not expandable as it is not able to store
arbitrary entities, attributes and values, as well as relations between entities, which is
beneficial to make the database adaptable to any kind of up-coming medical annotation
data (108).
A more recent study presented the Advanced Breath Analysis platform (ABA-Cloud),
also called ABA-Cloud (76). Its purpose is to document and store breath analysis stud-
ies to enable full automatic reproducibility. The studies are stored as Problem Solving
Environments (PSE) encapsulating algorithms and data using learning platforms such
as R (115), Octave (Eaton and Others) and Matlab (2). Each study is annotated and
searched by predefined attributes or keywords. Working with uploaded data requires
knowledge about the structure of the data and expert knowledge of the specific learning
platform.
In parallel the Automatic Analysis Framework (AAF) was developed. It stores breath-
omics data in cloud based Taverna activities and enables the user to reanalyze the data
automatically. The cloud based Taverna activities are provided for classification and
defines a easily extendable Taverna workflow for the automatic analysis. Moreover the
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usage of a modular evaluation procedure (k-fold cross validation) is provided to detect
overfitting (144). The usage of PSEs and Taverna, enables both frameworks to store
projects of arbitrary structure and content. However, this freedom leads to difficulties
when automated analysis of combinations of different projects in terms of data, and or
analysis and evaluation approaches and strategies are required.
Beyond the field of breath research, there are two areas overlapping with the proposed
database framework.
Metabolomics Databases The first field covers the advanced processing and analysis
of metabolomics and proteomics data, including software tools as MeltDB (160; 124) or
the free software library OpenMS (204). MeltDB 2.0 is a web-based software platform re-
sponsible for storage, sharing, standardization, integration and analysis of metabolomics
experiments (124). OpenMS is a software pipeline for automated analysis for mass spec-
trometric data. It is an open project and offers many additional analysis packages for
special fields, such as proteomics or metabolomics (204).
Clinical Databases The second field deals with the problem of adequate and flexible
data storage. Some of these solutions are commercial, for instance Oracle Clinical (Oracle
Corporation, Redwood City, USA) and others are non-commercial like TrialDB (41) or
SenseLab (159). These projects focus on the development of flexible clinical data repos-
itories. While TrialDB focuses on clinical trials and outcome data, SenseLab provides
various modules for multiple different areas such as Brain, Neuron or others.
2.4 Hypothesis Testing
Hypothesis testing is a technique of inferential statistics. Hypotheses are assumptions
that can be tested on the bases of a set of measurable random variables. A statistical
tests validates the so called null-hypothesis and controls the error (frequently called α-
error) of incorrectly rejecting it. Depending on the applied test, the so called p-value is
calculated and compared to the α-error. The null-hypothesis is rejected, if the p-value
is smaller than the α-error and proves the alternative hypothesis. However, accepting
the null-hypothesis (p-value > α-error) does not disprove the alternative hypothesis. In
contrast, the methods of decision theory discussed later treat both (null and alternative)
hypothesis and therefore equally (137).
Statistical tests can be categorized in different ways, depending on the type of hypoth-
esis or the type of data, see Figure 2.4. Parametric tests, for instance can be applied
to data sets following a known parameterized distribution, most frequently the normal
distribution. The knowledge about the structure of the data enables more powerful test
on the parameters of the distribution, for instance the mean or median. On the other
hand, if the structure or distribution of the data is unknown, non-parametric tests are
applied. Nominal random variables follow a non-parameterized nominal distribution and
are therefore require a special type of non-parametric tests. Furthermore, the type of test
depends on the number of compared groups or classes as well as whether the data is paired
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Unpaired-Tests
Paired-Tests
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Unpaired T-Test
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-Rank-Test
Mann-Whitney
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Statistical Hypothesis Tests Parametric
Left-, Right-Tailed,
or Two-Tailed-Test
Figure 2.4: The Figure depicts the categorization of statistical hypothesis tests and ex-
amples (70). The ”Nominal Distribution” column is a sub category of non-parametric
tests and characterizes a group of tests suited for binomial or other nominal random vari-
ables. Further sub categories exist, like equal variances of the compared data sets, but
are beyond the scope of this thesis.
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or unpaired. Paired data often results from consecutive measurements of a set of objects,
for example patients pre- and post-treatment. Unpaired tests are applied to evaluate the
difference between groups of objects, for instance comparing diseases or treatments. On
the bases of methodological reasons it is known that the intensities of molecules within
the MCC/IMS chromatogram are not following a normal distribution (220). Hence, MC-
C/IMS breathomics studies focus on the application of non-parametric tests. Most fre-
quently used are the Wilcoxon-signed-rank and Mann-Whitney-U test based on ranking
the samples of the two groups. They verify whether the samples are drawn from the same
distribution, more precisely, evaluating if one of two samples of independent observations
tends to have smaller values than the others. Section 2.8 briefly describes several studies
analyzing MCC/IMS data based on the Mann-Whitney U test.
Misinterpretation of P-Values
In typical biomedical research, however, the sole use of p-values to show the significance
of the finding is widespread. The p-value represents the likelihood of getting the observed
value of the test statistic by chance, falsely rejecting the null-hypothesis. However, de-
spite the clear definition, the inferential meaning of p-value is very often misinterpreted.
For instance, it does not carry information about the magnitude of the differences and a
non-significant p-value only indicates that the data is consistent with the null hypothesis.
Recall, accepting the null-hypothesis (p-value > α-error) does not disprove the alternative
hypothesis. More details on p-value misconceptions and explanations of the consequence
of improper understanding and interpretation, was described by Goodman (92). Addi-
tionally, Malley et al. (151) provides information about the restrictions of the p-values
usage in biomedical research. It clearly outlines that p-values have limited function as
a quality measures. Specifically, the paper underlines the common misinterpretation of
the p-value as a probability statement of the hypothesis being true. It does not give rele-
vant information on physiological processes and might be even completely uninformative
biologically.
Multiple Testing Correction
Moreover, correcting over several hundred of tests by e.g. Bonferroni or False Discov-
ery Rate (FDR) assumes that the separate p-values are independent and the relations
between one VOC and next are set to zero. However, data produced in breathomics
are frequently correlated as (often not considered) cascades of metabolic pathways and
biochemical reactions connect to the measured VOCs. The significant p-value does not
give the probability that repeating the experiment the same conclusion can be drawn.
Consequently, Malley et al. suggest utilizing more sophisticated techniques and focusing
on predicting the class (i.e. disease) of a given sample (i.e. patient) rather than on some-
thing that is merely significant. Obviously this is the case of machine learning techniques.
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2.5 Multivariate Machine Learning
Breathomics, which typically comprises metabolomics studies of exhaled air, generates
huge data sets where the number of compounds exceeds the number of samples. More-
over, co-linearity between measured variables exists. In many cases, breathomics data
is, to some extent, sparse, i.e. a compound is present only in e.g. 20%-30% of the
samples. These issues have to be taken into account while applying machine learning
techniques (45). Multivariate statistical methods offer practical means of maximizing in-
formation recovery from complex breathomics data. Machine learning provides a plethora
of methods to explore and understand complex data and thus obtain valuable information
on biological changes. The analysis might start with data exploration and discovery. This
part of the analysis is blind and unsupervised approach and thus gives an unbiased first
view on the data, but might neglect useful information. Therefore, a typically approach
continues with supervised analysis in which a priori knowledge of the data structure is
utilized.
2.5.1 Exploratory Analysis
The term explorative analysis summarizes methods to evaluate main characteristics of
a data set. Promoted by Tukey in the early sixties, it comprises measures like mean,
median and quantiles as well as graphical analysis utilizing histograms, box or scatter
plots, see Figure 2.5. Further, methods for variance analysis and multidimensional scaling,
described in the following, are categorized as exploratory approaches.
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Figure 2.5: Examples for histogram, box and scatter plot. (1) The histogram shows the
general distribution of the data and allows discover left or right shifts in the distribution.
(2) The box plot depicts the quantiles and Whiskers of the distribution. The inner quantile
range (IQR) is defined as the difference between the Q1 = 25% and Q3 = 75% quantiles.
Q2 is equal to the median. The upper and lower Whisker are the minimum and maximum
values of the data, except outliers are present. An outlier is a value that is smaller than
than Q1 − 1.5I˙QR or larger than Q3 + 1.5I˙QR. (3) The scatter plot depicts a relation
between two variables.
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Principal Component Analysis
One of the most widely spread exploratory analysis technique is the principal component
analysis (PCA). The aim is to select a small number of orthogonal principal components
(PCs) that explain the majority of the variation in the data (199). Therefore, the first
principal component chosen to be the direction of the largest possible variation in the
data. Each following PC is selected as the most varying orthogonal component (102).
Finally, the PCA results in two matrices known as scores and loadings, representing new
coordinates for the samples and the weights of the linear combination of original variables
to calculate the PCs, respectively. A score and a bi-plot plot can visualize the outcome
of PCA. While the score plot presents the relations (i.e. similarity) between all samples
in breathomics data, the bi-plot, depicts on the correlation between compounds and the
difference in relative abundance between clusters of samples. Although the method is
well suited to summarize the variation of high-dimensional data, it was not developed
to find a pattern of variables that best distinguish classes of objects. In real world
data, homogeneous groups of objects are might distributed along the directions of largest
variance due to certain biases in the data and hence show in one of the first PCs. However,
if the PCA does not show a class separation since the class information is not present in
the high variance directions, does not mean that the data does not contain the necessary
information (62).
In most breathomics studies, PCA is used for exploring variation and biases in the data.
Clearly, PCA is a reasonable choice for such purposes. However, it is known that the
outcome of PCA depends on the applied scaling and the potential presence of outliers (63).
Moreover, the usage for classification is not suited and mostly leads to miss interpretation
of the data. The reduction of multidimensional data within reason is suitable to remove
noise variables lacking any variance, however, by removing low variance features, actual
important information might be discarded.
Multi-Dimensional Scaling
The visualization of high dimensional data is a challenging and complex task. Carotta
integrates the so-called multi-dimensional scaling (MDS), a standard method for this
purpose. It aims to find an embedding from the pairwise representation to a space of
lower dimension, such that the distances are preserved (241). Given N different objects
z in a high dimensional space p, the objects will be arranged in the low dimensional
space p in such a way that the pairwise distances are most similar to original distances.
Therefore, the objective is to minimize the squared distance of all pairwise distances,
Equation (2.1) (132).
S(z1, z2, ..., zN ) =
∑
i 6=j
(||xi − xj || − ||zi − zj ||)2 (2.1)
The resulting 2-dimensional or 3-dimensional coordinates can now be visualized by a
scatter plot. In contrast to PCA, MDS aims to preserve the pairwise distances between
each of the two coordinates, influenced by all variables equally. Since these distances are
the bases for the clustering, the MDA is a more reasonable choice for this purpose.
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2.5.2 Unsupervised Statistical Learning
Unsupervised methods try to find hidden structures without incorporating external knowl-
edge. Essentially popular unsupervised methods to analyze multivariate data are clus-
tering algorithms (226). They identify groups (clusters) of data objects that are more
similar to each other than to objects from other groups (101). These methods are based
on similarity measures, for example determining multivariate distances such as Euclidean
distance or Pearson correlation, see Section 2.5.2. Besides subgrouping, clustering is often
used to reduce the amount of data. For instance, if the clusters are compact it may be
sufficient to use only a part of the original data by removing redundancy and choosing
representatives for each cluster (199). In other cases, the methods utilize to divide large
data sets into reasonable packages of subsets that subsequently can be analyzed sepa-
rately. The most common examples are hierarchical or k-means clustering, also referred
to as prototype based clustering methods. Recently, they found various applications in
breathomics studies (65; 203; 80; 52; 243).
More sophisticated clustering approaches are distribution-based (e.g. Gaussian Mixture
Models (102)), density-based (130) or graph-based clustering methods (Spectral or Transi-
tivity Clustering (146; 235)). A comprehensive study recently compared the performance
of biomedical clustering methods indicated that they might be more suitable for certain
data sets (236). Nevertheless, most of them require more in depth knowledge of the
principles of the methodologies and the structure of the data, to be able to chose the
right approach and correctly set the parameters. Thus, they have not been applied in
breathomics before.
The following sections first introduce two common distance/similarity measures com-
monly used in the context of clustering. Subsequently, it focuses on two common cluster-
ing algorithms, namely hierarchical agglomerative clustering and transitivity clustering
and discuss good practice and parameter. Finally, two common and adequate measures
of clustering quality are described.
Dissimilarity and Similarity Measures
(106): The pairwise relation of two data points is defined by a similarity or dissimilar-
ity function. For a data set including N samples, the set of all pairwise relations can
be calculated and stored into a N × N matrix. It is generally called similarity or dis-
tance matrix. Clustering approaches each depend on either the similarity or dissimilarity
matrix. However, there is an inverse relation ship between similarity and dissimilarity
and they can equally be converted into each other. A similarity matrix is converted
into a dissimilarity matrix as follows: The entries of the new matrix are defined as
d(x, y) = max(|S|) − |s(x, y)|, where S is the matrix containing the original similar-
ity and s(x, y) corresponds to the similarity of objects x and y. The similarity based on
the dissimilarity is defined accordingly: s(x, y) = max(|D|)−|d(x, y)|. A pairwise relation
r can be symmetrical r(x, y) = r(y, x) or asymmetrical r(x, y) 6= r(y, x) which will sub-
sequently result in a symmetrical or asymmetrical relation matrix. In this thesis we will
focus on relations that are symmetrical, namely the Pearson and Spearman Correlation
as well as the Euclidean distance.
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Pearson Correlation Coefficient The Pearson correlation coefficient (154) is a mea-
sure of linear correlation. It is varying between −1 and 1, where −1 is negative correlation,
0 is no correlation and 1 is positive correlation.
cor(x, y) =
n∑
i=1
(
Xi − X¯
) (
Yi − Y¯
)
√
n∑
i=1
(
Xi − X¯
)2√ n∑
i=1
(
Yi − Y¯
)2 (2.2)
Hence, two features {a, b} with the correlation of cor(a, b) = x have an equally strong
relation to each other than two features {c, d} with a correlation of cor(c, d) = −x.
Depending its purpose, a clustering analysis can favor positive, negative or both relations.
When used for clustering the general strength of the relation is of main interest and
therefore focuses on the absolute value of the correlation.
Spearman Correlation Coefficient A non-parametric version of the Pearson product-
moment correlation is the Spearman correlation coefficient. The corresponding value
estimates how well one variable can be described as a monotonic function of another
variable. Similar to the Pearson Correlation it varies between −1 and 1, where −1 is
negative correlation, 0 is no correlation and 1 is positive correlation. It is defined as the
Pearson correlation coefficient between the ranks of variables (202). Again, we focus on
the absolute value of the correlation.
Euclidean Distance The Euclidean distance (154) is the most commonly-used dissim-
ilarity measure. It is defined by the following equation:
d(x, y) =
√√√√ n∑
i=1
(xi − yi)2 (2.3)
The function is given by the Pythagorean theorem and is always greater than zero, besides
the two points being equal.
Hierarchical Agglomerative Clustering
Hierarchical clustering is one of the most widely-used clustering methods (101), that is
based on the distances between the objects. There are two basic approaches: agglomer-
ative and divisive, while this thesis focuses on the first. In contrast to the divisive “top
down” approach, the hierarchical agglomerative clustering (HAC) algorithm starts by
assigning every object to its own cluster. Subsequently, an iterative process merges the
most similar (smallest distance) clusters. The result is a hierarchical structure base on
a multivariate dissimilarity which can be represented as a tree, commonly called dendro-
gram. The choice of agglomeration or linkage method, defines the equations to recalculate
the distances between two clusters, each containing a set of objects of different coordi-
nates. Popular examples are the average- or complete-linkage specified as the average
or the maximum of all pairwise dissimilarities of all objects between the two clusters,
respectively. Various other linkage methods to recalculate the distances exist. The most
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common ones and the corresponding equations are described below (102). Given two
clusters X and Y :
Average-linkage: Uses the average distance of all objects between X and Y .
D = 1|X||Y |
∑
x∈X,y∈Y
d(x, y)
Complete-linkage: Determines the maximum of all pairwise distances between the two
clusters.
D = max
x∈X,y∈Y
d(x, y)
Single-linkage: Selection of the smallest pairwise distances, also known as “nearest
neighbor clustering”.
D = min
x∈X,y∈Y
d(x, y)
Ward-linkage: Given X¯, Y¯ the means of clusters X and Y . This distance minimizes
the variance within the clusters. Therefore, it yields in clusters with equal size.
D = d(X¯,Y¯ )1
|X|+
1
|Y |
Centroid-linkage: This method uses the distance between the centroids of both clus-
ters.
The choice of the linkage method largely influences the result of the clustering. For
instance, the single linkage approach is prone to wrongly merging close clusters, a phe-
nomenon called “chaining phenomenon” (116). A more stable result can be achieved
using the average or Ward-linkage approaches. However, they are biased to find spherical
group arrangements (184; 33). Therefore, a closer look on the resulting dendrogram is
indispensable to verify the ultimate result.
Transitivity Clustering
Transitivity clustering is based on the weighted transitive graph projection problem (234).
A given similarity matrix is interpreted as a weighted similarity graph and split into a cost
graph by removing edges with weights below a user-given threshold. Such a putatively
intransitive cost graph G = (E, V ) will be transformed into a transitive graph G′ by
adding and removing a minimal number of edges. In practice, the edge weights are taken
into account, yielding a cost function for edge modifications that is to be minimized.
In 2010, Wittkop et al. published an algorithm that tackles this NP-hard problem by
combining exact and heuristic algorithms (235). The threshold influences the number of
clusters, as the average similarity of objects within one cluster is above the threshold,
while the average similarity of the object from different clusters is below the threshold.
Consequently, a high threshold leads to many small clusters, while a low threshold has
few, but bigger clusters. The Transitivity Clustering software also provides a hierarchical
clustering mode.
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Application and Thresholds
Besides methodological delineation the main difference between the two approaches is the
real-world interpretation of the threshold. In hierarchical clustering, it corresponds to the
number of clusters. In contrast, in transitivity clustering, it corresponds to the similarity
value S, for which the average similarity of all objects from different clusters is smaller
than S (and the similarities between objects from the same cluster is higher than S , on
average). The selection of the clustering method depends on the purpose of the study
and the data sets at hand. Using hierarchical clustering usually appears beneficial if we
may assume (or guess) a certain number of clusters. In data sets with few or no outliers,
this might become problematic. If prior knowledge on a preferable similarity cutoff is
available, transitivity clustering will be more appropriate. It is more robust to outliers,
as it is independent of the number of clusters (i.e., outliers would end up as singletons).
However, the main disadvantage of both methods is that it does not deliver informa-
tion about the compounds which are responsible for the resulting clustering. A solution
is for instance provided by methods like co-clustering also referred to as bi-clustering.
This approach simultaneously clusters data in its rows and columns (samples and com-
pounds) (44; 150).
Quality Measures
Finally, clustering quality measures give evidence of how well the groups of objects are
separated by the clustering. This can be assessed by either internal or external criteria.
Internal criteria like the Silhouette value rely solely on the underlying data and favor
clusterings with high inner and low between cluster similarity. In contrast, external
indices for instance the F-Measure, compare the clustering result to a user-given gold
standard, i.e., the primary outcome variable.
Silhouette Value A prominent example for an internal quality measure is the silhou-
ette value (184). It evaluates how well an object fits into the associated cluster depending
on the paired dissimilarity to the objects within its cluster in contrast to the objects in
all other clusters. It is defined as follows:
S(i) =
bi − ai
max{ai, bi} (2.4)
Here, ai is defined as the average dissimilarity to all objects in the same cluster, while
bi is the dissimilarity to the so-called neighbor cluster, which is the cluster of the next
lowest average dissimilarity to i. The average of all object silhouette values is called the
overall silhouette value of a clustering. The value varies between one and minus one. If
all elements are well clustered, the result will be one.
F-measure Let K be the gold standard defining a known grouping of the objects.
The F-measure compares the clustering C to the gold standard, whereas ti,j denotes the
number of common elements of Ki, i ∈ {1, . . . ,m} and Cj , j ∈ 1, . . . , n. It is defined as
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follows:
F −measure(C,K) = 1∑m
i=1 |Ki|
m∑
i=1
(
|Ki| ∗ max
i≤j≤n
2 ∗ ti,j
|Cj |+ |Ki|
)
(2.5)
The final F-measure among all clusters is varying between 0 and 1. While 0 corresponds to
a poor overlap with the gold standard, 1 indicates a perfect match (168). This measure
gives an impression of the clustering performance with respect to a user-defined gold
standard. However, many biomedical data sets do not provide such a standard. In
our case, though, we may utilize the outcome variables (disease annotation and/or the
confounding factor annotations, respectively).
2.5.3 Supervised Learning
In contrast to unsupervised learning methods, supervised approaches aim is to infer a
qualitative (classification) or quantitative (regression) outcome variable. Therefore, a
priori knowledge for instance about diseases, treatments, other groupings within the
data or a continuous measures is required.
In general, supervised learning methods aim to find a relation or pattern between a matrix
of input variables or features (e.g. MCC/IMS peak intensities) and the outcome variable
(e.g. a disease or a treatment group). All of these algorithms follow one or both of the
two main goals:
 Optimal prediction of outcome variable
 Identification of important predictors
The goal is to find a pattern or set of rules within the predictor matrix that best predicts
the outcome variable, not only on the data used for training, but on a separate data set
not used for creating the model, the so called test data, see Section 2.7 for more details.
However, often it is just as important to know which minimal set of predictors or also
called features is most informative or predictive within the model. In practice it enables
reducing the number of features needed and hence time and costs to acquire them.
Nowadays, a wide range of linear and non-linear statistical learning approaches are avail-
able. In the following, I will introduce the ones utilized in my work and if applicable their
capability for feature selection.
Naive Bayes
The most widely tested and straightforward linear method for statistical induction is
known as the naive Bayesian classifier (134). In this method, each class is represented by
a single probabilistic summary. To minimize the probability of error in the classification
assignment, the state of action that maximizes the posterior probability is chosen each
time. This is calculated by the Bayesian formula simply from the prior probabilities
and the conditional densities. Despite its simplicity, the naive Bayes works quite well in
practice and outperforms far more sophisticated techniques. The reason for this is that
although bias can hurt the individual class density estimates, this might not influence
the posterior probabilities as much, especially near the decision (102). The naive Bayes
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Figure 2.6: Example for a linear classification using support vector machine. The blue
and yellow samples are separated by a SVM. The samples marked by a square are the so
called support vectors.
method was implemented using the R package NaiveBayes (227), using the standard
parameters with activated usekernel parameter (103).
Support Vector Machine
The aim of a support vector machine (SVM) is to find a hyper plane that perfectly splits
two classes while maximizing the thickness of the margins. This margin corresponds to
the distance of the plane to the closest data point from either class. Nevertheless, in most
real world examples, classes are overlapping. Therefore, the margin is maximized while
penalizing the points that lie on the wrong side of the margin. In contrast to other linear
methods, solely the points on the boundary or the wrong side of the margin support the
split and, therefore, called ” support vectors”, see Figure 2.6
Although the SVM is only suitable for two class classification problems, it is a very
powerful method. Dune to the support vector approach the solution can be sparse since
it is built on a limited number of samples, this reduces the variance (bias-variance-trade-
off) without increasing the bias, and hence to some extend prevents the model from
overfitting.
In practice, most implementation of the SVM provide multi-class classification by splitting
the data set into a set of two class problems. The single SVM without the usage of a
non-linear kernel belongs to the class of linear methods and therefore, also called ” linear
SVM”. However, in 1992, Boser et al. suggested the application of the kernel trick as
a solution to create non-linear SVM classifiers, for example by using the Gaussian radial
basis function (39). See Section 2.5.3 for more details on kernels and kernel methods.
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Figure 2.7: The figure on the left side depicts a DT and the separation of the data.
The figure to the right shows the corresponding explanation of the key values, class
distribution, the corresponding decision, and the percentage of the original data within
this node.
Decision Tree
The most straightforward non-linear methods are based on Decision Trees. An example
is the classification and regression tree (CART) method proposed by Breiman (43). The
goal of CART is to find exclusive regions in the data that contain homogeneous subsets
of the data (i.e. defined classes). The outcome of the CART is presented as a binary tree.
The tree is constructed by recursively dividing the samples from a parent node into two
child nodes. Each node is described by a simple, logical rule based on one compound,
see Figure 2.7. Note that, at each split, a different compound is used; nevertheless the
same compound may appear more than once in a single tree. The splitting continues
until the similarity of the samples within each node is the highest one or nodes contain
the minimum number of samples (this has to be specified by the user). The splitting
compounds intuitively serve as the most important set of features.
Random Forest
The strong tendency of decision tree to overfitting results in a large variance between
single trees on slightly different data sets. Therefore, the combination of ensemble trees
reduces the overall variance of the models and thereby significantly increases the per-
formance (199). The random forest (RF) method as proposed by Breiman (42) is a
very popular example. RF builds a large collection of de-correlated trees each on a ran-
domly selected subset of the original samples (called bootstrap aggregation (bagging))
and on randomly selected subsets of compounds (102). The error rate of the RF model
depends on two factors: firstly the correlation between trees and secondly the strength
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of the individual trees. Advanced ensemble tree approaches like RF seem simple and
easy to understand. However, they are based on solid mathematical theories and hence
outperform other methods on many data sets in terms of classification accuracy. An
additional advantage is that they provide comprehensible importance estimations for the
single features which allow for supervised dimension reduction and the direct abstrac-
tion of potential biomarker patterns (13; 231; 103). It is a non-parametric approach and
therefore, does not assume any particular distribution in the data. In addition, the RF
technique is more resistant to the different types of outliers and mislabeled samples and
thus leads to generalizable models. The main disadvantage of RF is computational time
on huge data sets.
Feature Importance: The random forest method provides two measures of impor-
tance, both dependent on the accuracy of the trees. The first, called Gini index, accumu-
lates the improvement in the split-criterion, while growing the trees for each variable and
corresponding splits. The second uses the left out samples (called out of the box sam-
ples, OOB) of each tree to measure the prediction strength of each variable; it is further
referred to as OOB randomization. See Hastie et al. (2009) for more details (102).
Kernel-Based Models
Another very common non-linear category of techniques are the so called kernel-based
models. Kernel-based models require transformation of the data via specific functions
called kernel. The key idea of kernel transformation is to map the non-linear problem
in the original data into a higher-dimensional feature space, corresponding to a repro-
ducing kernel Hilbert space (RKHS), in a manner that the problem becomes linear and
thereby easily solvable. The kernel function calculates the inner products of the original
compounds in the RKHS without the need of transforming the whole data set, which is
called the ” kernel trick” or kernel property. For more details, we refer to Hastie et al.
(102). By mapping the original data of size (m×p where m is the number of samples
and p is the number of compounds) into the feature space, a kernel matrix of size m x
m is obtained. The kernel matrix has to be positive semi-definite and likely there are
many kernel functions which fulfill this constraint. The simplest kernel function is the
dot product of the data matrix. This is linear kernel and thus is considered as linear
approach, see previous Section on Linear SVM.
A widely used non-linear kernel transformation is the radial basic function. This function
has one parameter to tune, i.e. the width of the Gaussian function. The combination of
SVM and the radial basis function is often called the radial SVM. In general, the kernel
methods have a strong discrimination power, but the results are highly depending on the
chosen kernel function. Furthermore, the combination with the support vector approach
results in a more robust and less variable model, however, to complex kernel functions
might still lead to overfitting of biased data selections (199).
The disadvantage of most kernel-based methods is the lag of information about the com-
pounds importance, due to the kernel transformation. Hence, a direct interpretation of
discriminatory compounds remains impossible. Nevertheless, a recent paper by Krooshof
et al. (131) proposed a solution by applying a procedure based on non-linear bi-plot. Ad-
ditionally, the general recursive stepwise forward feature selection or backwards feature
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elimination approaches can be applied (98). The ranking reflects the importance of the
compounds in the classification problem. However, the interpretation of highly non-linear
classification problems remains a bottleneck. Section 2.8 will list a number of publications
utilizing this techniques in MCC/IMS breath studies (198; 142; 16).
Artificial Neural Networks
In 2013, Amato et al. (9) pictured the growing importance of artificial neural networks
(ANN) in medical diagnostics. ANN is a two-stage regression or classification model
which is typically represented as a layered network of neurons. The first level of an ANN
contains an ”input” layer including a node for each input variable. The last level is the
the ”output” layer, containing k output units, on for each class in a k-class classification
problem. Between these levels a sets of novel features so called ” hidden” layers are
derived as linear combinations of the input variables. An activation function, which is
usually chosen to be the sigmoid 1/1 + e−v within each hidden node leads to a non-
linear model. The final ”output” layer combines these features to model the target label.
This creates a very powerful and flexible method to model non-linear problems. The
interpretation of the effects of a compound in such a model however, is challenging. The
most common ”vanilla” neural net contains only one hidden layer and is called the single
layer perceptron. Variants of this approach have been applied in various areas of breath
analysis, for instance for analyzing sensor array results (191), mass spectrometry data (8).
Performance Measures for Supervised Learning
Finally, all classification and regression results should be assessed by a set of key per-
formance criteria. A performance measure gives evidence of how well the groups are
predicted, or a continuous value is fitted by the model. The validation process of regres-
sion problems are primarily based on goodness of fit measures, analysis of the randomness
of residuals and especially the performance on a separate test set. The most commonly
used is the R squared or coefficient of determination (R2), which is 1 minus the fraction
of the residual sum of squares and the total sum of squares.
R2 = 1−
∑n
i=1(yi − fi)2∑n
i=1(yi − y¯)2
(2.6)
Residual analysis allows for closer evaluation of the structure of the error. It includes
graphical and analysis of the model structure using partial residual plots and assessment of
hypothesis on the distribution of the model, auto-correlation and homoscedasticity (169).
The classification model is assessed via a set of various different quality measures, starting
with the so called confusion matrix, Table 2.1 and 2.2. It contains the counts of all true
positives(TP), true negatives(TN), false positives(FP) and false negatives (FN) for a two
class classification problem Table 2.1. Respectively, it contains the truly and the various
forms of falsely classified samples for a multi-class classification Table 2.2. Table 2.3 lists
some of the most important performance measures for classification and their equations for
two and three class problems. The accuracy (ACC) is the most common measure simply
assessing the percentage of correctly classified samples. However, in various applications,
sensitivity (SEN) and specificity (SPE) are far more important and informative. For
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Table 2.1: Confusion Matrix for two class classification
Real Class
Positive Negative
Predicted Class
Positive True Positive (TP) False Negative (FN)
Negative False Positive (FP) True Negative (TN)
Table 2.2: Confusion Matrix for three class classification: TPX represents the number of
samples correctly predicted as class X, FX→Y samples of label X, wrong classified as class
Y, and TNX accounts for the true negatives, the sum of samples correctly not predicted
as class X, e.g. TNA = TPB + TPC + FB→C + FC→B .
Real Class
Class A Class B Class C
Predicted
Class
Class A TPA FB→A FC→A
FA = FB→A + FC→A
PA = TPA + FA
Class B FA→B TPB FC→B
FB = FA→B + FB→C
PB = TPB + FB
Class C FA→C FB→C TPC
FC = FA→C + FB→C
PC = TPC + FC
RA RB RC
instance, in clinical diagnostics for a lethal disease, the sensitivity will have a higher
weight than specificity. In contrast, when a treatment for a certain disease has severe
side effects, the specificity is of greater importance. Additionally, positive predictive
value (PPV) and negative predictive value (NPV) are very commonly used performance
measures in medical science.
The so called receiver operating characteristic (ROC) curve depicts the balance of true
positive rate (sensitivity) and false positive rate (1-specificity), see Figure 2.8. There-
fore, the area under the ROC curve (ROC) serves as another very important measure of
classification performance (78). Calculating the AUC for multi-class problems relies on
separating the problem into multiple two class classification problems and weighting it
by the class prevalence in the data:
AUCtotal =
∑
ci∈C
AUC(ci)p˙(ci) (2.7)
Here AUC(ci) is the area under the ROC curve for class ci. The overall complexity of
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Table 2.3: Selection of most important performance measures for the two and three class
classification problem: ACC, SEN, SPE, PPV and NPV.
Classification Performance
Performance Two - class Three - class
ACC ACC = TP+TNP+N ACC =
TA+TB+TC
RA+RB+RC
SEN Sen(A) = TP(TP+FP ) Sen(A) =
TPA
(TPA+FPA→B+FPA→C)
SPE Spe(A) = TN(TN+FP ) Spe(A) =
TNA
(TNA+FPB→A+FPC→A)
PPV PPV = TP(TP+FP ) PPV (A) =
TPA
(PA+)
NPV NPV = TN(TN+FN)
this approach is O(|C|nlogn). More complex calculations for the multi-class AUC exist,
but exceed the scope of this thesis. For an excellent introduction to ROC curves and
AUC calculation as well as multi-class AUC the reader is referred to Fawcett et al. (78)
and Hand et al. (100).
2.6 Longitudinal Analysis and Mixture Models
The combination of both, fixed and random effects in so-called mixed-effect models
(MEMs) is useful for a wide variety of applications. However it is a particularly well
suited technique to model longitudinal data (178; 133; 29). The MEMs are an extension
of the more general linear model (LM), which only contain fixed effects, representing
explanatory variables that are supposed to be not random, for instance the medication
while modeling the disease progression.
In contrast, random effects or variance components assume a hierarchy of different pop-
ulations within the data set. Consider the analysis of a group of persons undergoing a
certain treatment, the treatment and the time are expected to be non random. However,
each person has a specific ”population” of measurements following a specific distribution,
resulting in a random effect.
Various extensions of linear mixed models have been developed to better accommodate
more complex data sets. In the frame of the proposed project, we will evaluate the capabil-
ities of more advanced models such as non-linear extensions of MEMs (224), hierarchical
MEMs (201), or multivariate MEMs (211). The latter is particularly suited to account
for multiple variables evolving in parallel. Another category of methods that has been
developed in the last decade are multi-variate longitudinal classification methods rely on,
for instance, SVM. These are combined with various kernel methods like dynamic time
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Figure 2.8: Receiver operating characteristics curve represents the relation between Sensi-
tivity and 1-Specificity. The AUC is the area under this so called ROC curve. The shown
diagram was plotted utilizing the R package pROC and the public R data set example
aSAH.
warping kernels (167) or a hierarchical structure of multiple kernels (54; 242). Other
techniques combine the concept of mixed effects least squares models and SVM (145).
In contrast to the described supervised methods, a set of unsupervised approaches have
been developed, for instance various clustering techniques (51; 136).
2.7 Validation and Permutation
In most clinical diagnostics studies the main aim is to get a comprehensive and robust
description of the data and its predictive potential. Therefore, often multiple machine
learning techniques are applied, evaluated and compared. However, the benefit of apply-
ing multiple techniques depends on the underlying problem. Within a set of linear and
non-linear techniques, the more sophisticated non-linear approaches most likely deliver
the highest accuracy (e.g. SVM, kernel-methods, RF) but might be too complex for the
problem and prone to overfitting, or often lack interpretability. The goal is to compare
approaches and determine the most suitable one for the given data and the corresponding
implications (e.g. non-linear / linear). Several breathomics studies presented integrated
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systems, including several machine learning methods, for VOC-based supervised classifi-
cation into patient groups (175; 34).
As mentioned before, different techniques enable selecting the most informative attributes
in the data. Their quality relies on the quality of the selected model. Therefore, an ade-
quate validation is crucial to give certainty and robustness to the findings, in particularly
to the differences between studied classes and the selected classifying compounds. The
model performance and predictive ability can be assessed by the previously described
quality measures, see Section 2.5.3.
2.7.1 Traditional Conservative Validation
Commonly, in supervised analysis, the model is constructed using a training set and
subsequently verified with an independent test set. Moreover, an ideal data setting for
statistical learning provides a sufficiently large number of samples, such that the data
can be divided into training, validation and test set, also called three-way-split. The first
subset is used to train a classification model with various parameters. During the next
phase, each of the resulting models is ”validated” on the second subset. Finally, the pre-
diction power of the best performing model is assessed on the test set. The corresponding
parameters can be used to build the final model. The test error or performance repre-
sents the most conservative but also most robust estimator for the real error. Popular
algorithms for splitting the data are for example Kennard and Stone algorithm (123), Du-
plex technique (200) or random selection. Nevertheless, the ultimate manner of assessing
prediction ability of a statistical model is to use a set of newly acquired samples coming
from an independently sampled population. This ultimate validation should be generally
favored.
2.7.2 Cross Validation
In the breathomics field, however, the sizes of data sets are often too small to apply the
standard training-validation-test split. In those scenarios cross-validation (CV) is the
most commonly applied approach. The easiest approach is the so called leave-one-out
CV (LOO CV) in which the data set is divided into as many folds as the number of
samples. During an iterative process each sample is excluded from the data once. The
model is trained on the resulting set consisting of the remaining n-1 samples (n equals
the total number of samples) and tested on the excluded sample. Since each sample is
excluded once, the accuracy is evaluated on the predictions of all samples. LOO CV is
used when the number of available samples per class is low. However, the method has
certain drawbacks, for instance, it requires n iterations of training and test and has a
high variance if the prediction rule is unstable (73). A very common alternative is the
k-fold CV, where k defines the number of subsets the data is divided into. Each subset is
excluded once and used as a test set for a model trained on the remaining k − 1 subsets.
If the number of samples is not sufficient for a three-way-split, it is advised to apply
multiple cross validation runs, or a so called nested cross-validation (10). In contrast to
the LOOCV, the k-fold CV is more conservative and less variable. However, to generate
unbiased results it is crucial that all aspects of classifier training take place within the CV
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Figure 2.9: The Figure depicts the overview of the permutation tests procedure. The
upper path shows the estimation of the real accuracy. The second path depicts the
estimation of the distribution of random accuracies. Finally, it can be evaluated if a
value equal to the real accuracy can occur by chance.
loop. This includes feature selection as well as classifier type and parameter optimization.
Any violation of these rules can result in very biased estimates of the true error (212).
2.7.3 Randomization and Permutation Tests
Another approach to evaluate the robustness of a classification model is utilizing ran-
domization and permutation tests. The key idea is to assess whether a real grouping of
the data set is significantly better classified than a randomly assigned grouping (229; 91),
see Figure 2.9. Therefore, at first the classification performance of the model trained
on the real labels is evaluated. Subsequently, for the permutation test, real class labels
are randomly permuted and a new classification model is built predicting these random
classes and evaluating the random performance. A large number of repetitions of this step
produces a distribution of random performances. It is expected that the mean random
performance lies around 50%. However, many real world data sets allow complex statis-
tical learning methods to overfit. The assumption is that the prediction of the real labels
is in fact better than the random distribution. The Null-Hypothesis of the permutation
test is that the real label is drawn out of the random distribution. A rejection of the test
shows that the real prediction is significantly better than the random model (166).
2.8 Overview of Related Work in Breathomics
During the last decade, the advances and developments of various analytical high through-
put and high resolution technologies have expanded the fields of application especially in
breathomics. This enabled a large number of studies within the area of clinical breath
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diagnostics. In the following I will present a selection of studies and software tools that
are focusing on MCC/IMS and breathomics data analysis and therefore most relevant to
this thesis.
2.8.1 Previous Breathomics Studies
Statistical Tests and Correlation Analysis: Many studies applied statistical hypoth-
esis tests to differentiate various diseases or states traditionally from a set of healthy
controls. While the first pilot studies were failing to account for the multiple testing
problem, later conducted studies included Bonferroni or false discovery rate (FDR)
corrections. The main focus of studies lies on the characterization of pulmonary
diseases, differentiation between diseases or towards a healthy control group. For
instance, chronic obstructive pulmonary disease (COPD), lung or bronchial can-
cer (31; 23; 231; 30). In other studies, simple statistics were applied to evaluate
disease subtypes, for instance distinguishing COPD patients with and without al-
pha 1-antitrypsin deficiency (127).
Another study by Maddula et al. utilized correlation analysis of IMS data to detect
relations of infectious agents in the airways (148).
Unsuvervised Learning and Principal Component Analysis: Some breathomics
studies utilize unsupervised learning techniques such as clustering, but the majority
focuses on simpler methodology like PCA. For instance to evaluate the variation
of metabolic breath profiles within different disease groups, like smoking related
diseases such as COPD or lung cancer (232; 65).
However, more common and advanced are the statistical techniques utilized in
breathomics studies involving traditional analytical techniques like ESI-MS or sen-
sor based systems. Examples are the evaluation and discrimination of bacterial
cultures of various strains (243; 56) or differentiation of patients with untreated
pulmonary sarcoidosis from controls (69) applying PCA. More advanced studies
use combinations of PCA, factor or clustering analysis to identify potential VOC
biomarkers for lung cancer (52) or subphenotyping of COPD stages (80).
Supervised Learning and Classification: One of the first studies applying more ad-
vanced supervised learning methods on MCC/IMS breath data was conducted by
Baumbach et al. in 2007. The software framework IMS2 was utilizing multiple
advanced methods such as SVM, ANN and Naive Bayes classifier to predict lung
cancer (16). Another pilot studies focussed on decision trees or probabilistic rela-
tional learning for medical diagnostics (85; 231).
However, in contrast to the relatively novel MCC/IMS technology, the data anal-
ysis of traditional analytical techniques in breathomics has proven the potential
of breathomics data in combination with advanced statistical learning techniques.
For instance, techniques like linear discriminant analysis where utilized to identify
breath biomarkers for liver cirrhosis (60). The partial least squares discriminant
analysis (PLS-DA) showed great potential in metabolomics in general (206) and
was therefore applied to find early predictive signatures of asthma in children (199).
Another popular method are artificial neural networks which have been applied to
determine blood glucose levels (191) or identify patients with colorectal cancer (8).
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2.8.2 State of the Art Software Packages
MCC/IMS specific software
VOCan The commercial software package VOCan, is provided by B&S Analytik (Dort-
mund, Germany) the manufacturer of several MCC/IMS devices, such as, for in-
stance, the BioScout, specialized for the analysis of human exhaled air. It is oper-
ating the MCC/IMS devices, handling the raw data flow and formating it into the
previously introduced raw data Excel files.
VisualNow The commercial software package VisualNow, is also developed by B&S
Analytik. It is implemented in Java and is one of the state of the art software tools
to visualize the whole MCC/IMS chromatogram as well as single IMS spectra in
two- and three-dimensional plots. The acquired data of the MCC/IMS file includes
a set of parameters describing the measurements’, experimental setup, which are
displayed in a separate area (35). Additionally, it provides all essential preprocessing
methods like RIP-detailing, baseline correction, smoothing, as described previously,
as well as the ability to manually and automatically pick peaks in the chromatogram
based on algorithms developed by Bader in 2008 (12).
IPHEX The software package IPHEX (by A. Bunkowski, University Bielefeld, Germany)
also supports the visualization of MCC/IMS chromatograms, including single spec-
tra and total the ion current of the MCC as well as basic preprocessing. It further
implements a peak detection based on the watershed transformation (49; 219) as
described in Section 2.2. In contrast to the VisualNow, the IPHEX software tool
provides a feature to visually compare a MCC/IMS measurement with a GC/MS
measurement, by plotting the MCC and GC retention times next to each other. Un-
fortunately, due to the time dependent changes in temperature in the GC/MS the
alignment between GC and MCC is not trivial. In a recent presentation, Sanders
et al. proposed linear functions representing the relation, mainly focused on cer-
tain classes of compounds (189). However, a cross species mapping function would
most likely require a non-linear function that includes more information about the
molecule and its family (152).
PeaX PeaX is a command line tool for MCC/IMS raw data processing, developed at
the Technical University of Dortmund. It focuses on the detection and modeling
of peaks within the MCC/IMS raw data (128). It provides basic functionality in
preprocessing, such as RIP-detailing, denosing, baseline correction and smoothing.
However, its main purpose is the peak detection and peak modeling. Therefore, it
provides several algorithms for finding potential peak candidates, clustering peak
candidates and an expectation maximization algorithm to fit a mixed model for
each peak.
General Metabolomics, Breathomics and Clinical software
The selection of software products is restricted to the projects that are most relevant to
this thesis.
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ABA-Cloud The Advanced Breath Analysis platform documents and stores breath
analysis studies to enable full automatic reproducibility. It also enables to sub-
mit keyword-based queries in order to search for conducted studies at collaborating
research centers (76). See Section 2.3 for more details.
AAF Automatic Analysis Framework is a Taverna based project enabling the user to
reanalyze existing data automatically (144). See Section 2.3 for more details.
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Chapter 3
Data Sets
3.1 COPD and Lung Cancer Data
chronic obstructive pulmonary disease (COPD) is an umbrella term used to describe
chronic lung diseases that cause a permanent blockage of airflow from the lungs, which is
not fully reversible (WHO). The most prominent symptoms are breathlessness, a chronic
cough, and excessive sputum production. Airways and lungs react to noxious particles or
gases, like smoke from cigarettes or fuel, with an increased inflammatory response (GOL).
However, despite the similarities, the disease is not just a simple ”smoker’s cough”, but a
leading cause of morbidity and mortality worldwide which is still widely under-diagnosed.
The World Health Organization (WHO) reported it as one of the four most frequent causes
of death. In the period between 2000 and 2011 alone, the disease caused 5.8% of all deaths
worldwide (WHO). Estimates show that COPD will become the third leading cause by
2030.
Furthermore, Young et al. reported in 2009 that COPD is both a common and impor-
tant independent risk factor for lung cancer (240). The National Cancer Institute (NCI)
defined lung cancer as an “uncontrolled cell growth in lung tissue”. It usually occurs
in the cells lining the air passages mostly functioning as an air filter for dust and nox-
ious particles (NCI). The small cell lung cancer and non-small cell lung cancer are two
main subtypes (NCI). The survival rate of patients within five years is less than 20%
depending on the stage of the lung cancer. Modern diagnosis is based on the microscopic
visual analysis of the cells. However, despite the severity of the disease, the majority of
bronchial carcinoma is still detected randomly during routine examinations.
The MCC/IMS breath profiles of COPD patients as well as healthy volunteers was uti-
lized. The present data set was previously published by Westhoff et al. in 2011 (231) and
kindly provided by our collaboration partners at the Lung Hospital in Hemer, Germany.
The study comprised the exhaled air profiles of 42 COPD patients, 52 patients suffering
from both, COPD and bronchial barcinoma (BC), as well as 35 healthy controls. The
metabolomics analysis of the patients’ breath was done using an ion mobility spectrometer
coupled with a multi-capillary column, as described previously. An automated prepro-
cessing by VisualNow and an expert driven manual peak evaluation resulted in a set of
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120 volatile organic compounds. Each of the compounds present in at least three of the
patients’ measurements. All patients were recruited from cooperating German hospitals.
This data set is utilized in multiple Chapters, to demonstrate the potential of modern
computational tools in breathomics studies. In Chapter 4 it serves as an example data
set that is stored in the MCC/IMS database. Additionally, the data is analyzed by state
of the art supervised and unsupervised learning techniques in Chapters 5 and 8.
3.2 GC/MS - MCC/IMS Comparison Data
The following data set was specifically conducted to analyze and develop a methodological
procedure to combine and compare GC/MS and MCC/IMS measurements. The state of
the art manual comparison is tedious. Therefore, this data set serves as a prove of concept
for the MIMA tool presented in Chapter 7. It requires the parallel analysis of the same
mixture of chemicals using the two different technologies.
Chemicals To create such a data set, the following chemicals (purchased from Merck
(Darmstadt, Germany)) were utilized in this experiment:
 Trans-anethole (98%)
 2-heptanone (98%)
 2-nonanone (99%)
 undecanal (97%)
 R-(+)-limonene (96%)
 R-(-)-carvone (99%)
 (-) menthol (99%)
Preparation of MCC/IMS and GC/MS Reference Mixture Each reference sub-
stance (10 µL, menthol 10 mg) has been filled into a 2 mL reaction vial (CS-Chromatography
Service GmbH, Langerwehe, Germany) with a screw cap including a gas permeable mem-
brane. All 7 vials were placed together in a 250 mL Schott flask and incubated for 48
hours at room temperature. The flask was equipped with a two ports screw cap.
MCC/IMS Measurement Finally the samples were measured using a MCC/IMS
(Type BioScout, B&S Analytik, Dortmund, Germany). For more details on the adjusted
parameters see Table 1 in Maurer and Hauschildet al. 2014 (152). Ports of the Schott
flask were used for sample collection and simultaneous synthetic air injection to avoid
negative pressure. Synthetic air flow rates were adjusted to be equal to the sampling flow
rate.
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GC/MS Sample Collection The sampling is done by using TENAX tubes (GER-
STEL, Mlheim, Germany). The tube is connected on one side to the sampling pump
(Universal XR Pump Model PCXR8, SKC Inc., Pennsylvania, USA) and on the other to
the Schott flask with the reference mixture. A flow of 150 mL/min for 6 min is adjusted to
collect the sample. Ports of the Schott flask were used for sample collection and synthetic
air injection. Synthetic air flow rates were equal to the sampling flow rate.
GC/MS Measurement The measurement of the TENAX tubes was done using a
GC/MS (Agilent Technologies 6890N Network GC System/Agilent 5973 Network Mass
Selective Detector) coupled with a cooling trap CIS (GERSTEL, Mlheim, Germany).
The TENAX tubes are located in the thermo desorption auto sampler (TDSA2), which
is connected to the thermo desorption system TDS 2 (GERSTEL). For more details on
the parameter settings we refer to Table 2 in Maurer and Hauschildet al. 2014 (152).
3.3 Anonymous Data
To evaluate the quality of peak detection methods in Chapter 6, a comparison to the
gold standard which equals to the manual peak picking by a domain experts is required.
These specialists are familiar with the result of previous studies, as for instance COPD
studies. In order to achieve an unbiased list of peaks, independent of previous results,
this set of patients was recruited anonymously and based on a disease unknown to the
person conducting the manual analysis.
The data set contains 69 MCC/IMS measurements: 39 from patients suffering from a
certain disease and 30 healthy persons in a control group. Due to confidentiality reasons
on sensitive patient data, this work has no permission to give more details on the disease.
The single samples correspond to one of the two classes “healthy” or “not healthy”. This
scenario therefore requires the implementation of a a classifier distinguishing patients from
controls, to evaluate whether the MCC/IMS is a valid diagnostic tool for this disease and
subsequently to support a physician by proposing the most likely patients condition.
3.4 Artificial Data
The artificial data set is dedicated to demonstrate and clarify the capabilities of unsuper-
vised learning methods in general. It consists of 16 samples and 12 metabolites associated
with three metabolite groups. Each of these groups is related to one of the three prede-
fined labels of the samples: (1) “health” (values: healthy (five), disease Subtype 1 (five),
disease Subtype 2 (six)); (2) “smoking” (values: smoker (nine), non-smoker (seven)); (3)
“nutrition” (values: apple juice (four), tea (four), orange juice (four), coffee (four)). The
label “health” is our primary outcome variable, while “smoking” and “nutrition” shall
be considered as potential confounding factors. Tables 3.1, 3.2 and 3.3 show the corre-
sponding mean and standard deviations used to generate normal distributions from which
the artificial dataset was sampled. Note that these simulated data are highly idealized.
This serves the sole purpose of exemplifying and clarifying the use and functionality of
unsupervised learning methods. In contrast to a real world data set, this artificial data
62 CHAPTER 3. DATA SETS
set that provides a known outcome, serves as a prove of concept for the Carotta tool
presented in Chapter 8.
Metabolite Healthy Subtype 1 Subtype 2 Standard deviation
Metabolite 1 1 4 3 0.25
Metabolite 2 3 6 5 0.1
Metabolite 3 6 9 8 0.5
Metabolite 4 0 3 2 0.7
Table 3.1: Distribution of metabolite expression mean intensities and their variance (stan-
dard deviation) for artificial patients with class label “Health”.
Metabolite Orange Juice Apple Juice Tee Coffee Standard deviation
Metabolite 1 0 2 4 6 1
Metabolite 2 2 4 6 8 1
Metabolite 3 5 7 9 11 0.5
Metabolite 4 -1 1 3 5 0.75
Table 3.2: Distribution of metabolite expression mean intensities and their variance (stan-
dard deviation) for artificial patients with class label “Nutrition”.
Metabolite Non-Smoker Smoker Standard deviation
Metabolite 1 -1 5 1
Metabolite 2 1 7 1
Metabolite 3 2 8 2
Metabolite 4 -2 4 0.7
Table 3.3: Distribution of metabolite expression mean intensities and their variance (stan-
dard deviation) for artificial patients with class label “Smoking”.
3.5 Longitudinal Rat Breath Data
This data set is originating from a recent pilot study of Fink et al. (83) and was kindly
provided by our collaboration partners at the Department of Anesthesiology, Intensive
Care, and Pain Therapy, Saarland University Medical Center, Homburg (Saar), Germany.
All rat experiments were conducted with approval from the Animal Care & Use Commit-
tee (Landesamt fr Soziales, Gesundheit und Verbraucherschutz; Saarbru¨cken; Germany)
and in accordance with the German Animal Welfare Act.
The exhaled air of 40 Male Sprague-Dawley rats (obtained from Charles River, Sulzfeld,
Germany) was analysed. The rats were kept in the institutional animal facility under
controlled conditions and fasting for a period of 12 hours. Afterwards, they were anes-
thetized, connected to the respirator and ventilated with highly purified synthetic air.
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A measurement of the metabolite composition of their exhaled air was taken continu-
ously every 20 Minutes using the MCC/IMS technique during the whole period of the
experiment (maximal 12 hours). Subsequently, each rat underwent the surgical proce-
dure according to the randomly assigned treatment group. A detailed description of the
surgical procedures can be found in Fink et al. 2014 (83).
CLI Sepsis was induced using a standardized model of Cecal Ligation and Incision of
the cecum as previously described (83).
SHAM Sham-operated rats were treated likewise but without ligation and incision.
Prior to connecting the rats to the MCC/IMS device and the surgical treatment, the
background concentrations of volatile compounds from the respirator was measured for
one hour and two to three measurements each. The combination of the respirator and
corresponding rat measurements are further referred to as one experiment. A blood test
at roughly 300 minutes, confirmed the induced/not-induced sepsis.
Warming plate
VOCan
Mean Arterial 
Preasure
& Heart Rate
Medication
Surgical
Procedures
Synthetic Air
MCC/IMS
Respirator
Exhaled Air
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Air
Figure 3.1: Shows a schematic of the operational procedure utilized for the sham operation
or to induce sepsis.
See Fink et al. for more details (83). This data set is analyzed in Chapter 9. It is focusing
on the evaluation of longitudinal data, such as introduced in this section.
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3.6 Summary
The previously described data sets are utilized in one or several of the following method-
ological Chapters. Table 3.4 gives an overview of the data sets and in which Chapters
they are used.
Table 3.4: This table depicts which Chapters utilize the previously described data sets.
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Clinical Breath Data
Management
The IMSDB database framework was developed in a collaborative fashion dur-
ing the course of the Master thesis of Till Schneider. The author of this PhD
thesis was responsible for the conception and structure of the software project
and advised the work. This includes most of the software engineering as well as
the design of the database structure. The contribution of Till Schneider was the
implementation of the project.
The high-throughput character of MCC/IMS technology facilitates the application in
large-scale health care screening studies. However, the computational methods to process
MCC/IMS data are limited to a few preprocessing and analysis tools. While multiple
issues have to be addressed to achieve a rapid analysis, one of the major issues is the
efficient management of large amounts of MCC/IMS raw data as well as the increasingly
complex information gathered in clinical studies.
Therefore, there is a need for a centralized and flexible data repository, which is ca-
pable of gathering metabolic data, like MCC/IMS chromatograms or GC/MS spectra,
and heterogeneous biomedical data, e.g. patient records, in a well structured manner.
Furthermore, the database application should support the storage of constantly evolv-
ing object-attribute-data. Additionally, the solution should provide the foundation for
a statistical analysis and data mining. To achieve user accessibility and acceptance, we
require a self-explanatory user interface, including automated data integration, data in-
tegrity validation, data backup and retrieval, as well as a basic data mining toolkit.
In summary, we need an intuitive software system for storing and managing breathomics
and heterogeneous biomedical data that does not require any prior knowledge or technical
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skills (195). This Chapter will first identify common requirements of a clinical breath-
omics database and evaluate to what degree they are fulfilled by state of the art software
solutions. Subsequently, a detailed description of the structure and implementation of
the IMSDB is given. This novel comprehensive database application and analysis plat-
form combines metabolic maps with heterogeneous biomedical data in a well-structured
manner. The IMSDB was previously published in (195), which is the main source of this
Chapter.
Objective:
To build a flexible and intuitive system for breath
data management and analysis, providing quick and
easy access.
4.1 Requirements and State of the Art
A clinical breathomics database needs to combine the flexible management of medical
data (diseases, medication, age, gender, etc.) and the efficient storage of analytical data
(MCC/IMS, GC/MS) provided by physicians or biologists. Moreover, a set of major
functionalities described in the following paragraphs have to be fulfilled.
Flexibility and Heterogeneous Clinical Data The database is required to store
study-subject specific attributes, such as gender and age for human subjects or antibiotics
resistances for bacterial samples, respectively. Other examples are important environmen-
tal factors such as nutrition, medication or diseases. These parameters can differ between
various projects. Therefore, the system has to provide a flexible and generic data structure
to store arbitrary information without changing the internal database scheme. The major
drawback of most generic models is the performance loss under particular circumstances
due to higher model complexity. In particular, more complex and attribute-centric queries
perform worse (53). However, a proper balance between flexible and efficient modeling
combined with performant database queries can alleviate these drawbacks.
Raw Data To hold huge amounts of breathomics raw data, the developed system needs
a fast and robust storage system. All further processing and analysis approaches, such as
preprocessing and peak detection, rely on the ability to efficiently access the raw data.
Additionally, experimental conditions, such as the temperature, carrier or drift gas flow,
and settings of the electric field, are of particular interest. This information allows for
the evaluation of the impact of various technical parameters and their optimization with
respect to VOC based biomarker investigations.
Metabolites Another important issue includes the storage of extracted metabolomics
or breathomics information. As previously described, the MCC/IMS chromatogram has
three dimensions: (1) retention time (RT), (2) inverse ion mobility (1/K0) and (3) peak
intensity. Metabolites can be interpreted as local maxima in the peak intensity. Under
standardized conditions the coordinates RT and 1/K0 are specific for a particular VOC.
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The corresponding peaks are detected by a sequence of existing computational preprocess-
ing algorithms for RIP-detailing, denoising, smoothing and peak detection. See Section
2.2.3 for more details. The provided metabolite information can be utilized by machine
learning and statistical methods to identify potential biomarkers and to assess the quality
of the various preprocessing techniques.
Statistical Analysis As a proof of concept, the system should provide simple sta-
tistical methods for classification and feature selection. A clear understanding of the
detailed composition of the analyzed air is necessary to distinguish between disease spe-
cific biomarkers and compounds originating from confounding factors, such as nutrition
or life-style. Therefore, the system needs to analyze the relation of peaks to an outcome
variable selected from the available subject attributes.
Usability As described previously, the success of a software tool is highly dependent
on its usability. An intuitive graphical user interface guides the user through the process
of automated data integration, curation, backup and retrieval followed by data analysis
and presentation.
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Requirements:
⇒ Flexible data handling of heterogeneous and evolving
project attributes, such as clinical data and
biological experiments.
⇒ Efficient storage of MCC/IMS raw data.
⇒ Storage of metabolite information in a reasonable
way.
⇒ Functionality for simple statistical analysis and
feature selection.
⇒ Intuitive and user friendly graphical user interface for
data acquisition and storage.
State of the Art
The first automated systems for IMS data analysis was published in 2007 by Baum-
bach et al. (16). In the same year, Lesniak developed the first database scheme to orga-
nize MCC/IMS data (138). However, the presented approaches do not fulfill the above
requirements. The static database scheme of Lesniak is not able to store flexible entities,
attributes and values, as well as relations between entities, which is essential to make the
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database adaptable to any kind of biomedical data. The data analysis system of Baum-
bach et al. does not account for confounding factors, such as patient data.
A more recent study presented ABA-Cloud, a platform to document, store and re-analyse
entire breath studies. The encapsulation into PSEs does not enforce a general common
structure of breath data. Therefore, the integration and analysis of the data from differ-
ent studies is tedious and error prone.
Beyond the field of breath research, there are two areas overlapping with the proposed
database framework. The field of Omics-databases covers the advanced processing and
analysis of metabolomics and proteomics data, including software tools such as MeltDB
(160; 161) or the free software library OpenMS (204). The clinical-database field deals
with the problem of adequate and flexible clinical data repositories described in Section
2.3. None of these projects are able to include both heterogeneous biomedical data, and
metabolomic data. Moreover, they do not include data validation. Oracle Clinical and
TrialDB for instance, make use of the entity-attribute-value (EAV) design (159) described
later. Others use the more advanced EAV with classes and relationships (EAV/CR) ap-
proach like SenseLab (159). Those databases focus solely on the storage of heterogeneous
biomedical data. However, they are not able to handle metabolomic data and neglect the
validation of input data. See Section 2.3 for more details on the different systems.
For the IMSDB database framework, we aimed at combining the strengths of both re-
search fields, to create a powerful solution that can handle metabolic data together with
heterogeneous biomedical data.
4.2 Methods
In this Section, we first describe the data structure and information of the MCC/IMS data
followed by the data model of the IMSDB framework and details of the implementation.
Finally, I will introduce an unpublished extension of the IMSDB called ClinicalGUI, which
focuses on user friendly data acquisition.
4.2.1 Structure of MCC/IMS Data
Commonly, MCC/IMS measurements, detected peaks and heterogeneous object data, are
stored in a set of well-defined file types. The MCC/IMS related file types are generated by
VisualNow, the firmware of the BioScout device (B&S Analytik, Dortmund, Germany),
as described in Section 2.8.2 of the background Chapter. The most important file types
are explained in the following.
IMS Measurement File The raw data is a comma separated text file that comprises
experimental and technical information as well as the raw spectra measured by an MC-
C/IMS instrument. The file format is described in (214). In the following, we do not
distinguish between MCC/IMS measurement files and MCC/IMS measurements, assum-
ing that the meaning can be deduced from the context.
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PeakAn File This file follows the Microsoft Excel xls format and contains information
about a particular peak region retrieved from a set of MCC/IMS measurements. A peak
region can be represented as a rectangle or ellipse defined by two corners describing the
bounding rectangle MCC/IMS coordinates. Recall that each MCC/IMS coordinate is
defined by RT and 1/K0. Ideally, all detected peaks within this defined peak region cor-
respond to a particular molecular compound. The PeakAn file comprises the maximum
signal intensity in the peak region and the corresponding MCC/IMS coordinate for each
measurement.
Object-Attribute-Table A manually generated Microsoft Excel spreadsheet that pro-
vides heterogeneous attributes of objects (synonymous to patient) obtained during the
examination at a specific time point. Each examination of an object is referred to as an
object case. It is denoted by a row in the table. The columns comprise distinct attribute
names and the data type of the attribute values. In order to identify an object case, an
ID attribute corresponding to the sample ID in the IMS measurement is included in the
first column. The name of the corresponding MCC/IMS measurement is given in column
imsfile. A class attribute denotes the hospital or institution the object/patient belongs
to. An example for an object-attribute-table is given in Table 4.1.
Table 4.1: This table illustrates the structure of the object-attribute-table format. The
first two rows comprise identifying attribute names and the corresponding data types.
id class imsfile attribute1 attribute2 ...
string string string boolean date ...
304856 hospital patient file1 ims.csv yes 01.01.2011 ...
305082 hospital patient file2 ims.csv no 01.01.2012 ...
... ... ... ... ... ...
4.2.2 Structured Data Model
The data model can be divided into three main components, namely the MCC/IMS mea-
surement, the generalized data structure and the peak component, which are described
in detail in the following. The connected components model, the relations between MC-
C/IMS measurements, peaks and object cases are shown in Figure 4.1.
1) Measurement component: It contains entities related to the MCC/IMS measure-
ments: ImsMetaData, ImsRawData, and Alignment, see Figure 4.1. The first represents
experimental conditions including all technical parameters selected for the experiment
and stored in the measurement file. ImsRawData comprises the MCC/IMS measurement
file. Due to environmental and instrumental variations such as ambient temperature or
pressure, MCC/IMS chromatograms can be slightly shifted. Therefore, the Alignment
refers to parameters of a linear transformation for each measurement.
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Figure 4.1: Overview of the three main database components and their relations. The
central core entities of each component are linked directly. Auxiliary entities of generalized
data structure and peak component can be found in the next paragraph. Associations
and maximum cardinalities (one or many) are represented as solid lines labeled with
characters 1, N, M.
2) Generalized data structure component: It models objects with arbitrary at-
tributes and is also referred to as ontology component. In addition, the concept of re-
lations allows for relationships between any two objects. See Baumbach et al. 2009 for
related work (17; 18). The ontology component is similar to an entity-attribute-value
(EAV) model for the organization of heterogeneous data, described in (159). Its main
function in this work is to model sparse object data retrieved from an Object-Attribute-
Table ensuring the flexibility of the system. New projects will require to store entirely
different sets of attributes and parameters. In contrast to conservative database schemes,
an EAV organization offers a general storage of attributes and values and does not require
any changes in the database structure. Figure 4.2 shows the participating entities and
relationships.
The central Concept entity represents an object, such as, for instance a patient case
referring to a row of the Object-Attribute-Table (Table 4.1). Many-to-many associations
between Concept and value entities (ValueBoolean, ValueDate, ValueDouble, ValueInt,
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Figure 4.2: Overview of the generalized data structure (ontology) component. The central
entity of this component Concept is associated to combinations of Attribute and value
entities. In addition, a Relation is used to associate Concept entities to each other.
ValueString) represent the assignment of attribute values to the Concept. Each of these
value entities, which include a value column of the corresponding type, is assigned to
an Attribute entity by using a many-to-one association. An Attribute contains a unique
name column. The application-logic ensures that the attribute-value-pairs are unique.
The objects in Attribute and Concept can be further categorized with meta information
(e.g. different institutions). They are associated to AttributeClass and ConceptClass,
respectively. Finally, Concepts can be linked to each other by the entity Relation. This
enables for instance the representation of the patient history that is modeled by the
connection of multiple consecutive consultations. The relationship between an object such
as a patient examination and the corresponding MCC/IMS measurement is represented
by a one-to-one association between the entities ImsMetaData and Concept (shown in
Figure 4.1).
3) Peak component offers a semi-generic structure for peak data persistence. This
comprises the compulsory parameters peak position and peak region . Moreover, it allows
for exchangeable peak attributes such as the maximum peak intensity. This flexibility
is required since modern automated peak detection methods like PME offer a variety
of measures for molecule quantity such as the peak volume or a number of parameters
fitting the peak model. Details of the peak component are shown in the Appendix Figure
A.1. An association between Peak and Concept, as shown in Figure 4.1, allows the
data model to support any kind of annotation. Chapter 7, for instance, presents a tool
for automated peak identification utilizing either parallel GC/MS measurements or a
MCC/IMS molecular database.
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4.3 Implementation
The presented breathomics database relies on a PostgreSQL database management system
(http://www.postgresql.org). The corresponding database application for integration,
view and analysis is based on Java SE 6. The integrated data analysis functionality takes
advantage of the free, comprehensive machine learning software package Weka (version
3.7.3) (99). The database model is fully incorporated in the Java application, which au-
tomatically generates the database scheme. Therefore, the Java code is annotated with
meta data specifying the mapping between objects in Java and the relational database.
The object-relational mapping (ORM) described in (15) deals with the automated per-
sistence of Java classes to database tables. The free Java software package Hibernate
(version 3.6) is utilized as an ORM tool (official website: http://www.hibernate.org).
Figure A.1 in the Appendix illustrates the system architecture.
4.3.1 Validation and Integration
The integration process is divided into three steps, where each step handles a specific
kind of information: (1) MCC/IMS measurements, (2) peaks, (3) object/patient data.
The IMSDB software comprises parsers, a comprehensive file and consistency validation
logic, and business logic for the integration of data collections. The validation logic ini-
tially triggers the parsers to read the different files. Prior to the import process, potential
violations of the specification such as missing entries, type errors and inconsistencies for
cross-related file entries are listed and presented to the user. Multiple unique entry con-
straints such as the PeakPosition require an additional select query before inserting a new
entry. Large datasets containing thousands of peaks would hence be unfeasible. There-
fore, the so called chunk query peak persistence (CQPP) method was developed to select
multiple entities at once (depending on the chunk size) instead of inefficiently executing
one query for each new entry. The insertion of missing entities is then handled in a JDBC
batch process. The analysis in Section 4.4.1 shows a significant increase in performance
compared to the native peak persistence method, which includes a number of queries to
insert only one peak entry with corresponding parameters.
4.3.2 Data Retrieval and Reorganization into data sets
In a typical target data set, peak intensities are stored in a matrix, where peak regions
correspond to columns and the corresponding MCC/IMS measurements to rows. De-
pending on the hypothesis, only measurements of particular sample objects should be
included in the data set, i.e. hypothesis specific labels for each instance are required.
Consider the following task: Differentiate all patients suffering from a certain disease
(e.g. COPD,COPD=TRUE see Section 3) from a control group of all persons not suffer-
ing from this disease (COPD=FALSE ). Thus, all the respective instances are required to
provide an associated value for the label COPD={TRUE, FALSE}. To generate such data
sets the data stored in EAV format is converted to a matrix of patients vs. attributes.
This is done by applying a dynamic pivoting (cross-tabulation) strategy utilizing the
PostgreSQL function crosstab(text, text) of the tablefunc module.
In a second step the peak information is inquired. Given the first partial data set of
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objects, corresponding MCC/IMS measurements and the set of common peak regions
for those measurements are extracted. A simplified query performing this task is shown
in Listing 4.1. The query delivers only those peak regions common to each MCC/IMS
measurement of the instances in the result set of patients.
Listing 4.1: Simplified hibernate query language (HQL) code for the retrieval of persistent
PeakRegion entity identifiers in context with the generation of a target data set. Given
a list of IMS measurement file names, the query returns only those PeakRegions which
are associated to all (and not less) IMS measurements in the list. The semantic of the
“group by - having” statement is explained in (122).
SELECT r.id
FROM
ImsMetaData i join i.peaks p join p.peakRegions r
WHERE
i . file in :fileNameList
GROUP BY r.id
HAVING count(i) = <fileNameList.size()>
Data Set Analysis
In order to find relations between peaks and attributes such as pharmaceuticals or dis-
eases, an automated analysis of a queried target data set is performed. The analysis
incorporates an evaluation of the classification performance of a decision tree algorithm
(WEKA, C4.5 decision tree), see Section 2.5.3 for details (182). Subsequently, the results
are evaluated using ten-fold cross validation approach integrated in the WEKA library.
Backup, Restore, and Versioning
To ensure data protection and to allow for recovery in the case of data loss, a backup
and restore system was developed. The end-user can create backups of the current state
of the IMS database and restore it to a previous state. This is ensured by triggering
the PostgreSQL dump and restore command line tools in the graphical user interface.
Integrating and restoring data may result in highly diverse changes. In order to track
changes in the IMS database, it incorporates a custom version control system. Major
changes, such as the integration of new MCC/IMS measurements or patient records, are
logged and induce an update of the current database version.
4.4 Results and Discussion
The IMSDB application offers a graphical user interface (GUI) including several windows,
tabs and dialogues to allow for an intuitive interaction between end-user and application.
The following key features are currently supported by the GUI:
 Automated integration and validation of MCC/IMS data combined with object-
attribute data.
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 Presentation of database objects and their attributes, such as, for instance, patient
records.
 Backup and restore platform with an integrated versioning.
 Dialogue-guided retrieval and automated decision tree analysis and validation of
target data sets along with decision tree visualization.
4.4.1 Database Upload
As explained in Section 4.3.1, the software provides a CQPP strategy, which reduces the
overhead of individual operations concerning peak data upload coupled with batch inserts.
Furthermore, the system is able to optionally store the raw data of MCC/IMS measure-
ment files into the database. The running time of the previously described conservative
and pivoting methods is compared using benchmarks datasets that reflect real world use-
cases. Five data sets of different size, increasing in the number of measurements (25,
50, 75, 100, 125) as well as the number of peak entries (3-, 6-, 9-, 12-, 15-thousand), are
uploaded to a clean database. The average MCC/IMS measurements file size is approxi-
mately 8MB. The benchmark is performed using the 64-bit database server PostgreSQL
9.0 (full logging activated) under 64-bit Windows 7 running on a Quad Core Intel Xeon
CPU (2.4GHz) workstation with 24GB RAM and a SATA hard disk. Average running
times of ten trials are reported in Figure 4.3.
4.4.2 Decision Tree Classification and Performance Evaluation
As a proof of concept, the breathomics database application was evaluated using the
COPD data set described in Section 3. The preprocessing of this data set resulted in 120
peak regions, which are evaluated for each MCC/IMS measurement. In this example, the
goal is to find peaks that are related to the COPD annotation. The attributes of interest
(COPD=TRUE, COPD=FALSE :=[”control”]) are selected in the GUI. Subsequently, the
software evaluates the data utilizing a ten-fold cross validation and the Weka machine
learning package for decision trees (see Figure A.4 of the Appendix). The quality of the
classification is validated by a set of performance measures shown in Table 4.4.2. See
Section 2.5.3 for details. Finally, a decision tree is trained on the complete data set and
the visualized in the GUI, see Figure 4.4.
4.5 Conclusion
The presented IMSDB is a comprehensive database and analysis platform capable of
combining metabolic data, like MCC/IMS chromatograms, and heterogeneous biomedi-
cal data, e.g. patient records, into a centralized data structure. In contrast to the pre-
vious work of Lesniak (138), the ontology component enables the storage of constantly
evolving object-attribute-data. In addition, the peak component ensures the fast storage
and retrieval of metabolic data. As opposed to the open source database TrialDB (41), a
database model was designed, that not only utilizes the EAV model but also features sim-
ple classes and relations. The combination of this design and the consistency-validation-
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Figure 4.3: The plot depicts the average running times determined by ten repetitions
of uploading data sets with an increasing number of IMS measurement files (25, 50, 75,
100, 125). Each raw file is associated with 120 peak regions. Four different uploading
strategies are shown. The two methods CQPP (black line, pink line) and native peak
persistence (red line, blue line) are thereby combined with the options for storing the IMS
raw data measurement files into the database.
Figure 4.4: Illustration of the decision tree built by training on the data set that contains
the combination of the labels (classes) COPD vs. Control.
and business-logic ensures the quality of the data, the relations and the object-attribute
combinations. The extension of this design towards a full EAV/CR would decrease the
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Table 4.2: Classification performance distinguishing COPD vs. control. The table on the
left shows the confusion matrix and the table on the right the performance measures for
the classification.
Real
COPD Control
Predicted
COPD 29 6
Control 8 75
Measure Performance
AUC 0.85
ACC 0.88
TPR 0.90
FPR 0.17
dependency on the application logic, but also decrease the performance of reading and
writing in the system. In summary, the major contributions to the IMS biomarker com-
munity are:
 An intuitive software system for biologists, chemists, physicists and physicians that
does not require any prior knowledge or technical skills.
 A general database model establishing the structure to combine heterogeneous
biomedical and metabolic data for the purpose of research and diagnostics.
 Finally, this work provides an outlook on a potential biomarker discovery and vali-
dation platform by means of direct access to statistical learning methods.
The IMSDB is the combination of two powerful computational tools, an extensible breath-
omics database and a machine learning toolkit, accessible through an intuitive graphical
user interface. This will accelerate and expand the opportunities of clinical diagnostic
research in the near future. The work fills a gap that hindered efficient analysis of breath-
based metabolomics in biomedical research. The IMSDB framework, the software package
and an artificial test data set are publicly available at http://imsdb.mpi-inf.mpg.de.
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Towards Robust Machine
Learning in Breathomics
The statistical evaluation within this chapter was conceptualized and conducted
by the author of this thesis. Prof. Dr. Jan Baumbach and Prof. Dr. Jo¨rg Ingo
Baumbach supported this project with their valuable insights on machine learning
and breath analysis.
The lack of sophisticated state of the art machine learning methods and robust evaluation,
are the main reasons that prevent the successful application of breathomics in modern
clinical diagnostics. This chapter evaluates the combination of MCC/IMS technology
together with properly applied sophisticated machine learning techniques for (1) VOC-
based feature selection and (2) supervised classification. In order to illustrate the potential
of this combination, the previously described COPD data set serves as an example of
an adequate analysis. To receive a broad overview of their potential for distinguishing
the patient groups, several statistical learning methods have been integrated into the
analysis. The content of this Chapter largely relies on a previously published study by
Hauschild et al. in 2012.
Objective: Proof of concept for the potential of sophisticated
statistical learning methods for breathomics analysis.
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5.1 Requirements and State of the Art
Typically, one of the major goals in breathomics is to identify the smallest subset of ex-
haled metabolites that can provide the most accurate and robust predictions regarding
the clinical variable of interest.
Common statistical approaches in previous studies include basic methods for separability
such as: hypothesis tests (e.g. Wilcoxon-Mann-Whitney test (WMW), (31; 79; 93; 197)),
correlation analyses (148; 197; 129), and PCA (232; 114). Sporadically, more advanced
learning methods demonstrating good predictability have been applied, such as decision
trees (231), probabilistic relational learning (85), support vector machines (16; 142), or
neural networks (8). Nevertheless, previous studies have mainly focused on separability
rather than predictability, or otherwise fail to demonstrate the robustness of their pre-
diction results. Thereby, these studies further fail to prove the reliability of the most
important features selected. Moreover, the field has been lacking a comprehensive com-
parative analysis for a broad set of sophisticated methods in combination with MCC/IMS
data to show their potential.
In contrast to previous studies, the focus of this work is a large-scale study of the potential
in combining clinical MCC/IMS data and sophisticated statistical learning methods. In
order to achieve a more robust estimate of the generalization error, results are evaluated by
a cross validation scheme. Finally, a set consisting of the most informative features, based
on established mathematical measures for feature importance are selected as potential
biomarkers.
Requirements:
⇒ Application of broad spectrum of linear and
non-linear machine learning methods.
⇒ Robust and generalizable evaluation of classification
results.
⇒ Advanced feature selection based on established
importance measures.
5.2 Methods
5.2.1 Data
The data set is previously described in chapter Materials as COPD data set, section 3.1.
In total, the data comprises 119 volunteers: 35 healthy controls (HC) and 84 patients
suffering from COPD, 54 out of the 84 COPD patients have also been diagnosed with
bronchial carcinoma (BC). Unless stated otherwise, we use the following abbreviations as
class labels:
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HC = healthy controls (35)
COPD = patients suffering from chronic obstructive pulmonary disease (84)
COPD+BC = COPD patients also suffering from BC (54)
COPD-BC = COPD patients not suffering from BC (30)
5.2.2 Overview
First, the measurements are captured by the BioScout, an MCC/IMS device as previously
described in Section 2.1, and the data set is saved on the attached computer (see Fig-
ure 5.1, step 1). Afterwards, the three-dimensional data files are preprocessed for noise
reduction and VOC detection (Figure 5.1, step 2). Finally, a set of statistical learning
techniques is applied and evaluated (Figure 5.1, steps 4 and 5) to estimate the classifica-
tion accuracy. Additionally, some of these methods are able to identify the VOCs that are
most relevant for the classification. To achieve the previously defined requirements with
COPD Patients 
Healthy Control
SpiroScout(a)
      &  MCC/IMS(b)
Preprocessing:
- Denoising
- Smoothing
- Peak detection
DATA
COPD vs. Healthy
Healthy
vs. COPD-BC
vs. COPD+BC
Machine Learning:
- Naive Bayes
- Neural Networks
- SVM
- Random Forest
Robust
Evaluation
Grouping Information
BioScout
(a)
(b)
Figure 5.1: Overview of the integrated statistical approach to evaluate COPD-related
metabolic MCC/IMS profiles. The numbering indicates the different steps of the ap-
proach.
respect to the described COPD data, the following two major questions are addressed
(Figure 5.1, step 3):
1. Are advanced machine learning methods applied to breathomics data suitable to
distinguish between healthy and COPD patients?
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2. Is it possible approach the three class problem: healthy, COPD-BC, and COPD+CB,
by combining breathomics data with the proposed set of tools?
5.2.3 Preprocessing
A MCC/IMS measurement contains 1 million intensities, 500 for the retention time axis
and 2000 for the drift time axis. At first, general preprocessing methods for denoising,
smoothing and peak detection, such as log-normal detailing and wavelet transformation
must be applied, see Section 2.2 for details. Both preprocessing and peak detection is
done with the aid of the VisualNow software (provided with BioScout by B&S Analytik),
see Section 2.8.2. The software tool allows for both manual peak picking and execution of
fully automatic peak finding algorithms. For this project, the data is preprocessed using
the standard settings of VisualNow and the manual peak picking procedure. The domain
expert determined 120 VOC positions. The final preprocessed data table consists of 119
measurements and the peak intensities for 120 compounds.
5.2.4 Methods
Several well established statistical supervised learning methods were selected, to obtain a
broad overview of the potential of the data and the different classification techniques for
clinical diagnostics. Thus, the project includes methods of varying complexity. On the
one hand, long-established approaches were applied, such as decision tree, naive Bayes,
and linear support vector machine (SVM). On the other hand, more recent and complex
techniques were used: neural net, random forest, and radial SVM. The statistical analysis
and feature selection was implemented in the R environment for statistical computing
(Version 2.13.1) (1). A detailed description of the theoretical background of methods is
provided in Section 2.5.3. A brief overview of the implementation and parameter settings
is given in the following.
Naive Bayes
A widely used method for linear statistical modeling is known as the naive Bayes classi-
fier (134). The naive Bayes method was employed using the R package NaiveBayes (227),
with default parameters and the usekernel parameter set to “true.
Decision tree
This method is a non-linear machine learning tool based on recursive partitioning. The
decision tree implementation in the R package rpart (207) was used, with default param-
eters.
Artificial Neural Networks
A well established non-linear method is the artificial neural network. The basic model
contains three layers: the input layer, the output layer, and at least one hidden layer.
The complexity of the model increases by the number of hidden layers (102; 9). In our
case, we set the number of hidden layers to 2. The weight decay and the maximal number
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of iterations were kept at the standard settings 0 and 100, respectively. The R package
used is called nnet (218).
Random Forest
Random forest is based on the two strategies of bagging and bootstrapping, reducing the
variance by building a forest of decorrelated decision trees (102). It provides two measures
for feature importance: Gini index and mean decrease in accuracy. The random forest
classification and feature selection were done using the randomForest R package, by Liaw
and Wiener in 2002 (139), with standard parameters number of trees equal to 500, where
each tree was grown to the maximum possible depth.
Support Vector Machine
SVM is a widely used statistical learning method, especially in combination with a non-
linear kernel like the Gaussian radial basis function. Both the linear as well as the radial
SVMs were implemented with the e1071 package (67). The cost and tolerance parame-
ters of the linear SVM were set to 100 and 0.01 respectivly, while the cost and gamma
parameters of the radial SVM were fixed to 1000 and 0.1.
5.2.5 Statistical Analysis and Validation
After preprocessing and peak finding the previously described statistical learning methods
are applied to solve two different classification tasks: COPD vs. HC and COPD-BC vs.
COPD+BC vs. HC. However, the data set consists of a rather small number of samples,
in our case 119. Thus, the evaluation using the ideal approach of training and test set as
described in Section 2.7, would lead to relatively noisy estimates of the predictive perfor-
mance. Therefore, cross validation is used to give a better estimate for the generalization
error of the predictive model, see Section 2.7 on Validation for more details. Stratified
cross validation was used to ensure that each subset covers instances from all classes, i.e.
the proportions of the class labels are preserved within each subset. In this pilot study
we are solely interested in getting a general idea of the suitability of MCC/IMS combined
with statistical learning for clinical diagnostics. Therefore, we refrain from performing
advanced parameter tuning of the learning methods. The R package pROC was used
to compute various measures of model performance (183): sensitivity, specificity and the
AUC, which is the area under the ROC curve. The class specific sensitivity and specificity
of the three-class-problem are calculated with the equations described in Section 2.5.3.
Feature Selection Both random forests and linear support vector machines provide
measures for feature importance. In order to investigate the feature importance of the set
of 120 compounds, the Gini index of random forest and the coefficients fitted by the linear
SVM model are evaluated for each cross validation (CV) run. Finally, the importance
vectors are averaged over all ten CV models, for each of the features. As a proof of
concept, the best ten features for each of the two methods will be discussed.
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5.3 Results and Discussion
The first classification problem aims at distinguishing between COPD patients and the
healthy control group. Table 5.1 shows the performance comparison of the results of the
six different methods. The decision tree and naive Bayes, achieved an accuracy between
82% and 85% and an AUC of around 80%. The linear SVM performed slightly better with
an AUC of 83% and an accuracy of around 87%. The more complex methods, i.e., neural
net and radial SVM, gave an accuracy of 89% and AUCs of 86% and 87%, respectively.
The best performing method classifying between COPD and HC was random forest, which
had the best prediction accuracy of 94% as well as high values for AUC (92%), sensitivity
(98%) and specificity (86%). As expected, methods with higher complexity performed
better. They have a relatively low bias, which means they make less strong assumptions
and fit the data more closely than the simpler methods. On the other hand, the basic
methods performed surprisingly well in terms of AUC and accuracy. However, due to the
unbalanced data set (COPD ≈ 70% vs. HC ≈ 30%), one has to take a closer look at
the sensitivity and specificity. While the sensitivity was good (between 87% and 98%),
the specificity of the more complex methods (80% to 85%) was in general higher. This
indicates that for those methods, COPD patients are still accurately discovered, however,
a larger percentage of healthy controls are falsely predicted to suffer from COPD. In
clinical practice this increase in false positives could lead to false information for the
patients and in the worst case to invasive follow-up examinations or harmful side effects
of unnecessary medication.
Table 5.1: Results of the two-class-classification problem, evaluating the differences be-
tween COPD and the HC.
Method AUC Accuracy Sensitivity Specificity
Decision Tree 81 85 91 71
Linear SVM 83 87 92 74
Naive Bayes 79 82 87 71
Neural Net 86 89 93 80
Radial SVM 87 89 92 83
Random Forest 92 94 98 86
To the best of our knowledge, the presented work is the first comprehensive study about
the performance of state of the art statistical learning tools for IMS-based metabolic pro-
filing of COPD and bronchial carcinoma patients. A recent study presented by Westhoff
et al. (2011) solely concentrated on rank sum tests and a decision tree trained on the VOC
to classify COPD and HC. The best VOC 98, given by the rank sum test, was reported
to result in a comparatively good training accuracy of 91%. However, the major issue of
that study (also briefly discussed in (231)) is the focus on separability and training error
as well as the lack of cross validation to avoid data overfitting.
Receiver Operating Curves The predicted classes of the supervised learning meth-
ods were used to evaluate the accuracy, area under the ROC curve, sensitivity and
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specificity(103). In addition, some of the presented methods estimate the probabilities
for each sample to belong to the one or the other class. Those results can be utilized to
plot the so called receiver operating curve, see Section 2.5.3 for more details. Figure 5.2
shows the corresponding ROC curves for the given statistical learning methods.
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Neural Net , ACC= 86.6 , AUC= 89.6
Radial SVM , ACC= 89.1 , AUC= 93.4
Random Forest , ACC= 93.3 , AUC= 98
Figure 5.2: ROC curves of the statistical learning methods based on the estimated class
probabilities.
Feature Selection
In this classification setting, features directly corresponded to molecules in the human
exhaled air. We are interested in finding those features that contribute most to the
classification performance. Therefore, the coefficients of the linear SVM and the Gini
index of the random forest were taken as a measure of importance. This enables to
discover a linear as well as a non-linear feature pattern. Figure 5.3 shows the ten best
features provided by the two methods linear SVM and random forest. The linear SVM
feature importance depends on the coefficients of the variables according to their weight
on the final linear model. The Gini index of the random forest is a summation of the
decrease in node impurity over all trees. Tables 5.2 and 5.2 show the two resulting subsets
of features.
Both ten best feature subsets did not overlap. This might result from the different
underlying mathematical approaches, in one case a linear model, in the other a non-
linear. Additionally, both subsets were compared to the peaks identified in the study of
Westhoffet al. by using the rank sum test (231). Interestingly, five of the compounds found
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Figure 5.3: Barplot of the ten best features determined by the feature selection of the
linear support vector machine and the random forest, on the COPD vs. HC classification.
Depicted are the ten best features according to their weights generated by the linear SVM
(left) and the Gini index provided by the random forest (right). The right Y-axis of each
Figure lists the names of peaks/VOCs, while the left Y-axis states the importance.
Table 5.2: Comparison of the 10 best features selected by linear SVM to the features
selected by random forest and the peaks identified by the study of Westhoff et al. 2011
using rank sum test (231). The × sign indicates a match. The peaks are ordered by the
rank of their weight in the linear SVM. Additionally, the coordinates in the MCC/IMS
chromatogram, the inverse drift time (1/K0) and the retention time (RT ) is shown.
Linear SVM Selected Peaks
Peak Nr. 64 79 94 116 48 101 7 5 2 69
1/K0 1.119 0.844 0.514 0.55 0.693 0.932 0.563 0.544 0.535 0.904
RT 189.8 501.1 248.1 56.5 100.7 110.4 6.2 3.4 4.3 233.4
Linear SVM × × × × × × × × × ×
RF × ×
Westhoff, ’11 × ×
in this study have also been found to be important by random forest. On the one hand this
proves the validity of the approach. However, it also indicates that further analysis of the
compounds found by the variable selection performed is necessary, both for previously
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mentioned peaks {48, 79, 98, 100, 103} and newly discovered peaks {93, 6, 48, 95, 21, 4}.
Another study by Bessa et al. in 2011 analyzed a data set of 13 COPDs and 33 HCs,
Table 5.3: Comparison of the 10 best features selected by random forest to the features
selected by linear SVM and the peaks identified by the study of Westhoff et al. 2011 using
rank sum test (231). The peaks are ordered by the rank of the Gini index generated during
the training of the random forest model. Additionally, the coordinates in the MCC/IMS
chromatogram, the inverse drift time (1/K0) and the retention time (RT ) is shown.
Random Forest Selected Peaks
Peak Nr. 98 93 103 6 100 79 48 95 21 4
1/K0 0.605 0.607 0.61 0.581 0.553 0.563 0.553 0.648 0.647 0.6
RT 22.3 16.9 18.9 78.5 49.6 20 17.9 17.6 21.9 11.9
Linear SVM × ×
RF × × × × × × × × × ×
Westhoff, ’11 × × × × ×
and reported a peak at position 1/K0 = 0.50 and RT = 26 to be the best discriminant
for that classification scenario with 100% accuracy. However considering 120 VOCs and
only 46 training and evaluation data points, does not allow for any save conclusions at
this point (31).
COPD+BC Classification
Table 5.4 depicts the classification results of the three-class problem. Prediction perfor-
mance was low (accuracy ≈ 70%) for each of the applied machine learning techniques,
except random forest (accuracy ≈ 79%). The AUC dropped by at least ten percent for
all of the methods except naive Bayes, which may be due to its simplicity and robustness.
Therefore, it remains unclear whether the information content in the data is high enough
for distinguishing between the three groups of volunteers. In fact, all of the methods
showed a very low sensitivity for the COPD class, which indicates that the differentiation
between class COPD and COPD+BC is a difficult problem for all of the models. While
the methods were still able to identify the HCs in a quite robust manner, most of the
measurements of COPD patients were falsely predicted to suffer from both COPD and
bronchial carcinoma, i.e. class COPD+BC. This was due to the fact that the number of
BC patients was almost double the number of patients solely suffering from COPD. This
is not surprising, since the cause of both diseases is highly dependent on the smoking
behavior of the patients, and both are reported to be strongly related to each other. This
is also supported by Younget al. (2009), where they identified COPD as a common and
important independent risk factor for lung cancer. The prevalence of the different groups
of COPD within lung cancer goes up to 60% (240). Consequently, we can assume that the
probability for each of the COPD patients to get a bronchial carcinoma is comparatively
high. Hence, we cannot exclude the possibility that an early stage bronchial carcinoma
might have been undetected, particularly since most types of lung cancer are detected in
late stages in the majority of cases.
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Table 5.4: Results of the three-class-classification problem, evaluating the differences
between COPD patients, COPD patients suffering from bronchial carcinoma, and the
control group. The class specific sensitivity and specificity assessed for class COPD as
well as COPD+BC, is based on the equations discussed in the methods section.
Method AUC Accuracy COPD COPD+BC
SEN SPE SEN SPE
Decision Tree 70 60 23 82 69 65
Linear SVM 71 59 0 93 80 48
Naive Bayes 75 62 43 79 61 72
Neural Net 73 61 20 82 69 62
Radial SVM 73 62 0 91 78 57
Random Forest 79 67 6 99 85 55
Although there has been no study using modern machine learning methods on COPD
MCC/IMS chromatograms, there were two studies for MCC/IMS data about BC patients.
One study applied naive Bayes, multi layer perceptron, and SVM to a set of MCC/IMS
chromatograms and achieved an outstanding performance (accuracy and AUC both 99%)
(16). Despite the good results, the study has some limitations. At first, the prediction was
done on a comparatively small sample and large feature set, where each chromatogram
was separated by a grid, while each feature was calculated as the average intensity of
the corresponding grid element. Secondly, the accuracy and AUC were evaluated on a
single cross validation neglecting the possible variation between different selections of CV
sets. Another study used relational probabilistic learning for the extraction of Markov
logic network formulas and achieved a cross validation accuracy of up to 90% during
classification (85). Unfortunately, a comparison with the results of the peak selection of
those two methods is difficult, as the authors did not make the peak or grid positions
publicly available. Besides, no further information on additional medical conditions of
the patients, such as COPD, was known.
Although the evaluation of classification performance using repeated cross validation runs
is an improvement to previous studies, we are still lacking more robust evaluations, such as
permutation tests as presented in Chapter 6. Another problem for the analysis of COPD
measurements is the medical COPD categorization itself. The patients were categorized
with respect to the severity of their COPD disease, which is done according to a defined
set of rules and tests. In addition, clinical practice and the subjective impression of
the physician play an important role, as well as other factors that can influence the
compounds in human breath, such as diet, smoking, and other secondary diseases, that
have not necessarily been tested.
5.4 Conclusion
This study shows that ion mobility spectrometry data of human breath can generally be
utilized for distinguishing between lung diseases such as COPD, if properly combined with
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statistical learning methods. To demonstrate this, we evaluated sophisticated machine
learning techniques on MCC/IMS chromatograms regarding their classification perfor-
mance and ability to identify the most important molecular compounds. Therefore, the
breath of 84 patients either suffering from COPD or both COPD and bronchial carcinoma
was processed and compared with 35 healthy volunteers. The by far best test error (AUC
91%, ACC 94% for COPD vs. HC; AUC 79%, ACC 67% for COPD vs. COPD+BC
vs. HC) were achieved with the random forest method. These results pinpoint a strong
potential to separate healthy from COPD, but also suggest that a further examination
of the differences between COPD and COPD+BC is needed. Linear SVM and random
forest extracted 10 important VOCs, respectively. Moreover, five of these were confirmed
to have discriminative power regarding COPD and healthy IMS chromatograms in other
studies. Parameter tuning is indeed a valuable method to adjust the present statistical
learning methods. However, it is only recommended on larger data sets and in combina-
tion with proper evaluation using permutation tests, for instance. In the future, we plan
to determine whether these 20 molecules are biologically related to COPD and to elimi-
nate those that are related to diet or other environmental influences. A further objective
is to optimize the standardized learning methods in order to improve the prediction per-
formance, on the one hand, and the identification of the smallest discriminating set of
biomarkers, on the other hand. If such a set of biomarkers can be found it might lead
to a tremendous progress in the field of COPD and cancer diagnostics. However, larger
data sets of patients with pulmonary diseases and lung cancer are necessary.
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Evaluating Automated Peak
Detection
This chapter is based on a collaborative project with the Bioinformatics group at
the technical university of Dortmund and funded through the Collaborative Re-
search Center SFB 876 (SFB) and the International Max Planck Research School
(IMPRS). The project partners Marianna D’Addario and Dominik Kopczynski
contributed with the implementation and results of two automated peak detection
methods: local maxima search and peak model estimation. The results of the
manual peak picking were provided by B&S Analytik in Dortmund. The author
of this thesis was primarily responsible for the study design, statistical analysis
and evaluation of the results. Additionally the author contributed the results of
the merged peak cluster localization and watershed transformation peak detection
methods.
Although sophisticated automated methods for peak finding exist, the majority of studies
still rely on manual peak picking, which is the current gold standard approach. However,
the daily increasing number of measurements, each with several dozens of potential peaks,
exceeds the possibility of manual processing and increases the necessity of an automated
data analysis and classification.
This chapter describes the evaluation of four state of the art approaches for automated
IMS-based peak detection: LMS, WST with IPHEx, MPCL with VisualNow, and PME
by PeaX. They are compared to the manual gold standard generated with the aid of
a domain expert. To avoid a bias by previous knowledge of the expert on the disease
specific peaks, the previously introduced anonymized breathomics data set of patients
and controls is utilized for the comparison (see Section 3.3). In contrast to the previous
intrinsic quality measures for peak detection, this study introduces two distinct qualitative
criteria. First, established machine learning methods are utilized to systematically study
the classification performance identifying patients on the bases of the detected peak lists
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as features. The second criteria investigates the classification variance and robustness
regarding perturbation and overfitting. This Chapter primarily relies on Hauschild et al.
from 2013 (107).
Objective:
Comprehensive and robust evaluation of the power
of available automated MCC/IMS peak detection
methods in comparison to the manual gold standard.
Outline The next Section describes the state of the art in peak detection and further
evaluates the requirements of a proper evaluation of these. The Methods Section 6.2 gives
an overview about the preprocessing as well as the peak detection methods we evaluate.
It further describes which machine learning and evaluation approaches we apply to assess
the quality of the peak detection methods. Section 6.3 describes the comparison results
and finally discusses these findings.
6.1 Requirements and State of the Art
One of the first steps in automatic high-throughput MCC/IMS data analysis is peak
detection, as each so-called peak represents a specific analyte in the exhaled air (see
Background Section 2.2.3). Such an automatic peak detection method should be as ac-
curate as a human annotation but fast enough to cope with thousands of measurements.
Several peak detection algorithms for MCC/IMS data have been proposed and described
in the literature (180; 37; 49; 128). Previous to this study, these were generally evaluated
using intrinsic quality measures, i.e., criteria that can be derived from the data, such as,
for instance, the goodness of fit of the peak models to the initially measured data.
However, for most projects that are searching for potential disease biomarkers it is im-
portant to optimize the set of detected peaks, rather than fit the shape of each peak
mathematically as exact as possible. Therefore, the final objective is to find such an opti-
mal peak set, such that the classification performance will allow us to distinguish between
patients and controls in the best possible way. The strategy of this project is to evaluate
four state of the art peak detection methods according to such data-independent criteria.
Hence, these criteria reflect the performance and robustness of the resulting peak lists,
regarding the final task: biomedical decision making.
A peak detection method transforms a raw data measurement (a matrix of values, see an
example heat map representation in Figure 2.2) into a set of peak descriptors. These will
be used as input features for two different classification algorithms, a linear support vector
machine and a random forest model. Subsequently, each peak detection method will be
evaluated by the corresponding qualitative criteria: the classification performances and
the robustness of the models. Finally, an MCC/IMS data analysis expert, will manually
select the peaks in the set of measurements. The resulting peak set as well as qualitative
criteria will be compared to the results of the automated methods.
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Figure 6.1: Shown is the structure of the evaluation pipeline. The three sections (1)
preprocessing, (2) peak detection and postprocessing, and (3) machine learning and eval-
uation describe the details of the overall analysis. The figure is adapted from Hauschild
et al. 2013 (104)
Requirements:
⇒ Compare the peak sets found by automated peak
detection methods to the manual gold standard.
⇒ Evaluate the classification performance of automated
peak detection methods.
⇒ Assess the robustness of the machine learning models
based on the automatic peak sets.
6.2 Methods
To evaluate the quality of five peak finding approaches, the previously introduced anonymized
data set of human exhaled air is utilized, see Section 3.3 for more details. Figure 6.1 gives
an overview of the following sections and the structure of the comparison process. At first,
preprocessing approaches such as homogenization, filtering and individual preprocessing
steps are described. In the second step the peak detection and merging approaches are
applied to extract a feature matrix of measurements vs. metabolites. Subsequently, we
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describe the evaluation scheme and the used machine learning methods.
6.2.1 Preprocessing
Homogenizing and Filtering a Set of Measurements
To ensure comparability within the set of measurements that potentially originate from
varying sources or hospitals, we define a list of rules and restrictions the measurements
have to satisfy.
 Drift gas flow: 100± 5 mL/min
 Sample gas flow: 100± 5 mL/min
 Carrier gas flow: 150± 5 mL/min
 MCC temperature: 40± 2 ◦C
 Drift gas: the same value for all measurements in the set
 Polarity: the same value for all measurements in the set
This step determines the measurement with the smallest retention time range, the so-
called cut-off time. Subsequently, in each MCC/IMS measurement, the set of measured
spectra is reduced to those before the cut-off time. The aim of these rules is to ensure
that all measurements in our set are generally comparable. Since most signals occurring
at retention times smaller than 5 seconds originate from the MCC/IMS device itself they
were discarded as well.
Preprocessing MCC/IMS Raw Data
In order to reduce the noise and increase the quality of the raw measurements, the fol-
lowing four preprocessing steps are applied: The first step is the RIP detailing or RIP
compensation filter, which subtracts the global median of each MCC spectrum from each
data point. To further denoise the data, a low-pass and Gaussian filter as described in
Section 2.2 are applied. They remove high frequencies and smooth the spectrum. Fi-
nally, a one-dimensional Savitzky-Golay filter smooths every single spectrum computing
a weighted average across the drift time axis with a window size of 9 data points (192).
6.2.2 Peak Detection and Postprocessing
In order to evaluate the peak detection approaches, they are applied to the preprocessed
MCC/IMS measurements. The current “gold standard” is the manual peak detection
Visual Now done by a domain expert, see Section 2.2.3. This chapter will compare it to
the four most common automated approaches:
LMS Automated local maxima search, Section 2.2.3
WST Automated peak detection via water shed transformation implemented in IPHEx,
Section 2.2.3
MPCL Automated peak detection via merged peak cluster localization supported by
VisualNow, Section 2.2.3
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PME Peak model estimation approach is the focus of the PeaX tool, Section 2.2.3
All of them transform the given raw measurements into a list of potential peaks. A peak
P is defined as a triple P = (r, t, s) containing the following parameters: retention time r,
inverse reduced mobility t and signal intensity s. See Section 2.2.3 in the Background
Chapter. In this chapter a set of multiple MCC/IMS measurements is given. Therefore,
we extend this peak description by the measurement index i resulting in P = (i, r, t, s).
For convenience, we use the notations i(P ) := i, r(P ) := r, t(P ) := t, s(P ) := s to define
the projections on each component. Finally, we arrive at a list of peaks for each method
and each measurement, i.e. each patient.
Subsequently, for each peak detector, the peak lists are merged to create a matrix of peaks
and patients that provides the intensity of the associated peak. Implicitly, this matrix
describes whether we observe a certain peak in a certain measurement (patient) or not,
and if so with which intensity. It can further be interpreted as a list of feature vectors,
which can be utilized for subsequent classification (next Section). Therefore, we need to
(1) correct for peaks that are too close to each other to be two separate peaks in reality
but should be merged to a single feature. We further need to (2) account for peaks that
occur in different measurements at “slightly” different positions, henceforth referred to
as “peak clusters”.
The peak merging method described by Boedecker et al. (37) is applied for this purpose.
See Chapter Background, Section 2.2.4 for details. Note that this procedure is applied
solely to the automated peak detection results. The manual peak detection with Visual-
Now directly resulted in a list of peak clusters for each measurement.
6.2.3 Evaluation Methods
The result of the previous processing steps is a set of peak clusters for each peak detection
tool and the intensity of the corresponding peak cluster for each measurement. Under the
assumption that one peak cluster originates from one specific compound or metabolite,
further bioanalytical techniques can determine the metabolite corresponding to each peak
cluster. In modern biomarker research, we essentially seek to find correlations between
those metabolites and a certain disease. This suggests a conditional relationship between
the metabolic pathways of the disease and the produced indicator components. Therefore,
it is desirable that a peak detection method is able to find all relevant peaks that trigger a
good and robust classification performance. To compare the results of the different peak
detection methods, two different steps are performed. First, the overlap of the peak lists
and peak clusters of the compared methods are assessed. In a second Step the mentioned
qualitative criteria are evaluated, based on the classification performance of the different
detection methods.
Peak Position Comparison
Recall that a peak in a measurement is described as P = (i, t, r, s) (see Section 6.2.2),
where i is the measurement index, t the inverse reduced mobility, r the retention time
and s the intensity. The different peak detection methods result in different peak cluster
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positions such that simply studying their intersection is infeasible because two peak clus-
ters that refer to identical molecules would only be recognized as the same if the clusters
had exactly the same coordinates. This is very unlikely. To overcome this problem, an
adapted version of the merging conditions defined in Section 6.2.2 are created. Let V , W
be two peak lists generated by two different peak detection methods. Two peaks clusters
P ∈ V and Q ∈W of the same measurement i(P ) = i(Q) are mapped (considered identi-
cal), if they fulfill the conditions defined in Section 6.2.2. The overlap of list V with list
W is defined as the number of peaks in V that can be mapped to at least one peak in
W . The resulting mapping count table is not symmetric, since each peak of list V can be
mapped to more than one peak from list W .
Machine Learning and Evaluation
The result of the postprocessing step is a feature matrix containing intensities of peak
clusters that presumably resemble the abundances of the corresponding molecules for each
of the patient measurements. These measurements or samples are each assigned by on of
the two class labels: K for control or D for diseased.
Two distinct standardized machine learning methods are trained on this data to predict
these class labels. The goal is to get an overview of the overall potential of the peak
detection methods in combination with different classification strategies. On the one
hand we chose a linear learning technique, namely the linear support vector machine.
On the other hand the non-linear random forest method is selected to evaluate potential
non-linear dependencies within the data. See Section 2.5.3 for a more detailed description
of the methods.
Evaluation: In order to achieve a robust estimation of the classification quality, the
evaluation embedded a ten-fold cross validation (CV) environment. In settings with
comparably small data set sizes, splitting the data into training-, validation- and test-set
leads to relatively noisy estimates of the predictive performance. Therefore, CV is used to
give a more accurate estimate for the actual accuracy of the predictive model. To ensure
that each subset covers the variety of both classes, the classes are balanced within each
CV subset. Furthermore, the CV procedure was repeated 100 times using 100 different
ten-fold cross validation sets. Thereby, the robustness of the different peak sets towards
changes in the measurement set can be analyzed.
The classification performances are evaluated based on the feature matrices emerging
from the five peak detectors by using different quality measures: (1)accuracy ACC, (2)
the AUC, which is the area under the receiver operating characteristic curve (183), (3)
the sensitivity, (4) the specificity, (5) the positive predictive value (PPV), and (6) the
negative predictive value (NPV). Furthermore, we give mean and standard deviation of
the AUC in boxplots.
Finally, we investigate the robustness and analyze, whether the feature sets and their
model performance are susceptible to classification parameter tuning, using a single ten-
fold cross validation set. We will pick the classifier that performs worse since the potential
for improvement will be higher. The parameters are varied systematically. In addition,
we randomize the class labels allowing us to judge the robustness to small parameter
6.3. RESULTS AND DISCUSSION 95
changes on both: (1) the original class labels as well as (2) the randomized class labels
(expected to lead to a decreased classification performance).
6.3 Results and Discussion
At first, the MCC/IMS measurements are preprocessed utilizing the previously described
homogenization and quality improving preprocessing steps such as denoising and smooth-
ing. The original data set contains 69 measurements of which two are discarded during
the homogenization phase. Subsequently, the peak detection methods are applied and
evaluated. Table 6.1 gives an overview on the results of the postprocessing.
Table 6.1: Number of peaks detected by all methods. Number of peak clusters after
merging the peak lists (postprocessing).
Method # Peaks # Peak Clusters
Manual (VisualNow) 1661 41
LMS (PeaX) 1477 69
MPCL (VisualNow) 4292 88
WST (IPHEx) 5697 420
PME (PeaX) 1358 69
After merging the overlapping peaks of the peak lists, the MPCL (VisualNow) and WST
(IPHEx) methods show the by far largest number of peaks, between 4,000 and 6,000. The
manual peak picking, LMS as well as the PME (PeaX) methods find a similar amount
of peaks, “only” about 1,500. The number of peak clusters is almost constant over all
methods, it varies between 40 and 90. An exception is the IPHEx implementation of
the WST peak picker, which finds 420 clusters. In theory, the underlying WST algo-
rithm provides different parameters to tune. However, the IPHEx implementation does
not support a change of these parameters and hence results in a huge number of peaks
and peak clusters. For both VisualNow-based methods, manual as well as automated,
the ratio between potential peaks and resulting peak clusters is comparably high. The
reason lies within the VisualNow implementation. Once a potential peak was found in
one measurement (out of the 67), it automatically assumes the presence of a peak at this
position in all other 66 measurements (presumably with low intensities), even if no actual
peak exists. This results in the observed high number of peaks that mainly correspond
to noise. This, as demonstrated later, may lead to problems within the classification pro-
cedure. In contrast, the IPHEx, LMS and PME implementations only assign intensities
to peak clusters for those measurements where a peak at the corresponding position was
detected.
6.3.1 Peak Position Comparison
The comparison of the peak cluster lists between the different peak detection methods
results in a matrix of overlaps, which is summarized in Table 6.2. The comparison of
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Table 6.2: Overlap of the five peak detection methods. The overlap of the peak list
A (row) and peak list B (column) is defined as the number of peaks in V that can be
mapped to at least one peak in W . Note that the resulting mapping count table is not
symmetric.
Method Manual LMS MPCL WST PME Software
Manual 1661 911 1522 1184 791 VisualNow
LMS 868 1477 1096 1074 1128 PeaX
MPCL 2667 2233 4292 2341 2082 VisualNow
WST 1112 1009 1157 5697 912 IPHEx
PME 737 1086 983 926 1358 PeaX
the peak cluster lists shows a large similarity of both peak lists created with VisualNow,
i.e. most peaks found in the manual evaluation were also identified with the automatic
MPCL peak detection of VisualNow. The IPHEx water level approach creates a huge
set of peaks. Hence it finds many peaks detected by the other approaches as well (≈
70% on average). Nevertheless IPHEx appears to be less redundant than the automated
VisualNow method since hardly any peaks from the other sets occur several times within
the IPHEx set. LMS and the PME method overlap highly (in both directions, ≈ 80%).
6.3.2 Evaluation via Statistical Learning
The evaluation of the classification performance is shown in Table 6.3 and Table 6.4.
Table 6.3 presents the results of the linear support vector machine indicating that all
methods perform almost equally well. The manual, LMS and MPCL peak detection
methods perform worst, in terms of AUC as well as accuracy. The automatic peak
detection in IPHEx shows a slightly better AUC and performs best in terms of 73%
accuracy. The peak detection method that produced the most informative features for
the linear method in terms of AUC ≈ 82% is the PME approach.
Table 6.3: Classification results of the linear support vector machine. The quality mea-
sures are the AUC, accuracy (ACC), sensitivity, specificity, positive predictive value
(PPV) and negative predictive value (NPV).
Method AUC ACC Sensitivity Specificity PPV NPV Tool
Manual 77.4 70.9 69.7 72.4 75.7 65.9 VisualNow
LMS 77 67.8 70.6 64.4 71 64 PeaX
MPCL 76.6 68.3 66.8 70.1 73.4 63.1 VisualNow
WST 79.8 73 70.5 76 78.4 67.6 IPHEx
PME 82.2 72.2 77.2 66.1 73.7 70.1 PeaX
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Figure 6.2: Boxplots of 100 runs of the ten-fold CV for the linear SVM and the random
forest method.
Table 6.4 shows the classification results of the random forest method. Again, all methods
vary little in their performance. The best set of features for this machine learning method
was generated by the gold standard (Manual VisualNow). The manual detection shows an
accuracy of ≈ 76% and an AUC of ≈ 87% and also outperforms all other peak detection
methods in all of the quality indices. The peak model estimation performs slightly better
in terms of AUC ≈ 82% and accuracy ≈ 74%, as well as most of the other measures.
Table 6.4: Classification results of the random forest. The quality measures are the AUC,
accuracy (ACC), sensitivity, specificity, positive predictive value (PPV) and negative
predictive value (NPV).
Method AUC ACC Sensitivity Specificity PPV NPV Tool
Manual 86.9 76.3 78.7 73.4 78.5 73.6 VisualNow
LMS 80.8 70.5 75 64.9 72.5 67.8 PeaX
MPCL 81.1 71.9 75.6 67.3 74.1 69.1 VisualNow
WST 80 68.9 72.8 64 71.4 65.6 IPHEx
PME 81.9 74.2 81.6 65 74.2 74.1 PeaX
Data Robustness
Figure 6.2 shows boxplots of the list of AUCs generated by 100 runs of the ten-fold cross
validation. The prediction results of the linear SVM with the manual and automated
MPCL in VisualNow are the most stable, while the LME shows the highest variation.
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The PME approach has a reasonable robustness and performs better than the simple
methods in almost all runs. In comparison, the AUC-measured classification performance
with random forest are most robust for the gold standard and the PME approach. The
other automated methods introduce larger variations, in particular IPHEx.
Tuning Robustness
Finally we investigate, if the feature sets and their model performance are susceptible
to parameter tuning on both learning methods. Initially the analysis will focus on the
worse performing classifier: the linear SVM. Therefore, we systematically vary the cost
and tolerance parameters ({0.1, 1.0, 100, 1000} and {0.01, 0.1, 1}, respectively) and in a
second run we randomize the class labels. The results of this analysis are shown in
Figure 6.3, which plots the variance of the AUC for both the original labels (left) as well
as the randomized labels (right). Figure 6.3 shows the results of the robustness analysis
of random forest and linear SVM. Here the parameters of the random forest, number
of trees (ntree = {100, 200, 300, 400, 500}) and number of features randomly sampled at
each split (mtry = {5, 10, 20, 30, 40}) are systematically varied. This parameter tuning
was applied to the real data set as well as a data set containing randomize the class
labels. The parameters tuned for the linear SVM are cost (cost = {0.1, 1, 100, 1000}) and
tolerance (cost = {0.01, 0.1, 1}) parameter.
At first glance, Figure 6.3 indicates that the performance (AUC) of the manual and
MPCL, as well as the IPHEx WST peak detection feature set can be heavily improved
by tuning the parameter of the linear SVM classifiers. However, when considering the
results for the randomized labels, these three tools seem to generate peak clusters that
are prone to overfitting, most likely resulting from the high number of detected potential
peaks. We would generally expect to observe a drastic drop in the classification quality
for the randomized labels compared to the real labels, which is not clearly observed
for all methods (overfitting), but LMS and PME. In addition to the comparably low
susceptibility to overfitting, PME has a quite small variability in AUC indicating stable
classification results. In contrast to the results of the linear SVM, the random forest
tuning results show that this method is considerably more stable. Most data sets show
considerable smaller potential for tuning of the random forest. Furthermore, for all data
sets a drastic drop in classification quality for the randomized labels compared to the
original labels can be observed. A classifier trained on a randomized class labels, is
expected to result in random predictions. Therefore, the present drop is a sign for a
reasonable predictor. One can generally say that random forest classification appears to
be more robust in terms of overfitting on this data set.
6.4 Conclusion
To summarize, four different approaches for automated peak detection on medical MC-
C/IMS measurements were compared: LMS, automated MPCL (VisualNow), IPHEx
WST, and PME of PeaX in comparison to the gold standard, manual peak picking. In
particular, their impact on the goodness of classical machine learning approaches that are
used for separating patients into “healthy” and “not healthy” was investigated. This is
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Figure 6.3: Boxplots illustrating the variation within the random forest and linear SVM
tuning results on a single ten-fold cross validation set respectively. The dark cyan boxes
show the results when tuning the original feature sets. The light cyan boxes show the
results when tuning the randomly labeled feature sets.
crucial in current biomarker research since it hugely influences medical decision making.
Our results indicate that the automated approaches can generally compete with manual
peak picking protocols carried out by experts in the field, at least with regard to subse-
quent health status classification. Although the manual peak picking remains the gold
standard, in medical studies yielding huge amounts of data one has to weigh the trade
off between a slightly higher accuracy (manual) and a huge increase in processing speed
(automatic). For example, a set of 100 MCC/IMS measurements is processed in less than
100 CHAPTER 6. EVALUATING AUTOMATED PEAK DETECTION
ten minutes, whereas an expert would need more than ten hours.
However, automated peak detection methods would process every kind of input, whereas
a domain expert would immediately recognize erroneous data. Although all methods per-
form almost equally good, the quite recently developed peak model estimation approach
slightly outperforms the other automated methods. PME is also robust against overfitting
in all tested learning approaches.
We conclude that all current automatic peak picking methods provide generally good
results. They are quite sensitive but might be improved in their specificity by optimizing
the number of peaks they predict per measurement. This will, however, be difficult to
implement while keeping the comparably high sensitivity rates.
Chapter 7
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This study was conducted in a collaborative fashion with Dr. Felix Maurer and
Kathrin Eisinger of the microfluidics & clinical diagnostics department at the
Korean Institute of Science and Technology (KIST). Kathrin Eisinger was re-
sponsible for the generation of experimental MCC/IMS and GC/MS data. Dr.
Felix Maurer conducted the manual data analysis and comparison to the auto-
matically mapped data. The author of this thesis developed the MIMA software
package for automated metabolite identification based on parallel GC/MS mea-
surements and the MCC/IMS substance database.
The previous chapters focused on the detection of peaks within MCC/IMS measurements
and the selection of those peaks suitable as potential biomarkers. The identification of
such molecules is crucial to distinguish between those that originate from confounding
factors or are directly related to a disease and can give further insights to molecular
background. To address this challenging goal in complex samples such as human exhaled
air, a reference database is necessary. Additionally, parallel measurements of GC/MS
and MCC/IMS technology may improve the accuracy of the analyte identification. The
MIMA (MS-IMS-Mapper) software tool was developed to automatically identify MC-
C/IMS peaks or generate a mapping between a MCC/IMS chromatogram and the corre-
sponding GC/MS data. It was previously published in the shared first author paper by
Hauschild and Maurer in 2014 (152), which is the main source of this Chapter. It demon-
strates the power of MIMA by successfully identifying the analytes of a 7-component
mixture.
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Objective:
Develop a fast and easy computational method for
assigning analyte names to yet un-assigned signals in
MCC/IMS data
Outline In the following, the automated workflow for processing GC/MS and MC-
C/IMS measurements is introduced to analyse a same sample performed in parallel. After
discussing the state of the art and requirements of such a system, the section will explain
the experimental setting used to demonstrate MIMA’s functionality in detail: An ana-
lyte mixture of 7 reference compounds will be analyzed by using MCC/IMS directly and
additionally via TENAX tubes and thermo desorption GC/MS. The Section 7.2 will out-
line the workflow behind MIMA’s automatic mapping procedure. A comparison between
MIMA and other previous methods and tools will be presented in the discussion.
7.1 Requirements and State of the Art
The most straightforward identification process is to utilize an MCC/IMS reference
database and manually match the entries to detected peaks. However, existing MC-
C/IMS reference databases are still in their infancy and do not currently identify all
analytes.
As mentioned earlier, another common approach relies on supplementary GC/MS mea-
surements of the same air sample. Decades of GC/MS research led to automated analysis
software for both GC/MS preprocessing, peak detection as well as sophisticated identifica-
tion. The mass spectrometric technology provides specific fragment profiles and therefore
enables the identification of compounds using various commercial databases. The largest
and most widely used is the NIST/EPA/NIH mass spectral library, which was developed
by the NIST and contains several hundred thousand entries. In contrast, the MCC/IMS
technology has developed more recently and, at time of publication, only preprocessing
and peak detection methods have been automated.
The MCC/IMS peak identification via corresponding GC/MS data requires a parallel
analysis of both, GC/MS and MCC/IMS data in many different manual steps. First the
data is analyzed with the firmware of the GC/MS manufacturer and compared to the
NIST-library (version 2.0, 2011)1. The first hits of the NIST-library search are subse-
quently screened by hand according to certain criteria for promising analytes. A typical
exclusion criterion is whether a molecule is non-volatile and cannot occur in an exhaled air
sample. Finally each of these analytes is searched for, within the MCC/IMS measurement,
utilizing the MCC/IMS firmware and a given IMS reference database (MCCIMS-DB) file.
To overcome this time-consuming and tedious manual procedure of peak identification,
the developed MIMA software tool has to fulfill the following requirements:
1see http://webbook.nist.gov/chemistry
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MIMA
Requirements:
⇒ An intuitive graphical user interface for the
identification of VOCs detected by MCC/IMS.
⇒ Main Tasks:
I) Finding the closest known molecule in the given
MCC/IMS database.
II) Mapping the MCC/IMS peaks to molecule
peaks detected within a parallel GC/MS
measurement.
7.2 Implementation
The suggested procedures rely on the previously developed methods for preprocessing
and peak detection.
7.2.1 MCC/IMS - MCC/IMS Mapping
The first approach solely requires the MCCIMS-DB file. For each MCC/IMS peak, it
searches for the closest fit within the given database file. We introduce four different
definitions for closeness that the user can choose:
1. Minimal Euclidean distances between the coordinates.
2. Maximal overlap of the two defined peak regions.
3. Equivalent to option 1. and maximal overlap in case the distances are indecisive.
4. Equivalent to option 2. and minimal Euclidean distance in case the overlap is
ambiguous.
7.2.2 MCC/IMS - GC/MS Mapping
The second approach relies on the parallel GC/MS measurements. Here, the whole process
of NIST-library extraction and IMS reference database lookup can be organized in the
following two main automation steps, see Figure 7.1.
Step 1: In the first step of the workflow, the OpenChrom software (version 0.8 2, BMC
Bioinformatics, 2010) is utilized to preprocess the GC/MS data (228). OpenChrom
is an open source application for chromatography and mass spectrometry, which is
capable of reading and analysing different kinds of MS data formats (e.g. GC/MS,
2see https://www.openchrom.net/
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Figure 7.1: Schematic view of the step by step process
LC/MS, Py-GC/MS, HPLC/MS) (228). The software provides a batch functional-
ity, to automatically process the chromatograms as follows:
A) Automatic peak finding within the chromatogram. (In our example, a GC/MS
measurement is utilized).
B) The signature of each peak is matched against the NIST-library and annotated
by a predefined number of most likely candidate molecules.
Finally, the procedure exports the list of MS peaks and a list of best matching
NIST-library candidates for each peak.
Step 2: In the second step of the workflow, the exported files are processed by the MIMA
software. For each MS peak in the list, the following steps are performed:
A) The corresponding NIST-library entries and their chemical abstract service
number (CAS-number) are extracted.
B) Each CAS-number is matched to the entries within the IMS reference database
file.
C) The IMS references successfully mapped to a CAS number are added to the
final IMS peak list.
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Once all MS peaks are processed, the duplicate list entries are removed and the IMS
peaks are saved to a new file, named IMS layer. An IMS layer mainly contains a list
of analytes and the corresponding coordinates within the MCC/IMS-chromatogram
(retention time RT and inverse reduced mobility 1/K0), as well as the radii repre-
senting the typical peak expansion in both directions. This information is extracted
from the MCC/IMS reference database file.
Note, the NIST-library contains non-volatile substance which might occur as first sug-
gestion in the search. Therefore, the MIMA package supports several rules to take a
set of NIST-library matches into account. The user can chose between three options (a)
All Analytes, considering all proposed analytes with the GC/MS peak list; (b) Best
Matching Analyte, selecting the first analyte in the GC/MS list that occurs in the
MCCIMS-DB file and (c) Best Analyte, solely searching for the first NIST-library hit
for each GC/MS peak in the MCCIMS-DB file. However, the matching to the MCC/IMS
reference database extracts only appropriate (e.g. volatile) substances from the NIST-
library selection.
Finally, the layer can be superposed on the IMS chromatogram, which corresponds to the
processed mass spectrometric chromatogram.
7.3 Results
The reliability of the MIMA strategy was tested by parallel GC/MS and MCC/IMS mea-
surements of a reference substance mixture containing 7 components. Subsequently an
automated MIMA analysis of the GC/MS data was performed, resulting in the previously
described IMS layer. This layer was overlayed on the MCC/IMS data that was measured
in parallel, see Figure 7.2. In total 24 GC/MS substance candidates identified by the
National Institute of Standards and Technology (NIST) database could be matched to
the MCC/IMS reference database. By discarding candidates that do not show a peak
in the MCC/IMS measurement, 17 signals in the IMS chromatogram could be identified
using the GC/MS layer. The assigned signals are summarized in Table 7.3. In total, 12 of
the 17 signals arise from the reference analytes as well as their dimers and trimers. Inter-
estingly the analytes No. 5 and 14-17 were not part of the reference analyte mixture, but
could, given their patterns known from previous studies, be clearly identified as decanal,
n-nonan and heptanal. As component in many fragrances it may have its origin in the
room air and entered the IMS during sampling. However, the appearance of all 7 used
reference compounds in the automatically generated layer confirms the functionality of
our software solution.
7.4 Discussion and Conclusion
The mapping of the GC/MS and MCC/IMS data was tested successfully by parallel mea-
surements of a 7 components mixture of reference substances. The results demonstrate
that the MIMA software tool extracts correct annotations for the MCC/IMS signals when
processing the accompanying GC/MS measurement data with the aid of OpenChrom and
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Table 7.1: Automatically identified signals
No. CAS compound
1 112-44-7 undecanal
2 104-46-1 anethol (trans-anethol)
3 6485-40-1 carvon (monomer)
4 6485-40-1 carvon (dimer)
5 112-31-2 decanal
6 2216-51-5 (-)menthol (monomer)
7 2216-51-5 (-)menthol (trimer)
8 821-55-6 2-nonanon (monomer)
9 821-55-6 2-nonanon (dimer)
10 5989-27-5 D-limonen (monomer)
11 5989-27-5 D-limonen (dimer)
12 110-43-0 2-heptanon (monomer)
13 110-43-0 2-heptanon (dimer)
14 111-84-2 n-nonan (monomer)
15 111-84-2 n-nonan (dimer)
16 111-71-7 heptanal (monomer)
17 111-71-7 heptanal (dimer)
NIST. Although the identification of all 7 reference compounds by the automatically gen-
erated layer demonstrated the functionality of the software, it needs to be emphasized
that this shall not reflect a propper large-scale evaluation. However, it demonstrates the
reduction in time consumption compared to similar manually performed data analysis
steps which is MIMA’s main aim.
Figure 7.3 shows the time expenditure evaluation of the automatic workflow compared
to the manual procedure. While the MCC/IMS measurement is reasonably fast, the
GC/MS measurement is equally time-consuming than the manual analysis (about 2h).
However, the GC/MS procedure can be automated and run over night. The manual
analysis of a standard human breath or air sample, comprising the GC/MS and MCC/IMS
chromatogram evaluation (about 1h) as well as the combination of the results typically
takes more than 2 hours, even for experienced users. The presented workflow with MIMA
will reduce this time to about 10 to 15 minutes. Furthermore, all tools in the workflow are
able to automatically process several measurements sequentially. An example workflow
as well as step-by-step instructions are available at the MIMA website3.
In comparison to other methods our workflow improves the automatic peak identifica-
tion in MCC/IMS chromatograms. Peak identification by alignment of MCC and GC
retention times, for instance, needs a manual and time-consuming comparison of the
chromatograms, which results in suggestions for the MCC/IMS signals. (117)
A previously presented software package for the comparison between MCC/IMS and
GC/MS spectra has been published by Bunkowski et al. 2010 (48). They propose a
mathematical function to convert MCC/IMS retention time in GC retention time and vice
versa. Nevertheless, the major drawback of this software is the mathematical function,
3http://mima.mpi-inf.mpg.de
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Figure 7.2: One MCC/IMS spectrum including the MIMA-generated layer (rectangles).
which was fitted on a small number of measured analytes, resulting in a reduced accuracy.
Because of the relatively low number of analytes the curve could not be fitted exactly for
all different analyte classes. Therefore, it remains a first approximation.
The main restriction of MIMA is the limited number of compounds in the existing IMS
reference database (about 600 compounds) (37; 223), which are used in comparison with
the NIST mass spectra database (212,961compounds) to generate the layer. The fact
that missing analytes cannot be displayed despite their presence in NIST necessitates the
extension of the existing IMS reference databases. The current version of OpenChrom
can provide a number of highest ranked candidate substances from the NIST suggestions.
Given that the first suggestion is not in the IMS reference database (e.g. solid matter)
the MIMA analysis can search for the next best NIST candidate to identify this peak.
However, it is not able to choose the substance which fits best the IMS-measurement of
interest. This remains a possible extension for future projects.
Still, this work presents the first software tool capable of automatic and thus effective
mapping of MCC/IMS and GC/MS spectra by integrating two machinery-specific sub-
stance databases. This eases analyte annotation by using the MCC/IMS signals, which
are stored in the MCC/IMS reference database file. Essentially, the proposed workflow
reduces the workload for the spectra analysis from more than two hours to less than 15
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Figure 7.3: Time expenditure evaluation of the manual and automatic workflow, esti-
mated for a standard human breath or room air sample containing 30 to 40 compounds
performed by an experienced postdoctoral researcher in our lab.
minutes and enables a sequential processing of many large-scale experiments. Evalua-
tion of the MIMA software on more complex samples will be carried out over the next
years when more MCC/IMS reference annotations become available in the MCC/IMS
databases.
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Uncovering Hidden Structures
with CAROTTA
The project was initiated during the course of the Bachelor thesis of Tobias Frisch
that I supervised. Tobias Frisch developed a Java and R based software package
including a data handling and visualization in Java, and machine learning in
R. During the development of the Carotta framework, the author of this thesis
refactored the structure of the data handling and processing towards a modu-
lar plug-in based system. The R functionality was replaced by Java packages.
Finally, the author refactored the user interface and added an automatically
generated parameter wizards.
Carotta is a new cluster analysis framework dedicated to uncovering hidden substructures
with the aid of sophisticated unsupervised statistical learning methods, as described in
Section 1.3. This chapter examines the performance of transitivity clustering and hi-
erarchical clustering with regard to two aspects. The first task is concerned with the
identification of groups of patients with a similar VOC intensity pattern. The second
task is concerned with the identifiaction of groups of VOCs with a similar expression
behavior across most patient breath samples. This analysis allows for the discovery of
dependencies between metabolites, which as two advantages: On the one hand, the ef-
fect of potential confounding factors hindering disease classification can be eliminated.
Examples for confounding factors can be behavioural or environmental factors, such as
smoking, nutrition, or contaminations of the inhaled air. On the other hand, VOCs asso-
ciated with disease subtypes or concomitant diseases can be identified.
Carotta is an open source software with an intuitive graphical user interface that can fa-
cilitate data handling, analysis and visualization. The back-end is designed in a modular
fashion, which makes it easily expandable with additional features. Thus, new clustering
methods and further statistical measures could be included in the future. Furthermore,
neiter extensive prior knowledge nor comprehensive technical skills are required for oper-
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ating Carotta’s functionality. This functionality is demonstrated by means of one artificial
data set. Moreover, to evaluate the power and applicability of the methodology, Carotta
is applied to the real-world example data set on COPD described in Chapter 3 (106).
Objective:
Development of an intuitive graphical software
framework for nested unsupervised learning on
breathomics data.
8.1 Requirements and State of the Art
Several data analysis frameworks have been developed to process, visualize and analyze
metabolomics data, particularly for GC/MS data. Some of them focus on the prepro-
cessing of raw data, but include advanced methods for alignment, peak detection, and
peak identification, e.g. mzMine (179). Others, such as the web application MeltDB,
address issues concerning storage, sharing, and standardization of metabolomics data, as
well as a binding to the R software package(115). This allows for the application of the
whole wealth of statistical data analysis tools integrated in R (124). However, the use of
R requires programming knowledge. More advanced services, such as XCMS Online (94)
and MetaboAnalyst (238), offer advanced statistical analysis techniques. XCMS Online
is optimized for LC/MS data and offers various parametric as well as non-parametric test
statistics, as well as extended visualizations for meta-analysis (Venn diagrams, for in-
stance). It further offers unsupervised learning techniques and visualization capabilities,
mainly PCA and HAC. However, it lacks adequate measures for internal and external clus-
tering quality, which are essential for evaluating the information content of the clusterings
and for selecting reasonable clustering parameters/thresholds. The MetaboAnalyst web
server also provides access to GC/MS data pre-processing, multivariate statistics, and
PCA, but focuses mainly on supervised learning and time series analysis afterwards. It
supports advanced learning methods, such as partial least squares, discriminant analysis,
and random forests as well as an evaluation framework, with which cross-validation, per-
mutation tests, and ROC curve analysis can be performed. However, it does not support
features for systematically exploring the results of unsupervised data processing technolo-
gies.
The design of Carotta was encouraged by this lack of comprehensive and user-friendly
software systems to fill the gap between the quickly emerging breathomics data sets and
the challenges of current breath data analysis as described in Section 1.2. The aim of the
Carotta project is a software application that provides easy access to advanced unsuper-
vised learning techniques specifically designed for breath data analysis. It addresses two
main goals, a user-friendly front-end as well as a flexible and modular back-end that al-
lows for functional extensions. Since the target users are biomedical researchers, an access
to these techniques without deeper knowledge of advanced computational approaches is
necessary. This requires a step by step guidance through the different steps of unsuper-
vised learning analysis, starting with the similarity function, clustering, cluster quality
evaluation, filtering and dimensionality reduction. Moreover, to increase the understand-
ing of the results and support in-depth investigation directly in the user interface, each
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intermediate or final result should be presented to the user by an interactive visualiza-
tion. Furthermore, a flexible plug-in system would allow future methods to be added in a
straight-forward fashion. This includes all described methodology of the steps: similarity
measure, clustering, clustering quality and dimension reduction.
Requirements:
⇒ User-friendly front-end supporting easy access to
unsupervised learning methods
⇒ A flexible and easily extensible back-end.
⇒ Detailed visualization of data and results.
8.2 Structure and Implementation
The Carotta software framework provides interactive pipelines that can reveal hidden
structures in metabolomics breath data. The typical Carotta workflow consists of six
processing steps depicted in Figure 8.1. Each of the six steps will described in detail in
the following paragraph.
Step 1 In the first step of the Carotta workflow, the data sets are imported into the sys-
tem and displayed. Prior to the import, the raw data is preprocessed by technology-
specific preprocessing methods, such as baseline correction, denoising, as well as
peak detection (for MCC/IMS and GC/MS), such that a data matrix, as shown
in Figure 8.1, is generated. This can be done by corporate or open source soft-
ware products such as VisualNow (B&S Analytics)(35) and OpenChrom(228). A
typical data matrix contains the relative compound abundances for each sample
measurement that correspond to objects of interest, such as patients. The matrix
resulting from the preprocessing of a set of MCC/IMS measurements comprises the
MCC/IMS peak intensities. This process is described in detail in Section 2.2 of the
Background Chapter.
Step 2 We define pairwise relation as a measure for the strength of an association be-
tween two objects that can either be a similarity or distance. The Carotta software
supports three different measures: correlation coefficient (Pearson or Spearman),
or Euclidean distance (154), that can be calculated on either study subjects (e.g.,
patients) or metabolites. The correlation coefficient corresponds to a similarity and
the Eucledian distance to a dissimilarity matrix, see Section 2.5.2 for more details.
These pairwise relations are stored in a matrix and depicted by a heat map. All
further methods require either a similarity or a dissimilarity matrix; therefore, the
dissimilarity matrix is converted into a similarity matrix, and vice versa, according
to the requirements of the following method. This is done as follows: The conver-
sion of a similarity matrix to a dissimilarity matrix is performed as follows. Let S
112 CHAPTER 8. UNCOVERING HIDDEN STRUCTURES WITH CAROTTA
Clustering and Quality Measures
Clustering Quality
Clustering Threshold
C
lu
st
er
in
g 
Th
re
sh
ol
d
Health
Smoking
Nutrition
C
lu
st
er
in
g
D
at
a 
S
el
ec
ti
on
V
is
u
al
is
at
io
n
1
1
1
1
0
0
0
0
0
1
1
1
1
0
0
0
0
1
1
1
0
0
1
Data and Similarity Matrices
Data
S
im
ila
ri
ty
 M
at
ri
x
1
2
5
4
63
MDS Visualisation of Similarity MDS Visualisation of Clustering
Figure 8.1: The Carotta pipeline consists of several steps: (1) importation of pre-processed
data; (2) similarity calculation; (3) clustering; (4) clustering quality; (5) similarity or clus-
tering visualization; (6) subset selection. Intermediate results can be inspected, optimized,
and repeated with an arbitrary depth.
be the matrix containing the original similarity values, where s(x, y) corresponds
to the similarity of object vectors x and y. Then dˆ(x, y) = max(|S|) − |s(x, y)|,
defines the dissimilarity of x and y constructing the dissimilarity matrix D. The
conversion of the dissimilarity matrix to a similarity matrix is defined accordingly:
sˆ(x, y) = max(|D|)−|d(x, y)|, where D is the original dissimilarity matrix. Further,
these pairwise relations can be visualized in a two-dimensional scatter plot by using
MDS (241), such as depicted in Figure 8.1, Step 5. Details on the multidimensional
scaling approach can be found in Section 2.5.1.
Step 3 A clustering algorithm can be applied to the similarity or dissimilarity matrices
calculated in Step 3. The system integrates two state of the art clustering algo-
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rithms. The furst algorithm is hierarchical agglomerative clustering (101), which
is based on pairwise dissimilarities. The second algorithm is transitivity clustering
(TC) (234), which is based on similarities. Details on the methodology of the clus-
tering algorithms are given in Section 2.5.2. The result of a clustering algorithm is a
list of clusterings, each corresponding to a certain threshold. The thresholds depend
on the method and the selected parameters. For clarity, this Chapter will refer to
the set of all clusterings as the clustering result and to each individual clustering
solely as clustering.
Step 4 The quality of these clusterings is evaluated and compared by means of two
quality measures, the silhouette value and the F-measure.
Step 5 At this step, several clusterings and clustering results may have been produced.
The user can choose to visualize each individual custering using the MDS coor-
dinates of the underlying similarity. The resulting scatter plot is color-coded by
cluster.
Step 6 Finally, filtering methods can be utilized to select a subset of the data. For
example, the user can choose a certain clustering and extract a representative for
each cluster or select all objects in one cluster.
By repeating steps one to four on the selected subsets of the data, Carotta explores
various layers of potentially hidden sub-structures. Especially the nested-clustering of
metabolites and samples can reveal novel information; see Figure 8.2.
In short, Carotta can be used to split the set of metabolites into subsets (defined by clus-
ters), which, in turn, can be used individually to inspect their association with the primary
outcome variable, i.e., the disease. This allows for eliminating large sets of metabolites
that correlate with potential confounding factors and not with the investigated disease.
In this way, uninformative features are eliminated. Most notably, Carotta automatizes
these steps and intuitively visualizes intermediate and final results.
8.2.1 Visualization of Data and Results
The graphical user interface (see Figure 8.3) is split into three basic regions: (1) the data
and results area, showing a list of all generated results ordered in a tree-like structure;
the categories correspond to the previously described processing steps (data, similarity,
clustering results, clustering quality, visualization); (2) a details panel, reporting the
parameter used for the calculation of the currently presented result; this also includes, for
instance, general information on the data set (such as the minimum and maximum values);
(3) the main result visualization panel displays the results of the different intermediate
steps, as well as the final results. The following paragraphs describe the visualization of
each of the steps introduced Section 8.2, in the graphical user interface.
Data and similarity matrix. Each data or similarity matrix as described by Step 1
and 2, is displayed as a heat map tagged by the corresponding metabolite names and
sample label, on the columns and rows, respectively. Labels can be changed to arbitrary
annotation details included in the original data matrix.
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Figure 8.2: The subset selection allows for a nested analysis of the hidden structures
in the data. Steps 2–4 from Figure 8.1 are repeated on a selected subset (or all subsets).
In this example, the artificial data is first clustered by metabolites. In the next step, a
threshold is selected that splits the data into three metabolite clusters and the data is
separated accordingly. Subsequently, the data for each of these metabolites is used sepa-
rately to access the distances between the samples (patients). These similarity matrices
are further used for clustering the samples. Finally, an external quality measure is used
to evaluate the association of each set of metabolites to the selected patient annotations
(i.e., labels; here: health, nutrition and smoking). The F-measure plots show to what
extent the metabolite clusters explain the different labels.
Clustering. The heat map of the underlying similarity matrix is displayed in the center
of the visualization of the clustering results. The rows and columns are sorted by the
corresponding clustering. For hierarchical clustering, results can be inspected interac-
tively by selecting a clustering threshold. This is facilitated by sliders at each of the two
dendograms which can be altered by using the mouse. Leaf nodes correspond to clustered
objects; inner nodes depict how the data set is split (top down) or merged (bottom up)
during the clustering. For the transitivity clustering (hierarchical = FALSE), one can
manually adjust the threshold through a bar on the right side. Depending on the selected
cut, colors encode the resulting clusters. Note that this does not depend on the selected
clustering method. The axis labels can be defined by the user.
Cluster quality. The quality of a clustering can be evaluated for varying cuts/thresh-
olds and visualized by line plots, see Section 2.5.2 for details on the utilized quality
measures. The F-measure is most appropriate to identify which threshold best reflects
a given labeling or gold standard. Using Carotta, the F-measure can be calculated and
visualized. In order to compare different class labels with respect to their consistency
8.2. STRUCTURE AND IMPLEMENTATION 115
Figure 8.3: The graphical user interface is split into three basic regions: (A) the data
and results area lists available (intermediate and final) results; (B) the details panel
lists attributes of the data, such as mean or minimum values, or the history of previous
processing steps; (C) the main result panel displays the visualization of the intermediate
and final results.
with a specific clustering, several labels can be selected by the user and visualized in a
single F-measure line plot. Equally, different clusterings can be selected and compared to
a single label. However, if a data set does not provide a gold standard, a reasonable cut or
threshold for the clustering can be identified by the internal quality measure: silhouette
value.
Multi dimensional scaling. The visualization of the similarity of a set of objects is
provided by a customizable scatter plot, based on coordinates determined by the MDS.
Besides the custom-defined labeling, the depiction of a clustering result can be colored
according to a chosen threshold. This representation can give the first indication of
whether a clustering is “good”.
8.2.2 Modularity and Extendibility
Due to the modular structure of Carotta, new functionality can be integrated easily.
Each of the previously described processing steps (similarity, clustering, cluster quality,
and visualization) can be expanded by additional methods and implementations. Java re-
flections guarantee a comfortable plug-in system that does not require any further editing
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of the previous code.
8.2.3 Import and Export
Convenient functions for exporting all intermediate and final results are included. The
system can export all visualizations of Carotta, as described before. The user can choose
between different resolutions of the resulting portable network graphics (PNG) image file.
Carotta further supports exporting into an MS Excel file (e.g., a similarity matrix or the
results of the quality measure).
8.2.4 Language and Packages
The Carotta software package and associated software libraries are purely Java-based.
The source code is available at the project website and underlies the Apache License
Version 2.0. More information on the technical aspects can be found in the Appendix
and the following address: http://carotta.compbio.sdu.dk/ (106). Carotta makes use of
the following software packages:
 The TransClust package for transitivity clustering (235).
 The HAC package for hierarchical agglomerative clustering (190).
 JExcelApi 2.6.12 for parsing the excel sheet into the internal data structure (JEx).
 The JFreeChart 1.0.14 visualization (clustering quality, scatter plot of MDS) (90).
 JHeatChart 0.6 for creating the heat map (JHe).
 The MDSJ calculation of the multi-dimensional scaling (6).
 The Guava & Reflections & Javassist Google Core Libraries (gua) and the Javas-
sist (57) are used for the reflections technology.
 log4j 2.0 for logging and debugging (3).
8.3 Results and Discussion
To demonstrate the abilities of the Carotta clustering framework, we analyze two data
sets, described in Chapter 3. At first, we discuss the results of the artificial data set,
followed by the real world COPD data set.
8.3.1 Results for Artificial Data Analysis
The artificial data set to demonstrate and clarify the capabilities of Carotta. It consists
of 16 samples and 12 metabolites associated with three metabolite groups. Each of these
groups is related to one of the three predefined labels of the samples: (1) health; (2) smok-
ing ; (3) nutrition while the label health is our primary outcome variable, the remaining
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label smoking and nutrition represent potential confounding factors. See Section 3.4 for
more details.
This data set is used to exemplify the power of Carotta. First, the Pearson correlation
coefficient is used for calculating the similarities between all metabolite occurrences, and
clustered them by both HAC and TransClust. Disregarding the clustering method, the
silhouette value indicates, an optimum of three different metabolite clusters, as expected.
As shown in Figure 8.2, the full data set is now split into three subsets, one for each cluster
of correlating metabolites. Subsequently, for each cluster, as well as for the full data set,
the Euclidean distance between all pairs of patient samples is computed for each cluster
separately. The three resulting clusterings gained from the three metabolite subsets are
compared against the clustering achieved with the full metabolite data. Therefore, the
F-Measure is used to assess the overlap of the four different clusterings with the initially-
designed class labels (health = green, smoking= red and nutrition=blue). Figure 8.4
shows the results of this clustering evaluation in terms of a line plot for each clustering
and a colored line for each label. In this artificial example, the entire data set is heavily
confounded by the influence of the smoking-related metabolites. Therefore, the cluster-
ing of the entire data set using all metabolites is heavily influenced by smoking related
metabolites that dominate the distance measure for the patients, see red curve in Figure
8.4. Consequently, the clustering of the entire data set does not reflect any overlap with
the gold standard label for health, depicted by the green curve. A detailed analysis of the
F-Measure curves for the clustering on the three subsets of the data (A, B, C), reveals
strong relations between the metabolite subsets and annotations: subset A and smoking,
subset B and health, and subset C and nutrition. Thus, according to the F-Measure, the
metabolites in subset A and C correspond to confounding factors. Solely the metabolites
clustered in subset B contain information that relates to the gold standard label of the
samples: health.
8.3.2 Results for COPD Data Analysis
COPD is an inflammatory lung disease characterized by a permanent blockage of airflow
from the lungs, which is not fully reversible. Here, we study the exhalome of COPD
patients using a data set from (231), described in detail in Chapter 3. It consists of
metabolic maps from 42 COPD patients, 52 patients suffering from both COPD and
bronchial carcinoma, as well as 35 healthy controls. The patients’ breath was captured
and analyzed using an MCC/IMS, as introduced in Section 2.1 of the background Chap-
ter. This data set was evaluated utilizing Carotta, following the previously introduced
standard workflow described in Section 8.2. At first, all 120 metabolites were clustered by
HAC and the Pearson correlation (converted to dissimilarity, as explained above). Several
thresholds were investigated, leading to a varying number and size of the clusters. This
resulted in an optimal threshold at T = 40. Subsequently, the set of metabolites was split
into 40 subsets, one for each cluster of correlating metabolites. All clusters with less than
three compounds were excluded, yielding a total of 14 metabolite sets.
Finally, the hierarchical agglomerative clustering was performed on the correlation matrix
(converted to the distance matrix, as previously described) of the patients for each of these
metabolite sets. Carotta subsequently evaluates the overlap of the patient clusters with
the three patient groups over varying clustering thresholds using the F-measure. Figure
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Figure 8.4: Result of the nested hidden structure analysis applied to the artificial data set.
Each plot depicts the F-Measure evaluation of the clustering on one of the four different
data sets: Entire Data Set, and each of the distinct Metabolite Subsets A-C. The subsets
were previously determined by a clustering of the metabolites. The lines show the F-
measure for the labels: health in green, smoking in red, and nutrition in blue, for every
clustering threshold. The top left plot depicts the result for the entire data set, it shows
a dominant effect of the confounder smoking, which overlays the main outcome variable
health. The other three plots show the results for each cluster of correlated metabolites,
separately. Each of the metabolite subsets clearly corresponds to one of the three labels:
health, smoking, and nutrition.
8.6 plots the results for four of the 14 metabolite subsets, as well as the results when
using the entire set of metabolites. For better visualization, only the five most interesting
results are displayed in the Figure 8.6. Specifically, the F-measure is plotted for the
entire metabolite set, the two metabolite sets with the highest F-measure and the two
metabolite sets with the lowest F-measure. Each patient is annotated with one of three
groups: healthy, COPD, or COPD+BC. Thus, the overlap of the clustering results at
T ∼ 2, corresponding to two splits of the data resulting in three clusters is investigated.
One can see two metabolite clustering subsets, namely Subsets 1 and 14, that peak around
three clusters. Both exceed the F-measure achieved using the full metabolite set.
The compounds within these clusters were compared manually (via their specific peak
coordinates) to the results of previous COPD studies utilizing supervised learning method-
ology (103). Three of the compounds in Subset 1 were previously reported as potential
biomarkers. This shows that the presented stepwise multi-dimensional clustering ap-
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Figure 8.5: Comparison of the clustering results of the 14 metabolite clusters. The plot
shows the F-measure for different clustering thresholds computed against the disease
annotation (COPD, COPD with BC, and healthy). Since the annotation defines three
groups of patients, the performance of the clustering results at a clustering threshold of
3 is of particular interest (x-axis).
proach points out putative COPD marker metabolites by using a purely unsupervised
approach. In contrast, the metabolites in Subsets 3 and 4 show a rapid decrease in the
F-measure for a growing number of clusters. The evaluation of the list of compounds
within these clusters uncovered that these subsets contain the menthol trimer (Subset 3),
as well as the menthol monomer and dimer (Subset 4) compounds, respectively. The oc-
currence of menthol in human exhaled air can be the result of various environmental and
nutritional influences, for example tooth paste or candy. This exemplifies where Carotta
is useful: when we expect yet uncharacterized confounders to exist, which have an effect
on the metabolic patterns that we like to detect and exclude. The human exhaled air in
particular can be influenced by various external factors, like nutrition and compounds in
the environmental air. They do not need to be known a priori, however. The menthol
example in human breath serves as a proof of concept here.
However, further analyses of the clustering results would be beneficial. It is of particular
interest to focus on the investigation of the extent to which the elimination of putative
confounding metabolites would improve the classification performance in a systematic
statistical learning study. This clearly goes beyond the focus of this work and should be
addressed in the future.
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Figure 8.6: Comparison of the clustering results on the entire COPD data set, i.e., using
all metabolites and the four most interesting metabolite clusters, including two clusters
showing the largest F-Measures and two clusters showing the smallest F-Measures. The
plot shows the F-measure for different clustering thresholds computed against the dis-
ease annotation (COPD with BC and healthy). The Y-axis corresponds to the clustering
threshold, in this case the number of splits. Given three groups of patients in the anno-
tation, we are particularly interested in the performance at T ∼ 2 (x-axis) resulting in
three clusters. This is shown in more detail in the zoomed cutout, as well as the table
of F-measure values at this position. Two subsets of metabolites overlap with the pa-
tients’ disease annotation better than the clusterings based on the entire metabolite set.
The two other metabolite subsets result in reduced F-measures, indicating a relation to
confounding factors, in this case menthol.
8.3.3 Comparison to Existing Software
A number of other data analysis frameworks for metabolomics data processing are avail-
able. However, most of them focus on a single task, such as preprocessing, storage and
distribution, or statistical analysis. Examples for this are mzMine (179) or MeltDB (115).
Other services, such as XCMS Online (94) and MetaboAnalyst (238) provide advanced
learning techniques for metabolomics data. Similar to Carotta, XCMS Online offers un-
supervised learning techniques and visualization capabilities. However, in contrast to
Carotta, it does not provide means for systematically exploring adequate measures for
internal and external clustering quality, which are essential for evaluating the information
content of the clusterings and for selecting reasonable clustering parameters/thresholds.
The MetaboAnalyst web server is designed for GC/MS data processing and supervised
learning. Nevertheless, the system is lacking features for the systematic analysis of cluster-
ing results. In contrast, the focus of Carotta lies in the de novo detection of confounding
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factors. For instance, Carotta can be used for performing an unsupervised analysis of
breath data sets which detangles potential biomarkers and confounders.
Existing methods for such multi-dimensional clustering, such as bi-clustering or co-
clustering (44; 205), do not provide graphical frameworks for systematically exploring the
parameter space. With Carotta, however, a sequence of various clustering combinations
of metabolites and samples can easily be used for investigating all results visually and
systematically while using different validity measures.
It needs to be emphasized that the main focus of Carotta is breath data analysis, yet its
utility is neither limited to MCC-IMS data nor to breath gas profiling. Applications in
transcriptomics (gene expression data) or related omics fields are generally possible. This
thesis focuses on breath data only. This kind of data is infested with yet undiscovered
confounders that emerge from the environment, nutrition or ambient air. In additon to
the high prevalence of systematic confounders in breath data, it might also be prone to
various types of technological noise. An extensive analysis of their effects is needed and
introduces interesting new research questions.
Unlike all other tools, with the expeption of MetaboAnalyst, Carotta allows for direct
processing of a metabolomics peak matrix (regardless of the utilized technology). Metabo-
Analyst, however, does not support systematic clustering exploration. The MCC/IMS
community has established a number of standard procedures for pre-processing, and a set
of integrated tools has been developed in the past; see (199; 61; 37). Like other frame-
works, Carotta does not yet include all of these standard procedures for pre-processing.
However, its flexible plugin architecture can be used for implementing preprocessing pro-
cedures, among other novel features, such as additional statistical learning approaches.
8.4 Conclusion
In this chapter the Carotta software for de novo detection of confounding factors and
disease sub-types is presented. It is open source and comes with an intuitive graphical
user interface for unsupervised breathomics data analysis and visualization. The flexible
back-end design can be easily extended with plugins, such as new clustering methods and
statistics. It intuitively guides the user through four steps: (1) (dis-)similarity matrix
computation; (2) clustering; (3) clustering evaluation; and (4) visualization and inter-
pretation of the results. This process requires neither extensive knowledge or advanced
technical skills to operate and is therefore suitable for non-technically trained person-
nel. By means of an artificial data set, the functionality and applicability of the Carotta
software framework for revealing hidden structures and confounding factors was demon-
strated. Additionally, the power of Carotta in practice was exemplarily shown by the
reanalysis of the real-world data set on COPD. It demonstrated how Carotta is useful in
finding potential informative metabolite clusters containing substances also supported by
previous studies. Most notably, it identified confounder metabolites (e.g., menthol), which
are related to nutrition and to the environment rather than to the primary outcome vari-
able (disease annotation, i.e., COPD and lung cancer). The Carotta software framework
offers easy access to extensive clustering analysis for non-technical personal working in
the area of breathomics. It is publicly available at http://carotta.compbio.sdu.dk (106).
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Longitudinal Breath Analysis
This chapter is based on a collaborative project with the Department of Anesthe-
siology, Intensive Care, and Pain Therapy, Saarland University Medical Cen-
ter, Homburg (Saar), Germany and the Division of Biostatistics, University
of Southern California (USC), Los Angeles, United States. The collaboration
partners in Homburg were responsible for sample preparation, generation of the
longitudinal experimental data set and assisted with the interpretation of the re-
sults. Prof. Dr. Sandy Eckel from the USC supervised the project and gave
valuable insights into longitudinal statistical analysis techniques. The author of
this thesis designed and implemented the pipeline for longitudinal analysis of
breath data and conducted the statistical evaluation of the example data set.
The majority of current breathomics research is restricted to investigations on cross-
sectional snapshots of a specific disease. However, most diseases traverse various stages
during their development, or emerge towards different subtypes depending on influences
such as genetics, environment or medication. Common examples are for instance the evo-
lution of genetic variants in cancer (164; 95), COPD stages (88), sepsis progression (176)
or lateral sclerosis (239). Thus an analysis that focuses on a single time point of the
patients’ metabolite pattern may overlook potential biomarkers. These so-called longitu-
dinal biomarkers show a relative change over time, which can be much more informative
than a single observation. A recent study of Langley et al. suggests that this might be
the case for sepsis in primates as well (135). Sepsis is the leading cause of death among
critically ill patients in USA and Europe and the number of incidences and sepsis-related
deaths is increasing (153; 194). It is caused by an uncontrolled, systemic, inflammatory
response to bacterial, viral or fungal infection. However, we lack a rapid and accurate
identification method for sepsis and its causative microorganisms, which would be essen-
tial to increase the chances of survival. Today, using the current diagnostic gold standard,
at least 24 hours are needed to get preliminary information on the causal organism, using
cultures of blood and other body fluids or tissues.
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Objective:
Development of a comprehensive framework for
longitudinal breath analysis using the specific
example of sepsis in rats.
9.1 Requirements and State of the Art
More recent approaches to diagnose sepsis use real-time polymerase chain reaction or
calorimetry to obtain a more rapid diagnosis of bacteria or fungi based sepsis. However,
the causative microorganism can be identified in the blood in only 20-40% of patients
with severe sepsis (193). Large false positive and false negative rates are common. Other
metabolomics or proteomics-based studies proposed more than 170 different compounds
as potential biomarkers, but so far none of them have sufficient specificity or sensitiv-
ity to be routinely employed in clinical practice (176). To address the unmet clinical
need for early and reliable diagnosis of sepsis, rapid and cost-efficient diagnostic tools are
needed (193).
MCC/IMS a Diagnostic Alternative? As previously discussed, the MCC/IMS ap-
proach has several key advantages compared to other analytical methods for measuring
metabolites in exhaled breath. Some of these advantages are crucial for a diagnostic tool
for sepsis. For example, MCC/IMS can be used to rapidly collect and analyze a sample
and is a robust and easy to handle instrument in a clinical setting (24; 20).
Methodological developments over the last decade have led to frequent use of MCC/IMS
for medical and biological applications, for instance evaluating pulmonary diseases, lung
cancer and airway infections (84). Of particular interest for the study of the causal agents
of sepsis, previous studies have shown the potential of MCC/IMS technology to identify
and distinguish between bacterial species (71; 147; 181; 118). Furthermore, a recent study
of Guamn et al. successfully utilized GC/MS and IMS to analyze the breath of rats with
systemic inflammation.
These results encouraged a pilot study by Fink et al. to investigate whether systemic
inflammation or sepsis influence the metabolite composition of the breath in rats. The
recently published results identify several compounds that significantly differentiate rats
with sepsis from control rats. (83). See Section 3.5 in Chapter Materials for more details.
Although, the study collected repeated breath samples over the entire timecourse of the
infection, the recently published analysis used only cross-sectional data, which might lead
to non-robust results, false positives or false negatives.
In contrast, this project aims to analyze the time dependent behavior of breath metabo-
lites by adapting established methods for longitudinal data analysis to breathomics.
Among others, a common problem in studies of clinical diagnostics are confounding fac-
tors resulting for instance from instrumental background. Therefore, in order to focus
on the real informative metabolites a screening approach is needed to sort out the back-
ground noise. Once a suitable longitudinal model is created, the aim is to identify possible
markers for sepsis. In contrast to previous approaches, the identification will focus on the
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time course of various volatile organic metabolites within the rat breath, during sepsis
progression. Furthermore, a better knowledge of the changes in the metabolic pattern of
the progressing disease could give more detailed insights of their biological background,
or indicate states that require a specific medication.
Requirements:
⇒ Proper preprocessing and screening of background
noise
⇒ Development and evaluation of suitable longitudinal
models
⇒ Identification of potential sepsis biomarker
9.2 Methods
This study utilizes the longitudinal rat breath data introduced by Fink et al. and de-
scribed in Section 3.5. It consists of two treatment groups: One group underwent an
operation that induced sepsis (CLI) and the control group underwent a sham operation
(SHAM).
Figure 9.1 shows the four general analysis steps in this project:
A At first, the rat breath is captured and analyzed by the MCC/IMS device, and the
resulting MCC/IMS chromatograms are preprocessed by a well established set of
methods to extract the compound signals.
B In the next step a well established screening is utilized to eliminate compounds that
belong to the background noise of the ventilation system.
C In the model selection phase, the structure of the data is analyzed by fitting a separate
longitudinal model for each compound. Subsequently, the model optimizing the
overall quality with respect to the data is selected.
D Finally we evaluate the model results and investigate which compounds show the best
potential for the discrimination of rats with induced sepsis. False discovery rate
correction is used to adjust for the multiple comparison problem.
9.2.1 Preprocessing
RIP detailing and baseline correction As described earlier, each MCC/IMS chro-
matogram contains a characteristic structure called the reactant ion peak (RIP). In
order to remove this structure, this workflow applies one of the most widely used
techniques. It subtracts the vector of median values (median spectrum) from each
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Figure 9.1: Workflow for longitudinal breath data analysis framework. The four steps
contain (A) MCC/IMS analysis of rat breath and subsequent preprocessing of MCC/IMS
chromatograms; (B) a mature screening for background noise; (C) model selection phase
evaluating the quality of longitudinal models; (D) model evaluation and identification of
most discriminating biomarkers.
IMS spectrum in the data matrix (108).
Denoising and Smoothing To improve the signal-to-noise ratio in the data, the me-
dian filter is applied to remove noise from the data. Finally, a Savitzky - Golay
filter and a Gaussian filter are both applied to smoothen the data (199; 108).
Peak Picking In the last step of data preprocessing, the peaks corresponding to molecules
within the samples are detected. Therefore, we utilize a semiautomated approach
to find a set of peaks. At first, the merged peak cluster localization which is pro-
vided by the commercial software package VisualNow (B&S Analytik, Dortmund,
Germany) is applied. Finally the list of peaks is manually curated by a domain
expert. See Section 2.2.3 for more details (199; 108; 107).
9.2.2 Background Screening
Background noise signals originating from experimental settings or random events can
hugely influence the signal pattern of the breath. In order to investigate the influence of
this contamination on the rat breath, MCC/IMS measurements of the respirator and the
ventilation system are taken. The data set contains two to three measurements, taken
every 20 minutes over the period starting one hour prior to the connection of the rats to
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the respirator system. This data enables the detailed evaluation and differentiation of the
volatile compounds originating primarily from the ventilator system as compared to those
from the rat metabolism. We hypothesize that all compounds of interest show a larger
variation in the breath of the rats as compared to the background noise. Therefore, we
developed a screening approach which excludes peaks that vary more in the background
distribution of the respirator samples than in the distribution of the rat breath samples.
To analyze this variation, two simple linear regression models are estimated for each
compound (one for the measurements of the compound intensity from the background,
respirator samples (S) and one for the measurements of the compound intensity during
the rat breath sample (T)), as shown in Equation 9.1. In this Equation, compound
intensity is indexed by i, which denotes the rat identification number, and by j, which
indexes the repeated samples over time.
Each set of measurements is thus grouped by the corresponding rat experiment.
Si,j = u
S
i + 
S
i,j
Ti,j = u
T
i + 
T
i,j
(9.1)
Here, Si,j and Ti,j indicate the respirator and rat intensities for a certain time point,
respectively and the individual experiment means for respirator and rat are modeled by
uSi and u
T
i . Finally, 
S
i,j and 
T
i,j correspond to the residuals of the model. This model
structure enables the comparison of the within-rat variance (variance in Si,j) to the within-
ventilator variance (variance in Ti,j) as well as the between rat variance (variance in µ
T
i )
to the between ventilator variance (variance in µSi ). The first comparison elucidates
the variation over time within the same experiment within each rat compared to the
variation over time in the corresponding ventilator measurements. The second evaluates
the variation in the mean values of the rats compared to the variation of the ventilator
means. Therefore, we compared each pair of variances using the Brown-Forsythe test.
The Brown-Forsythe test is a statistical test for the equality of group variances based on
performing an ANOVA on a transformation of the response variable (46). In contrast to
Levene’s test, the Brown-Forsythe test utilizes the median instead of the mean to get a
more robust result. The analysis is based on the two following assumptions:
1. All compounds of interest show a larger variance either within or between rats
compared to the background noise.
2. Components that wash out in the respiratory system of the rat are not of interest
for our study.
To exclude backgound noise VOCs from the set of selected analytes, the one-sided ver-
sion of the Brown-Forsythe test implemented in the R package car (87) is utilized, see
Equation 9.2. Let zij = |yij − y˜j | where y˜j is the median of group j and nj the number of
observations in that group. We further define N as the number of observations and p as
the number of groups. Thus the F statistic of the the Brown-Forsythe test is the ANOVA
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on zij , while z˜.j and z˜.. are the group and overall means of zij .
F =
(N − p)
(p− 1)
p∑
j=1
nj(z˜.j − z˜..)2
p∑
j=1
nj∑
i=1
(zij − z˜.j)2
(9.2)
All components showing a p-value below 0.005 for both of the tests are included into the
final set of components.
9.2.3 Model Selection
In order to appropriately model the variation of the single rats as well as the variation
within groups, a linear mixed-effects model was applied. The combination of both fixed
effect and random effect models is a state of the art technique for modeling longitudinal
data, see Section 2.6 for more details (178; 133). In our approach, we are expecting the
influence of the treatment groups on the measurements to be non-random, modeled by
fixed-effects. In contrast, the individual rats are treated as random effects, based on the
assumption that their intercepts and slopes follow a random normal distribution centered
by their treatment group mean. However, the probability distribution for multiple mea-
surements of a single rat have the same structure. This allows the explicit modeling and
analysis of between- and within-individual variation. The fundamental framework of the
linear mixed model is shown in Equation 9.3.
Yi,j =(β0 + β1CLI + u0,i)
+ (β2 + β3 ∗ CLI + u1,i) ∗ tj + i,j
Yi,j =Intensity for rat i at time j
CLI = Indicator for class CLI
u0,i =Rat intercept & u1,i = Rat slope
i,j =Residual error
tj =time j
(9.3)
Alignment of Time Points For comparability, the time points of the treatment (either
control=”SHAM” or sepsis=”CLI”) in the rats are aligned. All rats tested positive for
their particular treatment at about 300 minutes after their treatment. For practical
reasons, this time point of interest is shifted to zero and denoted by T0 in the following.
All other time points are adjusted accordingly.
Model Selection Frequently, the driving force of a septic condition is an underlying
bacterial infection in the organism. Therefore, in this study the sepsis is induced by in-
testinal bacteria. We assume that bacterial growth strongly influences the observed time
course of the septic condition. This growth typically follows four different phases, (1) lag
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phase, (2) exponential, (3) stationary, and (4) death phase (244). Thus, we derive the as-
sumption that these disease stages will be reflected in the metabolite patterns over time.
The death phase however is an exception and not relevant for our analysis, since the rats
will likely reach septic shock before entering this phase. In order to adjust the metabolites
model according to this knowledge, we refer to a recent study of Sekse et al. 2012. They
proposed a linear spline model that contains two knots producing three linear intervals
to directly model bacterial growth (196). Additionally, more advanced non-linear models
like polynomial, or cubic splines have been proposed. Nevertheless, the amount of data
for this first longitudinal attempt is limited. It is therefore appropriate to restrict the
complexity of the model and follow the approach proposed by Sekse et al. and apply a
two knot linear spline model.
In this study, we focus on the difference of the treatment groups at our time point of inter-
est (T0) and the behavior of the molecular species resulting in this divergence. Therefore,
the second knot point is fixed at TK2 = T0. However, the position of the first knot point
TK1 has to be determined empirically using the data. In order to find the optimal time
point, a set of spline models with varying knot positions (TK1 = 50, 100, 150, 200 or 250
minutes) is constructed for each compound. For comparison, the simple linear model as
well as the single spline (knot at T0) are added. All in all we are fitting 7 models for each
compound.
Akaike Weights To evaluate the optimal knot point position, the Akaike weights are
calculated for the set of 7 models of each component. The Akaike weights are straightfor-
ward to compute from the raw Akaike information criterion (AIC) and provide an intuitive
interpretation as the probabilities of the given model as compared to the best model in an
AIC sense (222). Essentially, the relative likelihood L of the model i is estimated using
the shifted AIC values and normalized so that
∑
wi(AIC) = 1, see Equation 9.4.
∆i(AIC) = AICi −min(AIC)
wi(AIC) =
e(−0.5∗∆i(AIC))
K∑
k=1
e(−0.5∗∆i(AIC))
(9.4)
The sum of all Akaike weights for each knot position results in the overall quality, while
the maximum sum value indicates the optimal position for the second knot point denoted
by TK1.
Linear Mixed Effects Spline Model The overall hypothesis is that the two treatment
groups CLI and SHAM will show different intensities in a given compound at the time
point of interest or have different time-course patterns in the compound. Therefore, the
intercepts at the time point T0 and the slope of the preceding spline section have to be
assessed and compared using hypothesis tests. Additionally, a re-parameterization of the
time variable in the spline model is necessary. The times are shifted and scaled such that
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TK2 = T0 = 0 and |TK1 − TK2| = 1.
T < k1

t1 = 1− k1
t2 = k1
t3 = 0
k1 <= T < k2

t1 = 0
t2 = t
t3 = 0
k2 <= T

t1 = 0
t2 = k2
t3 = t− k2
(9.5)
Thus, the spline segments are modeled according to Equation 9.5 (89). Subsequently,
each compound is modeled by the linear mixed effect spline model, utilizing the previously
determined knot points according to the given Equation 9.6.
Yi,j =(β0 + β1CLI + u0,i)
+ (β2 + β3 ∗ CLI) ∗ (t1j + t2j + t3j )
+ u1,i ∗ tj + i,j
(9.6)
9.2.4 Evaluation and Identification
Finally, we evaluate the hypothesis that the SHAM and the CLI treatment groups are
varying in the slope of their second spline segment or consequential at the point of in-
terest T0. The conditional t-tests are based on the maximum likelihood estimates of
the variances. It is testing the marginal significance of the fixed effect coefficient (slope
and intercept) with the other fixed effects in the model. To account for the problem of
multiple testing a post hoc method called false discovery rate (FDR) correction is ap-
plied to adjust the p-values. The FDR method proposed by Benjamini and Hochberg
is less conservative compared to the Bonferroni approach, thus has improved statisti-
cal power (26). The FDR correction is applied separately for each hypothesis (intercept
and slopes). This is reasonable since intercept and slope and are dependent variables (58).
9.2.5 Implementation
The MCC/IMS raw data was preprocessed using the commercial VisualNow software
package. The statistical modeling and evaluation of the longitudinal models is imple-
mented in R (115) utilizing the following additional packages:
nlme for modeling linear mixed effect spline models (177);
car to performe the one-sided Brown-Forsythe test (87);
sm to create the density figures (40);
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9.3 Results
The pre-processing of the raw MCC/IMS data as described before, resulted in a set of
100 peaks of potentially interesting compounds.
9.3.1 Peak Screening
In order to remove the peaks related to the background noise of the ventilation system,
the between and within experiment variation was analyzed separately. As an example,
Figure 9.2 shows the comparison of the distribution of the rat and respiratory group
means and residuals of the fitted model for an example peak, respectively.
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Figure 9.2: The first plot shows the distribution of the rat and respiratory experiment
means. The second plot shows the distribution of the rat and respiratory residuals. The
variances of both the experiment means and residual values of the described linear rat
model vs. a simple linear respirator model are compared based on the Brown-Forsythe
test.
For each of the compounds, the Brown-Forsythe test is performed, on both sets of these
intercept and residual values, comparing rat vs. respirator variation. This background
screening evaluation of the distributions of the respirator and rat measurements identi-
fied 43 peaks that showed a significantly larger variation of peak intensities within the
background compared to the rat measurements. It follows that the set of compounds is
reduced from 100 to 57. These 57 compounds are selected for further processing.
9.3.2 Model Selection
To account for the nonlinear bacterial growth we follow the proposed two knot linear
spline model of Sekse et al. 2012. We extend this approach by combining it with a random
mixed effects model. While TK2 is fixed to our point of interest, we evaluate the potential
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of 6 different spline models based on varying positions for TK1 = 50, 100, 150, 200, 250
minute as well as the single knot spline and compare these to a simple linear model. The
sum of the Akaike weights is used to access the model quality over all peaks, shown in
Table 9.3.2. The highest value indicates the best fitting model. The results show that
the optimal position for the first knot point is at TK1 = 150. Thus, this model is used
for all further computations.
Model Sum of Akaike Weights
Linear 1.82
Single spline 5.16
250 8.27
200 7.46
150 13.43
100 12.65
50 8.22
9.3.3 Model Evaluation
Finally the resulting model was evaluated on all 57 relevant compounds. The FDR
corrected hypothesis tests show significant difference in the slope at 300 minutes for only
two of the components. However, twenty components showed a significant difference in
the slope of the treatment groups, see Table 9.3. Figure 9.4 gives an example for the
spline model of one of the two peaks that shows significance in both tests.
9.4 Discussion
We detected 100 VOCs in total in the exhaled air of the examined rats. A comparison
of the longitudinal intensity progression showed that 20 of these volatiles had statistical
significant differences between septic rats and control rats regarding the intercept or the
slope of the spine model (Figure 9.3). These volatile compounds were identified as ke-
tones, hydrocarbons, alcohols and aldehydes, which is consistent with earlier findings in
the breath of rats (97) and mice (215). The publication by Fink et al. that introduced
the data used for this study, focused on the comparison of peak intensities in two hourly
increments (83). They revealed two compounds with statistically significant differences in
septic rats compared to control animals. In accordance with the results of that previous
study we found the analytes acetone and 3-pentanone with a significant reduction in sep-
tic animals. This decrease in ketone bodies is most probably not due to low blood sugar
levels (165), but due to the increased utilization of ketone bodies by the peripheral tissue
which is not compensated by liver ketogenesis (165). In addition to these two compo-
nents, the analysis revealed 18 VOCs which differ between the two groups. These include
three further ketones, namely 3-hydroxy-2-butanone, 2-octanone and 2, 3-heptanedione,
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Figure 9.3: Table of components that show a significant treatment difference in either
the intercept or the slope of the spline model. The given p-values are corrected for
multiple comparison using the false discovery rate correction (26). The arrows indicate
the direction and strength of the change in the analyte intensity (CLI in yellow and SHAM
in green). The last column indicates the analyte class of the component.
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Figure 9.4: As an example, this plot shows the fitted two knot spline model of the
compound bbR022. The vertical lines represent the spline knot positions. The dashed
lines represent the predicted intensities from the model for each individual rat, while the
solid bold lines represent the average intensity for rats in each group. Both rats and
class curves are colored in green and yellow according to their grouping, SHAM and CLI
respectively.
with a significant increase in septic rats after 5h. 3-hydroxy-2-butanone was found to
be strongly released by Staphylococcus aureus (82) a facultative pathogen bacteria. 2-
octanone and 2,3-heptanedione were detected in the headspace of Enterobacter cloacae
respectively Proteus mirabilis cultures (118) which are common parts of the gut flora.
Another VOC which may be associated with intestinal bacteria strains is 1-pentanol. It
is produced by various bacteria but prominently by Escherichia coli (38) and strongly in-
creased in CLI animals after 5 hours. It has been detected in the headspace of Escherichia
coli infected blood cultures (7). A hypothesis to explain the late increase of those bacte-
rial associated VOCs would be the required bacterial reproduction time. Whether these
VOCs are bacterial products or otherwise related to the sepsis remains unclear. Another
three molecules, 1-propanol, butanal and 2-hexanone show significant differences between
septic rats and the control. Those have already been reported as significantly different
between lipopolysaccharide treated rats and control animals by Fink et al. 2014. Treat-
ment with lipopolysaccharide (LPS), which is an outer membrane part of gram-negative
bacteria, is mimicking a bacterial infection and causes an endotoxemic shock as in micro-
bial sepsis but is lacking the functional microorganisms. Therefore it is likely that septic
and endotoxemic shock share a common pattern in the breath. Summarizing the above, it
should be noted that it is unclear which of these VOCs might be useful for diagnostics to
indicate a septic state, especially because sepsis may progress differently in humans than
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in rodents. The presented framework was able to detect a new pattern of compounds
which differ between septic and healthy animals, however, certain limitations remain. A
major issue is the small number of samples that limits the generalizability of the study.
This restricts the design to linear splines instead of more complex models, such as, for
instance, cubic or polynomial splines. Furthermore, the transferability of the findings
resulting from a rodan study to humans is a subject of frequent discussions. Therefore,
additional work is needed to determine which exhaled VOCs are of diagnostic benefit in
humans.
9.5 Conclusion
Despite its limitations, our study provides an important extension of prior work on sepsis
progression and suggests future directions for clinical studies on exhaled air and computa-
tional breath analysis. Moving the point of view from single time points to sepsis progres-
sion and the analysis from hypothesis tests to accurate time dependent models, enabled
us to find 18 additional potential biomarkers. We discovered septic-typical phenomena
like a decrease of ketone bodies and the occurrence of compounds found in facultative
pathogen bacteria or species that are common parts of the gut flora, during the course
of the sepsis. Nevertheless, future work might require new and larger clinical studies,
for instance, the combination of several biomarkers (176) and more complex non-linear
models.
Breath analysis for clinical diagnostics Several general lessons can be drawn from
this work regarding the future of breath analysis studies and clinical diagnostics utilizing
exhaled air as an assessment:
 Cross-sectional time point analysis might not always be robust enough to pertur-
bations and individual patient variation.
 A thorough screening approach for background noise was established, which is gen-
eralizable to future longitudinal studies.
 Longitudinal analysis of the time course of volatile organic compounds in the rat
breath introduces a novel prediction model for sepsis progression.
 Longitudinal analysis might give better insights on the biological background of
sepsis progression in the future.
This study shows the potential of longitudinal studies to be beneficial for various kinds
of diseases, where single time point analysis is too noisy. It can be concluded that the
MCC/IMS, suitable for online monitoring, in combination with advanced modeling tech-
niques like mixed effect models, present an innovative tool to potentially complement
conventional diagnostic techniques.
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Chapter 10
Discussion and Conclusion
The innovations in clinical diagnostics during the last century made a huge step from ini-
tial conservative anamnesis to the analysis of diseases not only on cellular but molecular
level. Many of these techniques rely on body fluids or tissue samples and are, therefore,
often invasive and painful. This is further exacerbated by the fact that some techniques
show low accuracy or are too slow for fast progressing lethal diseases (84). These facts
drive the search for non-invasive and fast alternative diagnostic tools, for instance based on
the analysis of metabolites within the human exhaled air. The novel field of breathomics
emerged. The potential of well established analytical technologies such as MCC/IMS
or GC/MS for clinical diagnostics is beyond dispute. Variations of these methods allow
the discovery of a broad spectrum of components potentially related to specific diseases.
Prior to this project, studies mainly relied on manual and/or non - robust processing
and statistical analysis. The computational methods were mostly limited to automated
preprocessing approaches. In combination with small sample sizes, this led to little con-
cordance between studies, especially in terms of robust biomarker selection(173).
In contrast, the past decades showed that bioinformatics methods allow for tremen-
dous advances in various areas of biology and medicine, such as genetics (121), pro-
teomics (162), or metabolomics (81). The main focus of this thesis is to bring the benefits
of these advanced bioinformatics methods to the evolving field of breathomics and to drive
the transition towards more automatization and robustness of computational analysis in
breathomics research. The following sections will discuss, how these six studies address
the major challenges described in the introduction.
10.1 Data Accumulation and Heterogeneity
Handling the challenge of increasingly large amounts of metabolomics and increasingly
complex clinical data, requires an intelligent way of structuring and storing data. The
key factors are the fast storage and retrieval, as well as the management of constantly
evolving heterogeneous study and instrumental variables in a comprehensive centralized
data repository. The presented IMSDB package combines two powerful computational
tools, namely an extensible database and a machine learning toolkit. Both are fully
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accessible through an intuitive graphical user interface (195). This database combines the
advantages of a clinical open source data base like TrialDB (41) with a IMS metabolomics
database schema such as developed by Lesniak (138). Additionally, this expands the
opportunities of the diagnostic research in terms of confounder elimination, environmental
factor evaluation and the organization of large scale clinical studies. The integrated
statistical learning and feature selection process utilizes simple decision tree as proof of
concept and ensures general extendibility by other data mining packages, for instance
Weka (99). Further, the accessibility of the postgres database via Hibernate or ODBC
allows the advanced user to attach various statistical tools such as the RapidMiner (126)
toolkit or R (115). However, the following paragraph will discuss a number of limitations
of this software package that have to be addressed. So far, the IMSDB solely relies on
company specific MCC/IMS data format from VisualNow (B&S Analytik, Dortmund,
Germany), as well as the predefined format of the patient table for clinical data. In
recent years, other companies developed products for MCC/IMS analysis. Although
they are mainly focusing on industrial process monitoring or drug detection and solely
provide restricted access to the raw data, a general database for MCC/IMS research
should support data formats of a broad spectrum of manufacturers. Incorporating data
of analytical techniques utilized for breathomics such as GC/MS would complement the
software by guiding it towards a more general clinical breathomics database. Along with
growing sample and metabolite numbers, more adequate and advanced learning strategies
for prediction and feature selection are required. These challenges on the way towards a
more robust statistical analysis and evaluation and how they have been addressed in this
thesis are discussed in the following section.
10.2 Robust and Generalizable Statistical Analysis and
Evaluation
Prior to this thesis, the majority of studies focused on single variable statistical inference
methods like hypothesis tests, or utilized variance analysis methods like PCA to find a
relation to the label of interest (147; 230; 31; 23; 231). These methods entirely neglect the
possibility of multi-compound relations, or rely on the assumption that the direction of
the largest variance contains the most valuable information. In practice, this assumption
is true in some, but not all cases. However, if no relation is found, this by no means
implies that there is no information in the data. Moreover, confounding variables, such
as technological biases, often generate large variances and conceal the important infor-
mation.
Therefore, a handful of studies introduced more advanced statistical learning techniques
(16; 85; 231). Their main goal was optimizing classification performance. However, these
studies showed a few shortcomings: (1) insufficient validation, (2) only single methods
evaluated, (3) not accounting for overfitting. In contrast, several studies within this the-
sis, demonstrated a thorough analysis and evaluation of sophisticated statistical learning
methods. In 2012 we conducted a broad analysis of various linear and non-linear machine
learning methods, evaluated via a ten fold cross validation schema, shown in Chapter 5.
This demonstrated the general advantage of more sophisticated non-linear methods ap-
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plied to MCC/IMS data over previous studies. Subsequently, the advantage of this robust
approach was confirmed and extended while evaluating the peak detection methods, see
Chapter 6. It demonstrated that, the selected cross validation set has a large influence
on the classification performance on small data sets. This indicates that the evaluation
of the performance variance on a number of random cross validation sets is crucial to get
a deeper understanding of the real performance. It enabled a more robust evaluation and
estimation of the real prediction accuracy. However, it has been reported, that repeated
cross validation depending on number of samples and number of repetitions might lead
to an overestimation of the performance variance (210). The same study further showed
that MCC/IMS data sets influenced by the chosen peak detector are prone to overfitting if
the machine learning methods are heavily tuned. Therefore, we can conclude that future
MCC/IMS studies should ideally use permutation tests as shown in Chapter 6 to access
the extent of overfitting and reliability of the achieved performance.
In summary, future studies and especially automated analysis systems should provide and
recommend such an evaluation framework in general. Additionally, similar to the study
of Horsch et al., the presented results indicate that non-linear ensemble tree methods
and in particular random forest are favorable on MCC/IMS data sets. However, due to
time constrains, several critical statistical issues haven’t been addressed in this work. For
instance, unbalanced data sets, as present in many breathomics studies (232; 103), have
not been addressed by proper methodologies such as bootstrapping. Additionally, sophis-
ticated supervised learning methods have been applied but not customized for MCC/IMS
data.
Robust and Generalizable Biomarker Candidate Detection The second major
challenge, besides an accurate prediction, is the selection of robust biomarker candidates.
Previous studies focused on single VOC relations or unsuitable methods such as PCA.
Although, one ore more of the principal components might show discriminative power,
the estimation of the individual influence of each molecule is non-trivial. A single study
performed by Finthammer et al. established a interpretable model of equations utilizing
the peak intensities (85). However, similar to PCA, the assessment of the importance
of single VOC’s remains difficult. Therefore, an analysis of the importance of each sin-
gle molecules within a MCC/IMS data set utilizing more complex multi-compound ap-
proaches has been missing. This thesis, addressed this issue on several levels. The results
in Chapter 5, present a set of most important features via random forest and linear SVM,
which have been confirmed by comparisons with previous studies. The procedure of av-
eraging the importance measures over a set of cross validation runs, resulted further in
a more robust estimation of single feature importance. Another interesting approach is
shown in Chapter 9. Here, features are not solely evaluated by a single time point, but
their change over the time course of developing diseases. The results suggest that the
time course of a component may be more informative than a single time point. More
studies should investigate the evolution of metabolites in human exhaled air. However,
the main limitation of this study is the focus on single features rather than the combi-
nation of peaks. Another issue that was not addressed in this thesis is the problem of
correlated features. Tolosi et al. (208) showed that correlation in features can distort the
importance values reported by various learning methods. The importance of information
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that is similarly encoded by a large cluster of correlated features, will be largely under-
estimated.
In conclusion, although some weak points exist, this study introduced some of the most
relevant feature selection approaches to computational breathomics. Further, it described
a novel sequence of methods to discover longitudinal breath features.
10.3 Peak Detection Evaluation
A fully automated data analysis requires the users’ trust in reliable results of each step
of the processing pipeline. Although standard preprocessing procedures for quality en-
hancement are widely accepted in the community, automated methods for peak detection
were neglected. Therefore, we conducted a broad analysis on the performance of auto-
mated MCC/IMS peak detection, as described in Chapter 6. In summary, all available
software tools for MCC/IMS peak detection were evaluated by their ability to provide
a valuable set of peaks optimizing the classification performance of the underlying data
set. A comparison of the results to the manual selection shows a similar or only slightly
decreased prediction accuracy of the approaches. Hence, for the first time we proved that
these methods can be integrated into an automated analysis system, without the loss
of important information for a classification task. However, the study was limited to a
single data set and the methods were not optimized for their parameters. A recent study
by collaborators within the SFB in Dortmund targeted this issue. They cross-compared
the results of several preprocessing, peak detection, peak merging, and statistical learning
techniques on three different data sets. Their results accredit our findings: (1) automated
peak detection can compete with manual; (2) random forest showed the best overall re-
sults; (3) different peak detection approaches show less influence than the applied machine
learning methods. Nevertheless, a few factors are still underrepresented in the results:
The investigations did not evaluate the one-to-one measurement comparison of peak find-
ings and do not account for overlaying peaks.
This work layed the foundation for further studies such as Horsch et al. (113). We showed
that in order to gain the trust of the breathomics community in automated technologies,
an adequate assessment of their quality is necessary. Therefore, this work set the foun-
dation for more automatization in MCC/IMS data preprocessing and analysis.
10.4 Unknown Metabolites
Although the identity of an important metabolite that is key to the prediction of a disease
is not essential for its performance as a biomarker, it might provide proof and reliability
for its value as a predictor. Moreover, it encourages the research of the metabolic path-
ways of the disease that can ensure the direct relation of marker and disease. MIMA
provides the first automatization of such an identification utilizing a mapping between
MCC/IMS and the NIST-library search results of the corresponding GC/MS measure-
ment. A major limitation of the method, however, is the small number of VOCs in the
MCC/IMS compound database. Previous approaches, therefore, focused on the direct
mapping of the GC and MCC peaks (48). Unfortunately, there is no linear nor con-
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tinuously increasing relation between GC and MCC retention times. Depending on the
temperature program in the GC column, components might switch positions influenced
by their specific gas pressure (66). Other studies suggest that the corresponding relation
between GC and MCC retention times depends on their specific molecular family (189).
Nevertheless, the presented software tool provides a further step towards an automated
pipeline as previously described.
A more difficult task is the identification of molecules present in low quantities. In par-
ticular this is the case when molecules can not be detected by GC/MS or can not be
found in the MCC/IMS database. In these situations, the unsupervised learning methods
such as provided by the Carotta software may aid the search for a possible solutions. For
instance, a clustering of metabolites might yield a set of neighboring molecules that have
been identified before. These similar components might allow to draw conclusions on the
identity of the VOC of interest. This can either be decided for example upon common
pathways or similar molecular properties.
10.5 Background Noise and Confounding Factors
The metabolomic composition of the breath and air in general is very vulnerable to pertur-
bations such as environmental changes, nutrition, life style or instrumental background.
Therefore, it is crucial to extract these influences before the data set is processed by the
previously described learning and biomarker detection methods (156). The longitudi-
nal study of Chapter 9 introduced a preprocessing step for screening volatile molecules
originating from the instrumentation for ventilation of the rats. Previous studies have
shown that certain components such as plastic tubes or other parts within the venti-
lating device produce a particular background noise (237). To separate this noise from
the particles of interest, the variance of the respirator measurements are compared with
the rat measurements, to reject molecules that are more active and variable in the back-
ground measurements. However, this study provided specific information about potential
sources of confounding factors. If such information is missing, other approaches are re-
quired. Some very recent studies introduced unsupervised learning methods to analyze
breath (155; 47; 80). Nevertheless, they lack in-depth evaluations using internal or exter-
nal quality measures such as the Silhouette value or F-measure. Moreover, none of the
existing studies emerged with a software or bioinformatics toolbox addressing the commu-
nity’s need for automatic unsupervised processing of breathomics data. This is provided
by the Carotta software package presented in Chapter 8. The unsupervised methodol-
ogy of Carotta can support the identification of metabolite subgroups that are related to
confounding influences such as tooth paste. Thereby future studies can utilize Carotta
to identify and eliminate disturbing influences of confounding factors. Nevertheless, the
connection to a database of subject or patient attributes like the IMSDB as well as a
proper identification (MIMA) of the component is required to explicitly identify certain
molecules as confounding variables. Additionally, other promising approaches for multi-
dimensional clustering exist, such as bi-clustering or co-clustering (see, e.g., (44; 205)).
These might provide a more thorough assessment of the various influences of confound-
ing and non-confounding factors on the metabolite pattern of the breath. In summary,
both studies provide a solid example of confounding factor analysis and screening. They
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further highlight the importance of such screenings for future studies.
10.6 Heterogeneous Diseases and Disease Stages
The existence of disease heterogeneity and stages is rarely dealt with, but are widely
discussed in the breathomics community. Many pulmonary diseases are categorized by
certain clinical symptoms but might originate from entirely different sources. One of
the most prominent examples is COPD (chronic obstructive pulmonary disease), which
describes a sum of diseases permanently affecting the lung function (88). The most re-
cently published Carotta cluster analysis framework is dedicated to uncover, such hidden
substructures or diseases subgroups. The combination of several similarity measures and
sophisticated unsupervised statistical learning methods allow for a thorough analysis and
discovery of potential subgroups. To ensure the accuracy of these clusterings, certain qual-
ity measures can assess the reliability of the results. Carotta presents the first breathomics
dedicated software tool for automated disease subtyping and metabolite grouping. The
study is one of the first applications of unsupervised learning in the area of breathomics.
The main contribution of an easily accessible tool like Carotta is to further promote the
application of powerful approaches like clustering in this field.
However, general unsupervised learning techniques such as clustering do not entirely solve
the problem of evolving disease stages. Therefore, time dependent analysis of rat sepsis
progression and its influence in the breath was initiated. The unpublished longitudinal
analysis of this breath data represents the first of its kind. The effects of time on each
single rat as well as the two treatment groups were modeled. Although, mixed effect
models are common for longitudinal analysis, it is novel to evaluate bacterial driven sep-
sis via a spline structure. This particular model facilitates the observation of the rat
metabolism reacting upon the bacterial intoxication. Admittedly, the present model does
only evaluate a linear relations towards the grouping variable and treats each molecule
separately. Additionally, the sample size makes the study prone to miss interpretation
and does not allow a robust estimate. Nevertheless, this study serves as a proof of concept
that the integration and analysis of time dependent data, especially in terms of disease
progression, shows great promise. Time dependent data analysis further, provides a gen-
eral pipeline as a starting point for future experiments and studies and shows current
drawbacks, weaknesses as possible targets for improvement.
10.7 Usability, Maintainability and Re-Usability
In order to develop tools that serve the needs of inexperienced computer users or non
computer science researchers, such as usability, maintainability and re-usability have to
be met. The presented software tools: IMSDB, MiMa and Carotta aim to fulfill these
requirements. The common programming language utilized for the provided tools is
Java. This offers the advantage of easy portability to various platforms, for instance
Windows or Linux. The usage of the packages requires the installation of current version
of the Java Runtime Environment and postgres (IMSDB). Although, the installation is
not very difficult, it might require the assistance of a more advanced computer user. All
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packages provide an intuitive graphical user interfaces promoting data handling, analysis
and visualization, in particular for non computer experts (106) Especially the intuitive
menus and wizards guarantee an easy handling of the data import and result export. The
visualization of results, for instance the decision tree in the IMSDB or the heat maps,
dendogramms and multi-dimensional scaling plots in Carotta, further enhance the benefit
of the packages.
All systems support extendibility, via a well defined structure and consequent use of
standard interfaces. The IMSDB for example is easily expandable by integrating further
WEKA libraries, or a direct connection of other machine learning tools via ODBC. The
MiMa software provides simple extension of further data formats such as GC or MCC/IMS
component lists. Finally, Carotta offers a comprehensive plug-in system for additional
methods for all the described steps in the framework. This includes novel similarity
definitions, clustering approaches, quality measures as well as methods for dimension
reduction. All developed software packages are publicly available under the following
addresses.
IMSDB ⇒ http://imsdb.mpi-inf.mpg.de
Carotta ⇒ http://carotta.sdu.dk
MIMA ⇒ http://mima.mpi-inf.mpg.de
This ensures a full re-usability of the tools as well as the underlying Java code.
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Conclusion
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Figure 11.1: Schema of the steps in the automated pipeline: (1) Clinical IMS Database
(2) Peak Detection Evaluation; (3) Metabolite Identification; (4) Supervised Learning;
(5) Unsupervised Learning; (6) Longitudinal Analysis.
The vision of breathomics is a novel non-invasive tool for clinical diagnostics and medi-
cal research. This was further enhanced by the latest developments in high-performance
methods optimized for measuring human exhaled air. While these devices for breath-
omics exist, we are facing the typical biomarker research barrier that related technolo-
gies (GWAS, NGS, microarrays, etc.) have seen before and successfully addressed with
dedicated bioinformatics programs (72). The primary objective of my PhD project is
to overcome the described obstacles in “computational breathomics” and to move from
biomarker discovery to validation, from separability to predictability. Therefore, estab-
lished technologies from computer science and machine learning needed to be adapted and
integrated into breathomics research. Table 11.1 shows which of the briefly depicted study
objectives addressed the previously described challenges. A centralized data structure can
be the starting point for all the following analysis steps starting from preprocessing and
ending with the proposal of biomarkers. The identification of the metabolites adds value
to the results of potential confounders and biomarkers. The establishment of more ad-
vanced supervised, unsupervised and longitudinal learning methods will provide a large
benefit in future clinical studies. Each of the introduced projects represents a small piece
of the big picture of an automated processing and analysis system. The combination of
these pieces sets the basis for an automated pipeline as depicted in Figure 11.1. Such
comprehensive computational systems providing automated analysis from raw data to
prediction would move the field forward towards more automatization, standardization
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Table 11.1: This table depicts which projects addressed the previously described chal-
lenges.
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and generalization. In summary, this thesis presented pioneering contributions on sev-
eral levels of MCC/IMS based data processing that have a major impact in the field of
computational breathomics.
Chapter 12
Outlook
Despite the achievements of this work, some challenges to further improve automated
computational breath analysis remain. The following paragraphs will outline the most
critical issues.
Generalized Platform As of now, the projects described in this thesis are treated sep-
arately and addressed in independent software tools or scripts. Consequently, each
program requires installation, operation and additional import and export of data.
This circumstance is time consuming, confusing and not user friendly. Therefore,
the most important future goal is the combination of the described projects into a
sequential pipeline and to integrate it into a single user friendly system. Moreover,
such a system could integrate the previously developed preprocessing methodology,
such as denoising or peak detection, to further improve usability. Like in Carotta,
an easy extensibility with novel pre- and postprocessing as well as methods for sta-
tistical analysis, enables a straight forward reanalysis of previously collected data
sets with the goal to gain new insights.
Centralized Web Service In practice, several professions such as physicians, chemists,
biologists, physics and statistical computer scientists are collaborating on one project.
Therefore, an additional advantage will be to design the system as a centralized web
service, which will enable easy but secure access. Updates and changes to the data
will be instantly available to all participants. Moreover, every project member could
add new methodology or combine these to a pipeline of processes and directly share
this or the results with project members. User and access management will allow
handling many projects with various rights for different sets of persons. Easy ini-
tiation of collaborations by simple changes of rights or, for instance, merging of
projects.
Data Expansion Smolinska et al. proposed the fusion of data originating from several
analytical technologies in order to improve predictive power (199). Therefore, the
integration of, for instance, GC/MS measurements and the proposed data fusion
methods (199) will allow for advanced cross platform analysis. For further advances,
this data fusion might not only contain breathomics but also be extended to other
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metabolomics or other omics data. In addition, the integration of GC/MS data in
combination with the MIMA tool and NIST-library will provide automated peak
identification. This knowledge allows for the connection to systems biology tools
like KeyPathwayMiner (5) and would reveal more detailed information about the
underlying molecular mechanisms of the disease.
In addition to a centralized storage and analysis framework, an integrated system
would benefit from the following general improvements.
Data Management The IMSDB currently relies on a powerful postgreSQL database
management system, which requires extra installation and handling by a more ad-
vanced computer user. However, postgreSQL could be substituted by Java file
based databases such as the H2 database engine (4) or HyperSQL database (96).
This would eliminate the required expert steps and ensure an easy handling by non
computer expert users.
Method and Parameter Evaluation The evaluation approach described in Chapter
6 and by Horsch et al. assesses a broad spectrum of preprocessing, peak detec-
tion, merging and machine learning methods. However, the proposed generalized
platform in combination with additional analytical data and statistical methods,
will further allow for fully automated evaluation of all of the processing steps. In
particular, this enables the comparison of various analytical technologies as well as
other experimental parameters.
Peak Identification MIMA provides an easy and fast identification of MCC/IMS metabo-
lites. Its main limitation is the dependence on the IMS component library. Since
the analytical assessment of metabolite coordinates is comparably expensive, the
expansion of this library is fairly limited. Different studies, however, have indicated
the possibilities of MCC to GC mapping, in particular within a group of similar
structured molecules (189). Hence, there is great potential to build models for sim-
ilar molecules from the database. The key would be to define the physical and
chemical properties that are most important to characterize the molecules. Conse-
quently, these properties could be utilized as features to build a general retention
time and/or mobility prediction model. Moreover, these models and the feature
space spanned by the most important properties could yield information for the
optimal selection of the next metabolite to be characterized. A set of unknown
molecules that explores a void area in this space, would optimize the information
gain and enlarge the database most efficiently.
Robust and Generalizable Statistical Learning This thesis presented two projects
that introduced robust statistical analysis of MCC/IMS data by means of two exam-
ples, COPD data and peak evaluation. The analysis was implemented utilizing the
statistical platform R. However, R requires certain expert knowledge in statistical
programming. In contrast to this, a future system for supervised learning would be
integrated into the previously described platform and allow for user friendly han-
dling similar to Carotta. Besides various supervised learning methods, such a system
would integrate various evaluation approaches. The most important examples are
cross validation, variance or confidence intervals estimation as well as permutation
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tests. Another issue are unbalanced data sets, as present in many breathomics stud-
ies (232; 103). The field of machine learning offers several methods to handle over
representation of certain labels. Popular examples are bootstrapping and artificial
balancing of the data sets by over of under-sampling. A general advanced analysis
framework would provide and propose this functionality to the user, if required.
Unsupervised Learning Another future goal is the fusion of such a system with the
Carotta framework in order to combine the functionality of supervised and unsu-
pervised learning methods. For instance, a common application is the clustering of
features in order to reduce redundancy and correlation in the data set. As previ-
ously explained, these are frequent sources for overfitting or distorted importance
values (208).
Longitudinal Analysis In order to improve the modeling of longitudinal breath data,
two main developments are inevitable. At first, we need to move from single towards
multiple component models enabling interactions between several molecules. In
addition to linear or linear-spline models, non-linear models, such as polynomials,
need to be considered. However, more complex models require a larger number of
experiments to achieve robust results. Although very few studies are dealing with
longitudinal analysis of breath so far, this is expected to change in the near future.
The evaluated analytical technologies in combination with modern bioinformatics ap-
proaches present a promising tool for future clinical diagnostics. However, a lack of
large screening studies and automated computational analysis hinders a translation to
the world outside laboratories. Clearly, the presented PhD thesis is the first step towards
such an automated analysis system. The described possible future optimizations will fur-
ther enable this automatization. Finally, the combination with larger clinical studies and
standardized as well as real world optimized devices will pave the way towards clinical
practice. Consequently, a close collaboration between the research fields, starting with
physics and medicine to statistical bioinformatics, will play a key role in this development.
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Figure A.1: Overview of the peak component which models IMS peaks. The central Peak
belongs to a particular ImsMetaData entity and is associated to a PeakValueDouble that
is, in turn, bound to a PeakAttribute for the representation of an intensity, volume or any
other peak parameter. A Peak is further associated to a unique PeakPosition comprising
retention time and inverse mobility coordinates. Furthermore, a Peak belongs to multiple
PeakRegions which correspond to a rectangle in the IMS coordinate system. Multiple
Peak entities (e.g. from different IMS chromatograms) are associated to a particular
PeakRegion retrieved from the corresponding PeakAn file.
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Figure A.2: Overview of the layered system architecture based on a recommendation
presented in (15). The communication between objects (denoted by arrows) of the layers
starts at the presentation layer and ends at the persistence layer. This from top-to-
bottom approach makes each layer dependent on the next lower layer, whereas the lower
layer does not depend on the top layers. The presentation layer includes a graphical
user interface (relying on Java Swing) where commands according to specific concerns
can be triggered. In this work, the commands are modeled as java classes implementing
a method to perform the specific concern which is part of the business logic. The busi-
ness layer corresponds to the business logic and encapsulates all command classes and
additional data containers which are not directly related to database tables. Persistent
entity classes and their modifiers (data access objects), however, are directly related to
database tables and therefore included in the persistence layer. The Hibernate interfaces
(query, transaction, annotation, session) in this context are used in the persistence layer
for database specific operations such as SQL query execution, transaction demarcation
and JDBC connection pooling, where the latter is handled by integration of the free soft-
ware c3p0 (http://sourceforge.net/projects/c3p0/, accessed october 2012) into the
Hibernate framework.
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Figure A.3: This snapshot of the graphical user interface shows a tree which includes
the patient data of a project. Leafs of the tree correspond to particular patient cases.
When selecting a leaf, the stored attributes of this patient concept are shown on the right
side. In order to protect anonymity, relevant identifying characteristics like identifiers
were altered in this example.
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Figure A.4: This snapshot of the database application presented in this work illustrates
the decision tree classification performance, which is retrieved by means of a ten-fold
cross-validation, for a target data set comprising the labels (classes) COPD vs. control.
